131.ww.38jjj.com

CHAPTER2018-13CommitteeSubstituteforCommitteeSubstituteforHouseBillNo.
21Anactrelatingtocontrolledsubstances;creatings.
456.
0301,F.
S.
;requiringcertainboardstorequirecertainregisteredpractitionerstocompleteaspecifiedboard-approvedcontinuingeducationcoursetoobtainauthor-izationtoprescribecontrolledsubstancesaspartofbienniallicenserenewalandbeforeaspecifieddate;providingcourserequirements;providingthatthecoursemaybeofferedinadistancelearningformatandrequiringthatitbeincludedwithinrequiredcontinuingeducationhours;prohibitingtheDepartmentofHealthfromrenewingthelicenseofaprescriberunderspecifiedcircumstances;specifyingadeadlineforcoursecompletion;providinganexceptionfromthecourserequirementsforcertainlicensees;requiringsuchlicenseestosubmitconfirmationofcoursecompletion;authorizingcertainboardstoadoptrules;amendings.
456.
072,F.
S.
;authorizingdisciplinaryactionagainstpractitionersforviolatingspecifiedprovisionsrelatingtocontrolledsubstances;amendings.
456.
44,F.
S.
;definingtheterm"acutepain";requiringtheapplicableboardstoadoptrulesestablishingcertainguidelinesforprescribingcontrolledsubstancesforacutepain;providingthatthefailureofaprescribertofollowspecifiedguidelinesisgroundsfordisciplinaryaction;limitingopioiddrugprescriptionsforthetreatmentofacutepaintoaspecifiedperiodundercertaincircumstances;authorizingsuchprescrip-tionsforanextendedperiodifspecifiedrequirementsaremet;requiringaprescriberwhoprescribesanopioiddrugforthetreatmentofpainotherthanacutepaintoincludeaspecificindicationontheprescription;requiringaprescriberwhoprescribesanopioiddrugforthetreatmentofpainrelatedtoatraumaticinjurywithaspecifiedInjurySeverityScoretoconcurrentlyprescribeanemergencyopioidantagonist;amendingss.
458.
3265and459.
0137,F.
S.
;requiringpainmanagementclinicstoregisterwiththedepartmentorholdavalidcertificateofexemption;requiringcertainclinicstoapplytothedepartmentforacertificateofexemption;providingrequirementsforsuchcertificates;requiringthedepartmenttoadoptrulesnecessarytoadministersuchexemptions;amendings.
465.
0155,F.
S.
;providingrequirementsforpharmacistsforthedispensingofcontrolledsubstancestopersonsnotknowntothem;definingtheterm"properidentification";amendings.
465.
0276,F.
S.
;prohibitingthedispensingofcertaincontrolledsubstancesinanamountthatexceedsa3-daysupplyunlesscertaincriteriaaremet;providinganexceptionforthedispensingofcertaincontrolledsubstancesbyapractitionertothepractitioner'sownpatientsforthemedication-assistedtreatmentofopiateaddiction;providingrequirementsforpractitionersforthedispensingofcontrolledsubstancestopersonsnotknowntothem;definingtheterm"properidentification";amendings.
893.
03,F.
S.
;correctingacross-reference;conformingthestatecontrolledsubstancesscheduletothefederalcontrolledsubstancesschedule;amendings.
1CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
893.
04,F.
S.
;authorizingapharmacisttodispensecontrolledsubstancesuponreceiptofanelectronicprescriptionifcertainconditionsaremet;amendings.
893.
055,F.
S.
;revisingandprovidingdefinitions;revisingrequirementsfortheprescriptiondrugmonitoringprogram;authorizingrulemaking;requiringdispenserstoreportinformationtothedepartmentforeachcontrolledsubstancedispensed;providingapplicability;requiringthedepartmenttomaintainanelectronicsystemforcertainpurposeswhichmeetsspecifiedrequirements;requiringcertaininformationtobereportedtothesystembyaspecifiedtime;specifyingdirectaccesstosysteminformation;authorizingthedepartmenttoenterintoreciprocalagreementsorcontractstoshareprescriptiondrugmonitoringinforma-tionwithcertainentities;providingrequirementsforsuchagreements;authorizingthedepartmenttoenterintoagreementsorcontractsforsecureconnectionswithpractitionerelectronicsystems;requiringspec-ifiedpersonstoconsultthesystemforcertainpurposeswithinaspecifiedtime;providingexceptionstothedutyofspecifiedpersonstoconsultthesystemundercertaincircumstances;requiringthedepartmenttoissuecitationstoprescribersordispenserswhofailtomeetspecifiedrequire-mentsrelatingtoconsultingthesystem;providingasystemfordisciplineofspecifiedpersonsforfailingtomeetsuchrequirements;prohibitingapersonfromfailingtoreportthedispensingofacontrolledsubstancewhenrequiredtodoso;specifyingpenalties;authorizingthedepartmenttoenterintoagreementsorcontractsforspecifiedpurposes;providingforthereleaseofinformationobtainedbythesystem;allowingspecifiedpersonstohavedirectaccesstoinformationforthepurposeofreviewingthecontrolleddrugprescriptionhistoryofapatient;providingprescriberordispenserimmunityfromliabilityforreviewofpatienthistorywhenactingingoodfaith;providingconstruction;prohibitingthedepartmentfromspecifiedusesoffunds;requiringthedepartmenttoconductorparticipateinstudiesforspecifiedpurposes;requiringanannualreporttobesubmittedtotheGovernorandLegislaturebyaspecifieddate;providingreportrequirements;authorizingthedepartmenttoestablishacertaindirect-supportorganizationforspecifiedpurposes;definingtheterm"direct-supportorganization";requiringadirect-supportorganiza-tiontooperateunderwrittencontractwiththedepartment;providingcontractrequirements;requiringthedirect-supportorganizationtoobtainwrittenapprovalfromthedepartmentforspecifiedpurposes;providingforanindependentannualfinancialauditbythedirect-supportorganization;providingthatcopiesofsuchauditbeprovidedtospecifiedentities;authorizingthedepartmenttoadoptcertainrulesrelatingtoresourcesusedbythedirect-supportorganization;providingforfuturerepealofprovisionsrelatingtothedirect-supportorganization;requiringthedepartmenttoadoptrulestoimplementthesystem;amendings.
893.
0551,F.
S.
;revisingprovisionsconcerningthereleaseofinformationheldbytheprescriptiondrugmonitoringprogram;amendings.
893.
13,F.
S.
;correctingcross-references;increasingtheseverityofafelonyforahealthcarepractitionerwhoprovidesorapersonwhoobtainscertaincontrolledsubstancesthatarenotmedicallynecessaryundercertaincircumstances;amendings.
893.
147,F.
S.
;prohibitinganypersonfromCh.
2018-13LAWSOFFLORIDACh.
2018-132CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
possessing,purchasing,delivering,selling,orpossessingwithintenttosellordeliveratabletingmachine,anencapsulatingmachine,orcontrolledsubstancecounterfeitingmaterialswithknowledge,intent,orreasonablecausetobelievethatitwillbeusedtomanufactureacontrolledsubstanceorcounterfeitcontrolledsubstance;providinganexceptionforpersonswhomeetcertaincriteria;definingterms;providingcriminalpenaltiesforpersonswhoviolatespecifiedprovisionsrelatingtotabletingmachines,encapsulatingmachines,andcontrolledsubstancecounter-feitingmaterials;amendingss.
458.
331,459.
015,463.
0055,782.
04,893.
135,and921.
0022,F.
S.
;correctingcross-references;conformingprovisionstochangesmadebytheact;providingappropriations;provid-ingeffectivedates.
BeItEnactedbytheLegislatureoftheStateofFlorida:Section1.
Section456.
0301,FloridaStatutes,iscreatedtoread:456.
0301Requirementforinstructiononcontrolledsubstanceprescrib-ing.
—(1)(a)TheappropriateboardshallrequireeachpersonregisteredwiththeUnitedStatesDrugEnforcementAdministrationandauthorizedtoprescribecontrolledsubstancespursuantto21U.
S.
C.
s.
822tocompleteaboard-approved2-hourcontinuingeducationcourseonprescribingcon-trolledsubstancesofferedbyastatewideprofessionalassociationofphysiciansinthisstatethatisaccreditedtoprovideeducationalactivitiesdesignatedfortheAmericanMedicalAssociationPhysician'sRecognitionAwardCategory1CreditortheAmericanOsteopathicCategory1-Acontinuingmedicaleducationcreditaspartofbienniallicenserenewal.
Thecoursemustincludeinformationonthecurrentstandardsforprescrib-ingcontrolledsubstances,particularlyopiates;alternativestothesestandards;nonpharmacologicaltherapies;prescribingemergencyopioidantagonists;andtherisksofopioidaddictionfollowingallstagesoftreatmentinthemanagementofacutepain.
Thecoursemaybeofferedinadistancelearningformatandmustbeincludedwithinthenumberofcontinuingeducationhoursrequiredbylaw.
ThedepartmentmaynotrenewthelicenseofanyprescriberregisteredwiththeUnitedStatesDrugEnforcementAdministrationtoprescribecontrolledsubstanceswhohasfailedtocompletethecourse.
ThecoursemustbecompletedbyJanuary31,2019,andateachsubsequentrenewal.
Thisparagraphdoesnotapplytoalicenseewhoisrequiredbyhisorherapplicablepracticeacttocompleteaminimumof2hoursofcontinuingeducationonthesafeandeffectiveprescribingofcontrolledsubstances.
(b)Eachpractitionerrequiredtocompletethecourserequiredinparagraph(a)shallsubmitconfirmationofhavingcompletedsuchcoursewhenapplyingforbienniallicenserenewal.
(c)EachlicensingboardthatrequiresalicenseetocompleteaneducationalcoursepursuanttothissubsectionmustincludethehoursCh.
2018-13LAWSOFFLORIDACh.
2018-133CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
requiredforcompletionofthecourseinthetotalhoursofcontinuingeducationrequiredbylawforsuchprofessionunlessthecontinuingeducationrequirementsforsuchprofessionconsistoffewerthan30hoursbiennially.
(2)Eachboardmayadoptrulestoadministerthissection.
Section2.
Paragraph(gg)ofsubsection(1)ofsection456.
072,FloridaStatutes,isamendedtoread:456.
072Groundsfordiscipline;penalties;enforcement.
—(1)Thefollowingactsshallconstitutegroundsforwhichthedisciplinaryactionsspecifiedinsubsection(2)maybetaken:(gg)Engaginginapatternofpracticewhenprescribingmedicinaldrugsorcontrolledsubstanceswhichdemonstratesalackofreasonableskillorsafetytopatients,aviolationofanyprovisionofthischapterorss.
893.
055and893.
0551,aviolationoftheapplicablepracticeact,oraviolationofanyrulesadoptedunderthischapterortheapplicablepracticeactoftheprescribingpractitioner.
Notwithstandings.
456.
073(13),thedepartmentmayinitiateaninvestigationandestablishsuchapatternfrombillingrecords,data,oranyotherinformationobtainedbythedepartment.
Section3.
Paragraphs(a)through(g)ofsubsection(1)ofsection456.
44,FloridaStatutes,areredesignatedasparagraphs(b)through(h),respec-tively,anewparagraph(a)isaddedtothatsubsection,subsection(3)ofthatsectionisamended,andsubsections(4),(5),and(6)areaddedtothatsection,toread:456.
44Controlledsubstanceprescribing.
—(1)DEFINITIONS.
—Asusedinthissection,theterm:(a)"Acutepain"meansthenormal,predicted,physiological,andtime-limitedresponsetoanadversechemical,thermal,ormechanicalstimulusassociatedwithsurgery,trauma,oracuteillness.
Thetermdoesnotincludepainrelatedto:1.
Cancer.
2.
Aterminalcondition.
Forpurposesofthissubparagraph,theterm"terminalcondition"meansaprogressivediseaseormedicalorsurgicalconditionthatcausessignificantfunctionalimpairment,isnotconsideredbyatreatingphysiciantobereversiblewithouttheadministrationoflife-sustainingprocedures,andwillresultindeathwithin1yearafterdiagnosisiftheconditionrunsitsnormalcourse.
3.
Palliativecaretoprovidereliefofsymptomsrelatedtoanincurable,progressiveillnessorinjury.
Ch.
2018-13LAWSOFFLORIDACh.
2018-134CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
4.
AtraumaticinjurywithanInjurySeverityScoreof9orgreater.
(3)STANDARDSOFPRACTICEFORTREATMENTOFCHRONICNONMALIGNANTPAIN.
—Thestandardsofpracticeinthissectiondonotsupersedethelevelofcare,skill,andtreatmentrecognizedingenerallawrelatedtohealthcarelicensure.
(a)Acompletemedicalhistoryandaphysicalexaminationmustbeconductedbeforebeginninganytreatmentandmustbedocumentedinthemedicalrecord.
Theexactcomponentsofthephysicalexaminationshallbelefttothejudgmentoftheregistrantwhoisexpectedtoperformaphysicalexaminationproportionatetothediagnosisthatjustifiesatreatment.
Themedicalrecordmust,ataminimum,documentthenatureandintensityofthepain,currentandpasttreatmentsforpain,underlyingorcoexistingdiseasesorconditions,theeffectofthepainonphysicalandpsychologicalfunction,areviewofpreviousmedicalrecords,previousdiagnosticstudies,andhistoryofalcoholandsubstanceabuse.
Themedicalrecordshallalsodocumentthepresenceofoneormorerecognizedmedicalindicationsfortheuseofacontrolledsubstance.
Eachregistrantmustdevelopawrittenplanforassessingeachpatient'sriskofaberrantdrug-relatedbehavior,whichmayincludepatientdrugtesting.
Registrantsmustassesseachpatient'sriskforaberrantdrug-relatedbehaviorandmonitorthatriskonanongoingbasisinaccordancewiththeplan.
(b)Eachregistrantmustdevelopawrittenindividualizedtreatmentplanforeachpatient.
Thetreatmentplanshallstateobjectivesthatwillbeusedtodeterminetreatmentsuccess,suchaspainreliefandimprovedphysicalandpsychosocialfunction,andshallindicateifanyfurtherdiagnosticevaluationsorothertreatmentsareplanned.
Aftertreatmentbegins,theregistrantshalladjustdrugtherapytotheindividualmedicalneedsofeachpatient.
Othertreatmentmodalities,includingarehabilitationprogram,shallbeconsidereddependingontheetiologyofthepainandtheextenttowhichthepainisassociatedwithphysicalandpsychosocialimpairment.
Theinterdisciplinarynatureofthetreatmentplanshallbedocumented.
(c)Theregistrantshalldiscusstherisksandbenefitsoftheuseofcontrolledsubstances,includingtherisksofabuseandaddiction,aswellasphysicaldependenceanditsconsequences,withthepatient,personsdesignatedbythepatient,orthepatient'ssurrogateorguardianifthepatientisincompetent.
Theregistrantshalluseawrittencontrolledsubstanceagreementbetweentheregistrantandthepatientoutliningthepatient'sresponsibilities,including,butnotlimitedto:1.
Numberandfrequencyofcontrolledsubstanceprescriptionsandrefills.
2.
Patientcomplianceandreasonsforwhichdrugtherapymaybediscontinued,suchasaviolationoftheagreement.
Ch.
2018-13LAWSOFFLORIDACh.
2018-135CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
3.
Anagreementthatcontrolledsubstancesforthetreatmentofchronicnonmalignantpainshallbeprescribedbyasingletreatingregistrantunlessotherwiseauthorizedbythetreatingregistrantanddocumentedinthemedicalrecord.
(d)Thepatientshallbeseenbytheregistrantatregularintervals,nottoexceed3months,toassesstheefficacyoftreatment,ensurethatcontrolledsubstancetherapyremainsindicated,evaluatethepatient'sprogresstowardtreatmentobjectives,consideradversedrugeffects,andreviewtheetiologyofthepain.
Continuationormodificationoftherapyshalldependontheregistrant'sevaluationofthepatient'sprogress.
Iftreatmentgoalsarenotbeingachieved,despitemedicationadjustments,theregistrantshallreevaluatetheappropriatenessofcontinuedtreatment.
Theregistrantshallmonitorpatientcomplianceinmedicationusage,relatedtreatmentplans,controlledsubstanceagreements,andindicationsofsubstanceabuseordiversionataminimumof3-monthintervals.
(e)Theregistrantshallreferthepatientasnecessaryforadditionalevaluationandtreatmentinordertoachievetreatmentobjectives.
Specialattentionshallbegiventothosepatientswhoareatriskformisusingtheirmedicationsandthosewhoselivingarrangementsposeariskformedicationmisuseordiversion.
Themanagementofpaininpatientswithahistoryofsubstanceabuseorwithacomorbidpsychiatricdisorderrequiresextracare,monitoring,anddocumentationandrequiresconsultationwithorreferraltoanaddictionmedicinespecialistorapsychiatrist.
(f)Aregistrantmustmaintainaccurate,current,andcompleterecordsthatareaccessibleandreadilyavailableforreviewandcomplywiththerequirementsofthissection,theapplicablepracticeact,andapplicableboardrules.
Themedicalrecordsmustinclude,butarenotlimitedto:1.
Thecompletemedicalhistoryandaphysicalexamination,includinghistoryofdrugabuseordependence.
2.
Diagnostic,therapeutic,andlaboratoryresults.
3.
Evaluationsandconsultations.
4.
Treatmentobjectives.
5.
Discussionofrisksandbenefits.
6.
Treatments.
7.
Medications,includingdate,type,dosage,andquantityprescribed.
8.
Instructionsandagreements.
9.
Periodicreviews.
10.
Resultsofanydrugtesting.
Ch.
2018-13LAWSOFFLORIDACh.
2018-136CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
11.
Aphotocopyofthepatient'sgovernment-issuedphotoidentification.
12.
Ifawrittenprescriptionforacontrolledsubstanceisgiventothepatient,aduplicateoftheprescription.
13.
Theregistrant'sfullnamepresentedinalegiblemanner.
(g)Aregistrantshallimmediatelyreferpatientswithsignsorsymptomsofsubstanceabusetoaboard-certifiedpainmanagementphysician,anaddictionmedicinespecialist,oramentalhealthaddictionfacilityasitpertainstodrugabuseoraddictionunlesstheregistrantisaphysicianwhoisboard-certifiedorboard-eligibleinpainmanagement.
Throughouttheperiodoftimebeforereceivingtheconsultant'sreport,aprescribingregistrantshallclearlyandcompletelydocumentmedicaljustificationforcontinuedtreatmentwithcontrolledsubstancesandthosestepstakentoensuremedicallyappropriateuseofcontrolledsubstancesbythepatient.
Uponreceiptoftheconsultant'swrittenreport,theprescribingregistrantshallincorporatetheconsultant'srecommendationsforcontinuing,modify-ing,ordiscontinuingcontrolledsubstancetherapy.
Theresultingchangesintreatmentshallbespecificallydocumentedinthepatient'smedicalrecord.
Evidenceorbehavioralindicationsofdiversionshallbefollowedbydiscontinuationofcontrolledsubstancetherapy,andthepatientshallbedischarged,andallresultsoftestingandactionstakenbytheregistrantshallbedocumentedinthepatient'smedicalrecord.
Thissubsectiondoesnotapplytoaboard-eligibleorboard-certifiedanesthesiologist,physiatrist,rheumatologist,orneurologist,ortoaboard-certifiedphysicianwhohassurgicalprivilegesatahospitalorambulatorysurgerycenterandprimarilyprovidessurgicalservices.
Thissubsectiondoesnotapplytoaboard-eligibleorboard-certifiedmedicalspecialistwhohasalsocompletedafellowshipinpainmedicineapprovedbytheAccred-itationCouncilforGraduateMedicalEducationortheAmericanOsteo-pathicAssociation,orwhoisboardeligibleorboardcertifiedinpainmedicinebytheAmericanBoardofPainMedicine,theAmericanBoardofInterventionalPainPhysicians,theAmericanAssociationofPhysicianSpecialists,oraboardapprovedbytheAmericanBoardofMedicalSpecialtiesortheAmericanOsteopathicAssociationandperformsinter-ventionalpainproceduresofthetyperoutinelybilledusingsurgicalcodes.
Thissubsectiondoesnotapplytoaregistrantwhoprescribesmedicallynecessarycontrolledsubstancesforapatientduringaninpatientstayinahospitallicensedunderchapter395.
(4)STANDARDSOFPRACTICEFORTREATMENTOFACUTEPAIN.
Theapplicableboardsshalladoptrulesestablishingguidelinesforprescrib-ingcontrolledsubstancesforacutepain,includingevaluationofthepatient,creationandmaintenanceofatreatmentplan,obtaininginformedconsentandagreementfortreatment,periodicreviewofthetreatmentplan,consultation,medicalrecordreview,andcompliancewithcontrolledsub-stancelawsandregulations.
FailureofaprescribertofollowsuchguidelinesCh.
2018-13LAWSOFFLORIDACh.
2018-137CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
constitutesgroundsfordisciplinaryactionpursuanttos.
456.
072(1)(gg),punishableasprovidedins.
456.
072(2).
(5)PRESCRIPTIONSUPPLY.
—(a)Forthetreatmentofacutepain,aprescriptionforanopioiddruglistedasaScheduleIIcontrolledsubstanceins.
893.
03or21U.
S.
C.
s.
812maynotexceeda3-daysupply,exceptthatuptoa7-daysupplymaybeprescribedif:1.
Theprescriber,inhisorherprofessionaljudgment,believesthatmorethana3-daysupplyofsuchanopioidismedicallynecessarytotreatthepatient'spainasanacutemedicalcondition;2.
Theprescriberindicates"ACUTEPAINEXCEPTION"onthepre-scription;and3.
Theprescriberadequatelydocumentsinthepatient'smedicalrecordstheacutemedicalconditionandlackofalternativetreatmentoptionsthatjustifydeviationfromthe3-daysupplylimitestablishedinthissubsection.
(b)Forthetreatmentofpainotherthanacutepain,aprescribermustindicate"NONACUTEPAIN"onaprescriptionforanopioiddruglistedasaScheduleIIcontrolledsubstanceins.
893.
03or21U.
S.
C.
s.
812.
(6)EMERGENCYOPIOIDANTAGONIST.
—ForthetreatmentofpainrelatedtoatraumaticinjurywithanInjurySeverityScoreof9orgreater,aprescriberwhoprescribesaScheduleIIcontrolledsubstancelistedins.
893.
03or21U.
S.
C.
s.
812mustconcurrentlyprescribeanemergencyopioidantagonist,asdefinedins.
381.
887(1).
Section4.
EffectiveJanuary1,2019,presentsubsections(2)through(5)ofsection458.
3265,FloridaStatutes,arerenumberedassubsections(3)through(6),respectively,paragraphs(a)and(g)ofsubsection(1),paragraph(a)ofpresentsubsection(2),paragraph(a)ofpresentsubsection(3),andparagraph(a)ofpresentsubsection(4)ofthatsectionareamended,andanewsubsection(2)isaddedtothatsection,toread:458.
3265Pain-managementclinics.
—(1)REGISTRATION.
—(a)1.
Asusedinthissection,theterm:a.
"Boardeligible"meanssuccessfulcompletionofananesthesia,physicalmedicineandrehabilitation,rheumatology,orneurologyresidencyprogramapprovedbytheAccreditationCouncilforGraduateMedicalEducationortheAmericanOsteopathicAssociationforaperiodof6yearsfromsuccessfulcompletionofsuchresidencyprogram.
Ch.
2018-13LAWSOFFLORIDACh.
2018-138CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
b.
"Chronicnonmalignantpain"meanspainunrelatedtocancerwhichpersistsbeyondtheusualcourseofdiseaseortheinjurythatisthecauseofthepainormorethan90daysaftersurgery.
c.
"Pain-managementclinic"or"clinic"meansanypubliclyorprivatelyownedfacility:(I)Thatadvertisesinanymediumforanytypeofpain-managementservices;or(II)Whereinanymonthamajorityofpatientsareprescribedopioids,benzodiazepines,barbiturates,orcarisoprodolforthetreatmentofchronicnonmalignantpain.
2.
Eachpain-managementclinicmustregisterwiththedepartmentorholdavalidcertificateofexemptionpursuanttosubsection(2).
3.
Thefollowingclinicsareexemptfromtheregistrationrequirementofparagraphs(c)-(m)andmustapplytothedepartmentforacertificateofexemptionunless:a.
AThatclinicislicensedasafacilitypursuanttochapter395;b.
Aclinicinwhichthemajorityofthephysicianswhoprovideservicesintheclinicprimarilyprovidesurgicalservices;c.
ATheclinicisownedbyapubliclyheldcorporationwhosesharesaretradedonanationalexchangeorontheover-the-countermarketandwhosetotalassetsattheendofthecorporation'smostrecentfiscalquarterexceeded$50million;d.
ATheclinicisaffiliatedwithanaccreditedmedicalschoolatwhichtrainingisprovidedformedicalstudents,residents,orfellows;e.
ATheclinicthatdoesnotprescribecontrolledsubstancesforthetreatmentofpain;f.
ATheclinicisownedbyacorporateentityexemptfromfederaltaxationunder26U.
S.
C.
s.
501(c)(3);g.
AThecliniciswhollyownedandoperatedbyoneormoreboard-eligibleorboard-certifiedanesthesiologists,physiatrists,rheumatologists,orneurologists;orh.
AThecliniciswhollyownedandoperatedbyaphysicianmulti-specialtypracticewhereoneormoreboard-eligibleorboard-certifiedmedicalspecialists,whohavealsocompletedfellowshipsinpainmedicineapprovedbytheAccreditationCouncilforGraduateMedicalEducationorwhoarealsoboard-certifiedinpainmedicinebytheAmericanBoardofPainMedicineoraboardapprovedbytheAmericanBoardofMedicalSpecialties,theAmericanAssociationofPhysicianSpecialists,ortheAmericanCh.
2018-13LAWSOFFLORIDACh.
2018-139CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
OsteopathicAssociation,performinterventionalpainproceduresofthetyperoutinelybilledusingsurgicalcodes.
(g)Thedepartmentmayrevoketheclinic'scertificateofregistrationandprohibitallphysiciansassociatedwiththatpain-managementclinicfrompracticingatthatcliniclocationbaseduponanannualinspectionandevaluationofthefactorsdescribedinsubsection(4)(3).
(2)CERTIFICATEOFEXEMPTION.
—(a)Apainmanagementclinicclaiminganexemptionfromtheregistra-tionrequirementsofsubsection(1)mustapplyforacertificateofexemptiononaformadoptedinrulebythedepartment.
Theformmustrequiretheapplicanttoprovide:1.
Thenameornamesunderwhichtheapplicantdoesbusiness.
2.
Theaddressatwhichthepainmanagementclinicislocated.
3.
Thespecificexemptiontheapplicantisclaimingwithsupportingdocumentation.
4.
Anyotherinformationdeemednecessarybythedepartment.
(b)Thedepartmentmustapproveordenythecertificatewithin30daysafterthereceiptofacompleteapplication.
(c)Thecertificateofexemptionmustberenewedbiennially,exceptthatthedepartmentmayissuetheinitialcertificatesofexemptionforupto3yearsinordertostaggerrenewaldates.
(d)Acertificateholdermustprominentlydisplaythecertificateofexemptionandmakeitavailabletothedepartmentortheboarduponrequest.
(e)Anewcertificateofexemptionisrequiredforachangeofaddressandisnottransferable.
Acertificateofexemptionisvalidonlyfortheapplicant,qualifyingowners,licenses,registrations,certifications,andservicespro-videdunderaspecificstatutoryexemptionandisvalidonlytothespecificexemptionclaimedandgranted.
(f)Acertificateholdermustnotifythedepartmentatleast60daysbeforeanyanticipatedrelocationornamechangeofthepainmanagementclinicorachangeofownership.
(g)Ifapainmanagementclinicnolongerqualifiesforacertificateofexemption,thecertificateholdermustnotifythedepartmentwithin3daysafterbecomingawarethattheclinicnolongerqualifiesforacertificateofexemptionandregisterasapainmanagementclinicundersubsection(1)orceaseoperations.
Ch.
2018-13LAWSOFFLORIDACh.
2018-1310CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
(3)(2)PHYSICIANRESPONSIBILITIES.
—Theseresponsibilitiesapplytoanyphysicianwhoprovidesprofessionalservicesinapain-managementclinicthatisrequiredtoberegisteredinsubsection(1).
(a)Aphysicianmaynotpracticemedicineinapain-managementclinic,asdescribedinsubsection(5)(4),ifthepain-managementclinicisnotregisteredwiththedepartmentasrequiredbythissection.
Anyphysicianwhoqualifiestopracticemedicineinapain-managementclinicpursuanttorulesadoptedbytheBoardofMedicineasofJuly1,2012,maycontinuetopracticemedicineinapain-managementclinicaslongasthephysiciancontinuestomeetthequalificationssetforthintheboardrules.
Aphysicianwhoviolatesthisparagraphissubjecttodisciplinaryactionbyhisorherappropriatemedicalregulatoryboard.
(4)(3)INSPECTION.
—(a)Thedepartmentshallinspectthepain-managementclinicannually,includingareviewofthepatientrecords,toensurethatitcomplieswiththissectionandtherulesoftheBoardofMedicineadoptedpursuanttosubsection(5)(4)unlesstheclinicisaccreditedbyanationallyrecognizedaccreditingagencyapprovedbytheBoardofMedicine.
(5)(4)RULEMAKING.
—(a)Thedepartmentshalladoptrulesnecessarytoadministertheregistration,exemption,andinspectionofpain-managementclinicswhichestablishthespecificrequirements,procedures,forms,andfees.
Section5.
EffectiveJanuary1,2019,presentsubsections(2)through(5)ofsection459.
0137,FloridaStatutes,arerenumberedassubsections(3)through(6),respectively,paragraphs(a)and(g)ofsubsection(1),paragraph(a)ofpresentsubsection(2),paragraph(a)ofpresentsubsection(3),andparagraph(a)ofpresentsubsection(4)ofthatsectionareamended,andanewsubsection(2)isaddedtothatsection,toread:459.
0137Pain-managementclinics.
—(1)REGISTRATION.
—(a)1.
Asusedinthissection,theterm:a.
"Boardeligible"meanssuccessfulcompletionofananesthesia,physicalmedicineandrehabilitation,rheumatology,orneurologyresidencyprogramapprovedbytheAccreditationCouncilforGraduateMedicalEducationortheAmericanOsteopathicAssociationforaperiodof6yearsfromsuccessfulcompletionofsuchresidencyprogram.
b.
"Chronicnonmalignantpain"meanspainunrelatedtocancerwhichpersistsbeyondtheusualcourseofdiseaseortheinjurythatisthecauseofthepainormorethan90daysaftersurgery.
Ch.
2018-13LAWSOFFLORIDACh.
2018-1311CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
c.
"Pain-managementclinic"or"clinic"meansanypubliclyorprivatelyownedfacility:(I)Thatadvertisesinanymediumforanytypeofpain-managementservices;or(II)Whereinanymonthamajorityofpatientsareprescribedopioids,benzodiazepines,barbiturates,orcarisoprodolforthetreatmentofchronicnonmalignantpain.
2.
Eachpain-managementclinicmustregisterwiththedepartmentorholdavalidcertificateofexemptionpursuanttosubsection(2).
3.
Thefollowingclinicsareexemptfromtheregistrationrequirementofparagraphs(c)-(m)andmustapplytothedepartmentforacertificateofexemptionunless:a.
AThatclinicislicensedasafacilitypursuanttochapter395;b.
Aclinicinwhichthemajorityofthephysicianswhoprovideservicesintheclinicprimarilyprovidesurgicalservices;c.
ATheclinicisownedbyapubliclyheldcorporationwhosesharesaretradedonanationalexchangeorontheover-the-countermarketandwhosetotalassetsattheendofthecorporation'smostrecentfiscalquarterexceeded$50million;d.
ATheclinicisaffiliatedwithanaccreditedmedicalschoolatwhichtrainingisprovidedformedicalstudents,residents,orfellows;e.
ATheclinicthatdoesnotprescribecontrolledsubstancesforthetreatmentofpain;f.
ATheclinicisownedbyacorporateentityexemptfromfederaltaxationunder26U.
S.
C.
s.
501(c)(3);g.
AThecliniciswhollyownedandoperatedbyoneormoreboard-eligibleorboard-certifiedanesthesiologists,physiatrists,rheumatologists,orneurologists;orh.
AThecliniciswhollyownedandoperatedbyaphysicianmulti-specialtypracticewhereoneormoreboard-eligibleorboard-certifiedmedicalspecialists,whohavealsocompletedfellowshipsinpainmedicineapprovedbytheAccreditationCouncilforGraduateMedicalEducationortheAmericanOsteopathicAssociationorwhoarealsoboard-certifiedinpainmedicinebytheAmericanBoardofPainMedicineoraboardapprovedbytheAmericanBoardofMedicalSpecialties,theAmericanAssociationofPhysicianSpecialists,ortheAmericanOsteopathicAssociation,performinterventionalpainproceduresofthetyperoutinelybilledusingsurgicalcodes.
Ch.
2018-13LAWSOFFLORIDACh.
2018-1312CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
(g)Thedepartmentmayrevoketheclinic'scertificateofregistrationandprohibitallphysiciansassociatedwiththatpain-managementclinicfrompracticingatthatcliniclocationbaseduponanannualinspectionandevaluationofthefactorsdescribedinsubsection(4)(3).
(2)CERTIFICATEOFEXEMPTION.
—(a)Apainmanagementclinicclaiminganexemptionfromtheregistra-tionrequirementsofsubsection(1)mustapplyforacertificateofexemptiononaformadoptedinrulebythedepartment.
Theformmustrequiretheapplicanttoprovide:1.
Thenameornamesunderwhichtheapplicantdoesbusiness.
2.
Theaddressatwhichthepainmanagementclinicislocated.
3.
Thespecificexemptiontheapplicantisclaimingwithsupportingdocumentation.
4.
Anyotherinformationdeemednecessarybythedepartment.
(b)Thedepartmentmustapproveordenythecertificatewithin30daysafterthereceiptofacompleteapplication.
(c)Thecertificateofexemptionmustberenewedbiennially,exceptthatthedepartmentmayissuetheinitialcertificatesofexemptionforupto3yearsinordertostaggerrenewaldates.
(d)Acertificateholdermustprominentlydisplaythecertificateofexemptionandmakeitavailabletothedepartmentortheboarduponrequest.
(e)Anewcertificateofexemptionisrequiredforachangeofaddressandisnottransferable.
Acertificateofexemptionisvalidonlyfortheapplicant,qualifyingowners,licenses,registrations,certifications,andservicespro-videdunderaspecificstatutoryexemptionandisvalidonlytothespecificexemptionclaimedandgranted.
(f)Acertificateholdermustnotifythedepartmentatleast60daysbeforeanyanticipatedrelocationornamechangeofthepainmanagementclinicorachangeofownership.
(g)Ifapainmanagementclinicnolongerqualifiesforacertificateofexemption,thecertificateholdermustnotifythedepartmentwithin3daysafterbecomingawarethattheclinicnolongerqualifiesforacertificateofexemptionandregisterasapainmanagementclinicundersubsection(1)orceaseoperations.
(3)(2)PHYSICIANRESPONSIBILITIES.
—Theseresponsibilitiesapplytoanyosteopathicphysicianwhoprovidesprofessionalservicesinapain-managementclinicthatisrequiredtoberegisteredinsubsection(1).
Ch.
2018-13LAWSOFFLORIDACh.
2018-1313CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
(a)Anosteopathicphysicianmaynotpracticemedicineinapain-managementclinic,asdescribedinsubsection(5)(4),ifthepain-manage-mentclinicisnotregisteredwiththedepartmentasrequiredbythissection.
Anyphysicianwhoqualifiestopracticemedicineinapain-managementclinicpursuanttorulesadoptedbytheBoardofOsteopathicMedicineasofJuly1,2012,maycontinuetopracticemedicineinapain-managementclinicaslongasthephysiciancontinuestomeetthequalificationssetforthintheboardrules.
Anosteopathicphysicianwhoviolatesthisparagraphissubjecttodisciplinaryactionbyhisorherappropriatemedicalregulatoryboard.
(4)(3)INSPECTION.
—(a)Thedepartmentshallinspectthepain-managementclinicannually,includingareviewofthepatientrecords,toensurethatitcomplieswiththissectionandtherulesoftheBoardofOsteopathicMedicineadoptedpursuanttosubsection(5)(4)unlesstheclinicisaccreditedbyanationallyrecognizedaccreditingagencyapprovedbytheBoardofOsteopathicMedicine.
(5)(4)RULEMAKING.
—(a)Thedepartmentshalladoptrulesnecessarytoadministertheregistration,exemption,andinspectionofpain-managementclinicswhichestablishthespecificrequirements,procedures,forms,andfees.
Section6.
Section465.
0155,FloridaStatutes,isamendedtoread:465.
0155Standardsofpractice.
—(1)Consistentwiththeprovisionsofthisact,theboardshalladoptbyrulestandardsofpracticerelatingtothepracticeofpharmacywhichshallbebindingoneverystateagencyandshallbeappliedbysuchagencieswhenenforcingorimplementinganyauthoritygrantedbyanyapplicablestatute,rule,orregulation,whetherfederalorstate.
(2)(a)Beforedispensingacontrolledsubstancetoapersonnotknowntothepharmacist,thepharmacistmustrequirethepersonpurchasing,receiving,orotherwiseacquiringthecontrolledsubstancetopresentvalidphotographicidentificationorotherverificationofhisorheridentity.
Ifthepersondoesnothaveproperidentification,thepharmacistmayverifythevalidityoftheprescriptionandtheidentityofthepatientwiththeprescriberorhisorherauthorizedagent.
Verificationofhealthplaneligibilitythroughareal-timeinquiryoradjudicationsystemisconsideredtobeproperidentification.
(b)Thissubsectiondoesnotapplyinaninstitutionalsettingortoalong-termcarefacility,including,butnotlimitedto,anassistedlivingfacilityorahospitaltowhichpatientsareadmitted.
(c)Asusedinthissubsection,theterm"properidentification"meansanidentificationthatisissuedbyastateortheFederalGovernmentcontainingCh.
2018-13LAWSOFFLORIDACh.
2018-1314CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
theperson'sphotograph,printedname,andsignatureoradocumentconsideredacceptableunder8C.
F.
R.
s.
274a.
2(b)(1)(v)(A)and(B).
Section7.
Paragraph(b)ofsubsection(1)ofsection465.
0276,FloridaStatutes,isamended,andparagraph(d)isaddedtosubsection(2)ofthatsection,toread:465.
0276Dispensingpractitioner.
—(1)(b)ApractitionerregisteredunderthissectionmaynotdispenseacontrolledsubstancelistedinScheduleIIorScheduleIIIasprovidedins.
893.
03.
Thisparagraphdoesnotapplyto:1.
Thedispensingofcomplimentarypackagesofmedicinaldrugswhicharelabeledasadrugsampleorcomplimentarydrugasdefinedins.
499.
028tothepractitioner'sownpatientsintheregularcourseofherorhispracticewithoutthepaymentofafeeorremunerationofanykind,whetherdirectorindirect,asprovidedinsubsection(4).
2.
ThedispensingofcontrolledsubstancesinthehealthcaresystemoftheDepartmentofCorrections.
3.
ThedispensingofacontrolledsubstancelistedinScheduleIIorScheduleIIIinconnectionwiththeperformanceofasurgicalprocedure.
a.
ForanopioiddruglistedasaScheduleIIcontrolledsubstanceins.
893.
03or21U.
S.
C.
s.
812:(I)Forthetreatmentofacutepain,theamountdispensedpursuanttothissubparagraphmaynotexceeda3-daysupply,ora7-daysupplyifthecriteriains.
456.
44(5)(a)aremet.
(II)Forthetreatmentofpainotherthanacutepain,apractitionermustindicate"NONACUTEPAIN"onaprescription.
(III)ForthetreatmentofpainrelatedtoatraumaticinjurywithanInjurySeverityScoreof9orgreater,apractitionermustconcurrentlyprescribeanemergencyopioidantagonist,asdefinedins.
381.
887(1).
b.
ForacontrolledsubstancelistedinScheduleIII,theamountdispensedpursuanttothisthesubparagraphmaynotexceeda14-daysupply.
c.
TheexceptioninthissubparagraphexceptiondoesnotallowforthedispensingofacontrolledsubstancelistedinScheduleIIorScheduleIIImorethan14daysaftertheperformanceofthesurgicalprocedure.
d.
Forpurposesofthissubparagraph,theterm"surgicalprocedure"meansanyprocedureinanysettingwhichinvolves,orreasonablyshouldinvolve:Ch.
2018-13LAWSOFFLORIDACh.
2018-1315CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
(I)a.
Perioperativemedicationandsedationthatallowsthepatienttotolerateunpleasantprocedureswhilemaintainingadequatecardiorespira-toryfunctionandtheabilitytorespondpurposefullytoverbalortactilestimulationandmakesintra-andpostoperativemonitoringnecessary;or(II)b.
Theuseofgeneralanesthesiaormajorconductionanesthesiaandpreoperativesedation.
4.
ThedispensingofacontrolledsubstancelistedinScheduleIIorScheduleIIIpursuanttoanapprovedclinicaltrial.
Forpurposesofthissubparagraph,theterm"approvedclinicaltrial"meansaclinicalresearchstudyorclinicalinvestigationthat,inwholeorinpart,isstateorfederallyfundedorisconductedunderaninvestigationalnewdrugapplicationthatisreviewedbytheUnitedStatesFoodandDrugAdministration.
5.
Thedispensingofmethadoneinafacilitylicensedunders.
397.
427wheremedication-assistedtreatmentforopiateaddictionisprovided.
6.
ThedispensingofacontrolledsubstancelistedinScheduleIIorScheduleIIItoapatientofafacilitylicensedunderpartIVofchapter400.
7.
ThedispensingofcontrolledsubstanceslistedinScheduleIIorScheduleIIIwhichhavebeenapprovedbytheUnitedStatesFoodandDrugAdministrationforthepurposeoftreatingopiateaddictions,including,butnotlimitedto,buprenorphineandbuprenorphinecombinationproducts,byapractitionerauthorizedunder21U.
S.
C.
s.
823,asamended,tothepractitioner'sownpatientsforthemedication-assistedtreatmentofopiateaddiction.
(2)Apractitionerwhodispensesmedicinaldrugsforhumanconsump-tionforfeeorremunerationofanykind,whetherdirectorindirect,must:(d)1.
Beforedispensingacontrolledsubstancetoapersonnotknowntothedispenser,requirethepersonpurchasing,receiving,orotherwiseacquiringthecontrolledsubstancetopresentvalidphotographicidentifica-tionorotherverificationofhisorheridentity.
Ifthepersondoesnothaveproperidentification,thedispensermayverifythevalidityoftheprescrip-tionandtheidentityofthepatientwiththeprescriberorhisorherauthorizedagent.
Verificationofhealthplaneligibilitythroughareal-timeinquiryoradjudicationsystemisconsideredtobeproperidentification.
2.
Thisparagraphdoesnotapplyinaninstitutionalsettingortoalong-termcarefacility,including,butnotlimitedto,anassistedlivingfacilityorahospitaltowhichpatientsareadmitted.
3.
Asusedinthisparagraph,theterm"properidentification"meansanidentificationthatisissuedbyastateortheFederalGovernmentcontainingtheperson'sphotograph,printedname,andsignatureoradocumentconsideredacceptableunder8C.
F.
R.
s.
274a.
2(b)(1)(v)(A)and(B).
Ch.
2018-13LAWSOFFLORIDACh.
2018-1316CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
Section8.
Paragraph(c)ofsubsection(1)andsubsections(2)through(5)ofsection893.
03,FloridaStatutes,areamendedtoread:893.
03Standardsandschedules.
—Thesubstancesenumeratedinthissectionarecontrolledbythischapter.
ThecontrolledsubstanceslistedortobelistedinSchedulesI,II,III,IV,andVareincludedbywhateverofficial,common,usual,chemical,tradename,orclassdesignated.
Theprovisionsofthissectionshallnotbeconstruedtoincludewithinanyoftheschedulescontainedinthissectionanyexcludeddrugslistedwithinthepurviewof21C.
F.
R.
s.
1308.
22,styled"ExcludedSubstances";21C.
F.
R.
s.
1308.
24,styled"ExemptChemicalPreparations";21C.
F.
R.
s.
1308.
32,styled"ExemptedPrescriptionProducts";or21C.
F.
R.
s.
1308.
34,styled"ExemptAnabolicSteroidProducts.
"(1)SCHEDULEI.
—AsubstanceinScheduleIhasahighpotentialforabuseandhasnocurrentlyacceptedmedicaluseintreatmentintheUnitedStatesandinitsuseundermedicalsupervisiondoesnotmeetacceptedsafetystandards.
ThefollowingsubstancesarecontrolledinScheduleI:(c)Unlessspecificallyexceptedorunlesslistedinanotherschedule,anymaterial,compound,mixture,orpreparationthatcontainsanyquantityofthefollowinghallucinogenicsubstancesorthatcontainsanyoftheirsalts,isomers,includingoptical,positional,orgeometricisomers,homologues,nitrogen-heterocyclicanalogs,esters,ethers,andsaltsofisomers,homo-logues,nitrogen-heterocyclicanalogs,esters,orethers,iftheexistenceofsuchsalts,isomers,andsaltsofisomersispossiblewithinthespecificchemicaldesignationorclassdescription:1.
Alpha-Ethyltryptamine.
2.
4-Methylaminorex(2-Amino-4-methyl-5-phenyl-2-oxazoline).
3.
Aminorex(2-Amino-5-phenyl-2-oxazoline).
4.
DOB(4-Bromo-2,5-dimethoxyamphetamine).
5.
2C-B(4-Bromo-2,5-dimethoxyphenethylamine).
6.
Bufotenine.
7.
Cannabis.
8.
Cathinone.
9.
DET(Diethyltryptamine).
10.
2,5-Dimethoxyamphetamine.
11.
DOET(4-Ethyl-2,5-Dimethoxyamphetamine).
12.
DMT(Dimethyltryptamine).
Ch.
2018-13LAWSOFFLORIDACh.
2018-1317CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
13.
PCE(N-Ethyl-1-phenylcyclohexylamine)(Ethylamineanalogofphencyclidine).
14.
JB-318(N-Ethyl-3-piperidylbenzilate).
15.
N-Ethylamphetamine.
16.
Fenethylline.
17.
3,4-Methylenedioxy-N-hydroxyamphetamine.
18.
Ibogaine.
19.
LSD(Lysergicaciddiethylamide).
20.
Mescaline.
21.
Methcathinone.
22.
5-Methoxy-3,4-methylenedioxyamphetamine.
23.
PMA(4-Methoxyamphetamine).
24.
PMMA(4-Methoxymethamphetamine).
25.
DOM(4-Methyl-2,5-dimethoxyamphetamine).
26.
MDEA(3,4-Methylenedioxy-N-ethylamphetamine).
27.
MDA(3,4-Methylenedioxyamphetamine).
28.
JB-336(N-Methyl-3-piperidylbenzilate).
29.
N,N-Dimethylamphetamine.
30.
Parahexyl.
31.
Peyote.
32.
PCPY(N-(1-Phenylcyclohexyl)-pyrrolidine)(Pyrrolidineanalogofphencyclidine).
33.
Psilocybin.
34.
Psilocyn.
35.
Salviadivinorum,exceptforanydrugproductapprovedbytheUnitedStatesFoodandDrugAdministrationwhichcontainsSalviadivinorumoritsisomers,esters,ethers,salts,andsaltsofisomers,esters,andethers,iftheexistenceofsuchisomers,esters,ethers,andsaltsispossiblewithinthespecificchemicaldesignation.
Ch.
2018-13LAWSOFFLORIDACh.
2018-1318CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
36.
SalvinorinA,exceptforanydrugproductapprovedbytheUnitedStatesFoodandDrugAdministrationwhichcontainsSalvinorinAoritsisomers,esters,ethers,salts,andsaltsofisomers,esters,andethers,iftheexistenceofsuchisomers,esters,ethers,andsaltsispossiblewithinthespecificchemicaldesignation.
37.
Xylazine.
38.
TCP(1-[1-(2-Thienyl)-cyclohexyl]-piperidine)(Thiopheneanalogofphencyclidine).
39.
3,4,5-Trimethoxyamphetamine.
40.
Methylone(3,4-Methylenedioxymethcathinone).
41.
MDPV(3,4-Methylenedioxypyrovalerone).
42.
Methylmethcathinone.
43.
Methoxymethcathinone.
44.
Fluoromethcathinone.
45.
Methylethcathinone.
46.
CP47,497(2-(3-Hydroxycyclohexyl)-5-(2-methyloctan-2-yl)phenol)anditsdimethyloctyl(C8)homologue.
47.
HU-210[(6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methy-loctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol].
48.
JWH-018(1-Pentyl-3-(1-naphthoyl)indole).
49.
JWH-073(1-Butyl-3-(1-naphthoyl)indole).
50.
JWH-200(1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole).
51.
BZP(Benzylpiperazine).
52.
Fluorophenylpiperazine.
53.
Methylphenylpiperazine.
54.
Chlorophenylpiperazine.
55.
Methoxyphenylpiperazine.
56.
DBZP(1,4-Dibenzylpiperazine).
57.
TFMPP(Trifluoromethylphenylpiperazine).
58.
MBDB(Methylbenzodioxolylbutanamine)or(3,4-Methylenedioxy-N-methylbutanamine).
Ch.
2018-13LAWSOFFLORIDACh.
2018-1319CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
59.
5-Hydroxy-AMT(5-Hydroxy-alpha-methyltryptamine).
60.
5-Hydroxy-N-methyltryptamine.
61.
5-MeO-MiPT(5-Methoxy-N-methyl-N-isopropyltryptamine).
62.
5-MeO-AMT(5-Methoxy-alpha-methyltryptamine).
63.
Methyltryptamine.
64.
5-MeO-DMT(5-Methoxy-N,N-dimethyltryptamine).
65.
5-Me-DMT(5-Methyl-N,N-dimethyltryptamine).
66.
Tyramine(4-Hydroxyphenethylamine).
67.
5-MeO-DiPT(5-Methoxy-N,N-Diisopropyltryptamine).
68.
DiPT(N,N-Diisopropyltryptamine).
69.
DPT(N,N-Dipropyltryptamine).
70.
4-Hydroxy-DiPT(4-Hydroxy-N,N-diisopropyltryptamine).
71.
5-MeO-DALT(5-Methoxy-N,N-Diallyltryptamine).
72.
DOI(4-Iodo-2,5-dimethoxyamphetamine).
73.
DOC(4-Chloro-2,5-dimethoxyamphetamine).
74.
2C-E(4-Ethyl-2,5-dimethoxyphenethylamine).
75.
2C-T-4(4-Isopropylthio-2,5-dimethoxyphenethylamine).
76.
2C-C(4-Chloro-2,5-dimethoxyphenethylamine).
77.
2C-T(4-Methylthio-2,5-dimethoxyphenethylamine).
78.
2C-T-2(4-Ethylthio-2,5-dimethoxyphenethylamine).
79.
2C-T-7(4-(n)-Propylthio-2,5-dimethoxyphenethylamine).
80.
2C-I(4-Iodo-2,5-dimethoxyphenethylamine).
81.
Butylone(3,4-Methylenedioxy-alpha-methylaminobutyrophenone).
82.
Ethcathinone.
83.
Ethylone(3,4-Methylenedioxy-N-ethylcathinone).
84.
Naphyrone(Naphthylpyrovalerone).
85.
Dimethylone(3,4-Methylenedioxy-N,N-dimethylcathinone).
Ch.
2018-13LAWSOFFLORIDACh.
2018-1320CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
86.
3,4-Methylenedioxy-N,N-diethylcathinone.
87.
3,4-Methylenedioxy-propiophenone.
88.
3,4-Methylenedioxy-alpha-bromopropiophenone.
89.
3,4-Methylenedioxy-propiophenone-2-oxime.
90.
3,4-Methylenedioxy-N-acetylcathinone.
91.
3,4-Methylenedioxy-N-acetylmethcathinone.
92.
3,4-Methylenedioxy-N-acetylethcathinone.
93.
Bromomethcathinone.
94.
Buphedrone(alpha-Methylamino-butyrophenone).
95.
Eutylone(3,4-Methylenedioxy-alpha-ethylaminobutyrophenone).
96.
Dimethylcathinone.
97.
Dimethylmethcathinone.
98.
Pentylone(3,4-Methylenedioxy-alpha-methylaminovalerophenone).
99.
MDPPP(3,4-Methylenedioxy-alpha-pyrrolidinopropiophenone).
100.
MDPBP(3,4-Methylenedioxy-alpha-pyrrolidinobutyrophenone).
101.
MOPPP(Methoxy-alpha-pyrrolidinopropiophenone).
102.
MPHP(Methyl-alpha-pyrrolidinohexanophenone).
103.
BTCP(Benzothiophenylcyclohexylpiperidine)orBCP(Benocycli-dine).
104.
F-MABP(Fluoromethylaminobutyrophenone).
105.
MeO-PBP(Methoxypyrrolidinobutyrophenone).
106.
Et-PBP(Ethylpyrrolidinobutyrophenone).
107.
3-Me-4-MeO-MCAT(3-Methyl-4-Methoxymethcathinone).
108.
Me-EABP(Methylethylaminobutyrophenone).
109.
Etizolam.
110.
PPP(Pyrrolidinopropiophenone).
111.
PBP(Pyrrolidinobutyrophenone).
112.
PVP(Pyrrolidinovalerophenone)or(Pyrrolidinopentiophenone).
Ch.
2018-13LAWSOFFLORIDACh.
2018-1321CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
113.
MPPP(Methyl-alpha-pyrrolidinopropiophenone).
114.
JWH-007(1-Pentyl-2-methyl-3-(1-naphthoyl)indole).
115.
JWH-015(1-Propyl-2-methyl-3-(1-naphthoyl)indole).
116.
JWH-019(1-Hexyl-3-(1-naphthoyl)indole).
117.
JWH-020(1-Heptyl-3-(1-naphthoyl)indole).
118.
JWH-072(1-Propyl-3-(1-naphthoyl)indole).
119.
JWH-081(1-Pentyl-3-(4-methoxy-1-naphthoyl)indole).
120.
JWH-122(1-Pentyl-3-(4-methyl-1-naphthoyl)indole).
121.
JWH-133((6aR,10aR)-6,6,9-Trimethyl-3-(2-methylpentan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
122.
JWH-175(1-Pentyl-3-(1-naphthylmethyl)indole).
123.
JWH-201(1-Pentyl-3-(4-methoxyphenylacetyl)indole).
124.
JWH-203(1-Pentyl-3-(2-chlorophenylacetyl)indole).
125.
JWH-210(1-Pentyl-3-(4-ethyl-1-naphthoyl)indole).
126.
JWH-250(1-Pentyl-3-(2-methoxyphenylacetyl)indole).
127.
JWH-251(1-Pentyl-3-(2-methylphenylacetyl)indole).
128.
JWH-302(1-Pentyl-3-(3-methoxyphenylacetyl)indole).
129.
JWH-398(1-Pentyl-3-(4-chloro-1-naphthoyl)indole).
130.
HU-211((6aS,10aS)-9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methy-loctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol).
131.
HU-308([(1R,2R,5R)-2-[2,6-Dimethoxy-4-(2-methyloctan-2-yl)phe-nyl]-7,7-dimethyl-4-bicyclo[3.
1.
1]hept-3-enyl]methanol).
132.
HU-331(3-Hydroxy-2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cy-clohexen-1-yl]-5-pentyl-2,5-cyclohexadiene-1,4-dione).
133.
CB-13(4-Pentyloxy-1-(1-naphthoyl)naphthalene).
134.
CB-25(N-Cyclopropyl-11-(3-hydroxy-5-pentylphenoxy)-undecana-mide).
135.
CB-52(N-Cyclopropyl-11-(2-hexyl-5-hydroxyphenoxy)-undecana-mide).
Ch.
2018-13LAWSOFFLORIDACh.
2018-1322CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
136.
CP55,940(2-[3-Hydroxy-6-propanol-cyclohexyl]-5-(2-methyloctan-2-yl)phenol).
137.
AM-694(1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole).
138.
AM-2201(1-(5-Fluoropentyl)-3-(1-naphthoyl)indole).
139.
RCS-4(1-Pentyl-3-(4-methoxybenzoyl)indole).
140.
RCS-8(1-(2-Cyclohexylethyl)-3-(2-methoxyphenylacetyl)indole).
141.
WIN55,212-2((R)-(+)-[2,3-Dihydro-5-methyl-3-(4-morpholinyl-methyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone).
142.
WIN55,212-3([(3S)-2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone).
143.
Pentedrone(alpha-Methylaminovalerophenone).
144.
Fluoroamphetamine.
145.
Fluoromethamphetamine.
146.
Methoxetamine.
147.
Methiopropamine.
148.
Methylbuphedrone(Methyl-alpha-methylaminobutyrophenone).
149.
APB((2-Aminopropyl)benzofuran).
150.
APDB((2-Aminopropyl)-2,3-dihydrobenzofuran).
151.
UR-144(1-Pentyl-3-(2,2,3,3-tetramethylcyclopropanoyl)indole).
152.
XLR11(1-(5-Fluoropentyl)-3-(2,2,3,3-tetramethylcyclopropanoyl)indole).
153.
ChloroUR-144(1-(Chloropentyl)-3-(2,2,3,3-tetramethylcyclopropa-noyl)indole).
154.
AKB48(N-Adamant-1-yl1-pentylindazole-3-carboxamide).
155.
AM-2233(1-[(N-Methyl-2-piperidinyl)methyl]-3-(2-iodobenzoyl)in-dole).
156.
STS-135(N-Adamant-1-yl1-(5-fluoropentyl)indole-3-carboxamide).
157.
URB-597((3′-(Aminocarbonyl)[1,1′-biphenyl]-3-yl)-cyclohexylcar-bamate).
158.
URB-602([1,1′-Biphenyl]-3-yl-carbamicacid,cyclohexylester).
Ch.
2018-13LAWSOFFLORIDACh.
2018-1323CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
159.
URB-754(6-Methyl-2-[(4-methylphenyl)amino]-1-benzoxazin-4-one).
160.
2C-D(4-Methyl-2,5-dimethoxyphenethylamine).
161.
2C-H(2,5-Dimethoxyphenethylamine).
162.
2C-N(4-Nitro-2,5-dimethoxyphenethylamine).
163.
2C-P(4-(n)-Propyl-2,5-dimethoxyphenethylamine).
164.
25I-NBOMe(4-Iodo-2,5-dimethoxy-[N-(2-methoxybenzyl)]phe-nethylamine).
165.
MDMA(3,4-Methylenedioxymethamphetamine).
166.
PB-22(8-Quinolinyl1-pentylindole-3-carboxylate).
167.
FluoroPB-22(8-Quinolinyl1-(fluoropentyl)indole-3-carboxylate).
168.
BB-22(8-Quinolinyl1-(cyclohexylmethyl)indole-3-carboxylate).
169.
FluoroAKB48(N-Adamant-1-yl1-(fluoropentyl)indazole-3-carbox-amide).
170.
AB-PINACA(N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-pentylinda-zole-3-carboxamide).
171.
AB-FUBINACA(N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluor-obenzyl)indazole-3-carboxamide).
172.
ADB-PINACA(N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-penty-lindazole-3-carboxamide).
173.
FluoroADBICA(N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(fluoropentyl)indole-3-carboxamide).
174.
25B-NBOMe(4-Bromo-2,5-dimethoxy-[N-(2-methoxybenzyl)]phe-nethylamine).
175.
25C-NBOMe(4-Chloro-2,5-dimethoxy-[N-(2-methoxybenzyl)]phe-nethylamine).
176.
AB-CHMINACA(N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(cyclo-hexylmethyl)indazole-3-carboxamide).
177.
FUB-PB-22(8-Quinolinyl1-(4-fluorobenzyl)indole-3-carboxylate).
178.
Fluoro-NNEI(N-Naphthalen-1-yl1-(fluoropentyl)indole-3-carbox-amide).
179.
Fluoro-AMB(N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1-(fluoro-pentyl)indazole-3-carboxamide).
Ch.
2018-13LAWSOFFLORIDACh.
2018-1324CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
180.
THJ-2201(1-(5-Fluoropentyl)-3-(1-naphthoyl)indazole).
181.
AM-855((4aR,12bR)-8-Hexyl-2,5,5-trimethyl-1,4,4a,8,9,10,11,12b-octahydronaphtho[3,2-c]isochromen-12-ol).
182.
AM-905((6aR,9R,10aR)-3-[(E)-Hept-1-enyl]-9-(hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a-hexahydrobenzo[c]chromen-1-ol).
183.
AM-906((6aR,9R,10aR)-3-[(Z)-Hept-1-enyl]-9-(hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a-hexahydrobenzo[c]chromen-1-ol).
184.
AM-2389((6aR,9R,10aR)-3-(1-Hexyl-cyclobut-1-yl)-6a,7,8,9,10,10a-hexahydro-6,6-dimethyl-6H-dibenzo[b,d]pyran-1,9diol).
185.
HU-243((6aR,8S,9S,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-8,9-ditritio-7,8,10,10a-tetrahydro-6aH-benzo[c]chromen-1-ol).
186.
HU-336((6aR,10aR)-6,6,9-Trimethyl-3-pentyl-6a,7,10,10a-tetrahy-dro-1H-benzo[c]chromene-1,4(6H)-dione).
187.
MAPB((2-Methylaminopropyl)benzofuran).
188.
5-IT(2-(1H-Indol-5-yl)-1-methyl-ethylamine).
189.
6-IT(2-(1H-Indol-6-yl)-1-methyl-ethylamine).
190.
SyntheticCannabinoids.
—UnlessspecificallyexceptedorunlesslistedinanotherscheduleorcontainedwithinapharmaceuticalproductapprovedbytheUnitedStatesFoodandDrugAdministration,anymaterial,compound,mixture,orpreparationthatcontainsanyquantityofasyntheticcannabinoidfoundtobeinanyofthefollowingchemicalclassdescriptions,orhomologues,nitrogen-heterocyclicanalogs,isomers(includingoptical,positional,orgeometric),esters,ethers,salts,andsaltsofhomologues,nitrogen-heterocyclicanalogs,isomers,esters,orethers,whenevertheexistenceofsuchhomologues,nitrogen-heterocyclicanalogs,isomers,esters,ethers,salts,andsaltsofisomers,esters,orethersispossiblewithinthespecificchemicalclassordesignation.
Sincenomenclatureofthesesynthe-ticallyproducedcannabinoidsisnotinternationallystandardizedandmaycontinuallyevolve,thesestructuresorthecompoundsofthesestructuresshallbeincludedunderthissubparagraph,regardlessoftheirspecificnumericaldesignationofatomicpositionscovered,ifitcanbedeterminedthrougharecognizedmethodofscientifictestingoranalysisthatthesubstancecontainspropertiesthatfitwithinoneormoreofthefollowingcategories:a.
Tetrahydrocannabinols.
—Anytetrahydrocannabinolsnaturallycon-tainedinaplantofthegenusCannabis,thesyntheticequivalentsofthesubstancescontainedintheplantorintheresinousextractsofthegenusCannabis,orsyntheticsubstances,derivatives,andtheirisomerswithsimilarchemicalstructureandpharmacologicalactivity,including,butnotCh.
2018-13LAWSOFFLORIDACh.
2018-1325CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
limitedto,Delta9tetrahydrocannabinolsandtheiropticalisomers,Delta8tetrahydrocannabinolsandtheiropticalisomers,Delta6a,10atetrahydro-cannabinolsandtheiropticalisomers,oranycompoundcontainingatetrahydrobenzo[c]chromenestructurewithsubstitutionateitherorboththe3-positionor9-position,withorwithoutsubstitutionatthe1-positionwithhydroxyloralkoxygroups,including,butnotlimitedto:(I)Tetrahydrocannabinol.
(II)HU-210((6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methy-loctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol).
(III)HU-211((6aS,10aS)-9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methy-loctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol).
(IV)JWH-051((6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
(V)JWH-133((6aR,10aR)-6,6,9-Trimethyl-3-(2-methylpentan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
(VI)JWH-057((6aR,10aR)-6,6,9-Trimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
(VII)JWH-359((6aR,10aR)-1-Methoxy-6,6,9-trimethyl-3-(2,3-dimethyl-pentan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
(VIII)AM-087((6aR,10aR)-3-(2-Methyl-6-bromohex-2-yl)-6,6,9-tri-methyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol).
(IX)AM-411((6aR,10aR)-3-(1-Adamantyl)-6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol).
(X)Parahexyl.
b.
Naphthoylindoles,Naphthoylindazoles,Naphthoylcarbazoles,Naphthylmethylindoles,Naphthylmethylindazoles,andNaphthylmethyl-carbazoles.
—Anycompoundcontaininganaphthoylindole,naphthoylinda-zole,naphthoylcarbazole,naphthylmethylindole,naphthylmethylindazole,ornaphthylmethylcarbazolestructure,withorwithoutsubstitutionontheindole,indazole,orcarbazoleringtoanyextent,whetherornotsubstitutedonthenaphthylringtoanyextent,including,butnotlimitedto:(I)JWH-007(1-Pentyl-2-methyl-3-(1-naphthoyl)indole).
(II)JWH-011(1-(1-Methylhexyl)-2-methyl-3-(1-naphthoyl)indole).
(III)JWH-015(1-Propyl-2-methyl-3-(1-naphthoyl)indole).
(IV)JWH-016(1-Butyl-2-methyl-3-(1-naphthoyl)indole).
(V)JWH-018(1-Pentyl-3-(1-naphthoyl)indole).
Ch.
2018-13LAWSOFFLORIDACh.
2018-1326CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
(VI)JWH-019(1-Hexyl-3-(1-naphthoyl)indole).
(VII)JWH-020(1-Heptyl-3-(1-naphthoyl)indole).
(VIII)JWH-022(1-(4-Pentenyl)-3-(1-naphthoyl)indole).
(IX)JWH-071(1-Ethyl-3-(1-naphthoyl)indole).
(X)JWH-072(1-Propyl-3-(1-naphthoyl)indole).
(XI)JWH-073(1-Butyl-3-(1-naphthoyl)indole).
(XII)JWH-080(1-Butyl-3-(4-methoxy-1-naphthoyl)indole).
(XIII)JWH-081(1-Pentyl-3-(4-methoxy-1-naphthoyl)indole).
(XIV)JWH-098(1-Pentyl-2-methyl-3-(4-methoxy-1-naphthoyl)indole).
(XV)JWH-116(1-Pentyl-2-ethyl-3-(1-naphthoyl)indole).
(XVI)JWH-122(1-Pentyl-3-(4-methyl-1-naphthoyl)indole).
(XVII)JWH-149(1-Pentyl-2-methyl-3-(4-methyl-1-naphthoyl)indole).
(XVIII)JWH-164(1-Pentyl-3-(7-methoxy-1-naphthoyl)indole).
(XIX)JWH-175(1-Pentyl-3-(1-naphthylmethyl)indole).
(XX)JWH-180(1-Propyl-3-(4-propyl-1-naphthoyl)indole).
(XXI)JWH-182(1-Pentyl-3-(4-propyl-1-naphthoyl)indole).
(XXII)JWH-184(1-Pentyl-3-[(4-methyl)-1-naphthylmethyl]indole).
(XXIII)JWH-193(1-[2-(4-Morpholinyl)ethyl]-3-(4-methyl-1-naphthoyl)indole).
(XXIV)JWH-198(1-[2-(4-Morpholinyl)ethyl]-3-(4-methoxy-1-naphthoyl)indole).
(XXV)JWH-200(1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole).
(XXVI)JWH-210(1-Pentyl-3-(4-ethyl-1-naphthoyl)indole).
(XXVII)JWH-387(1-Pentyl-3-(4-bromo-1-naphthoyl)indole).
(XXVIII)JWH-398(1-Pentyl-3-(4-chloro-1-naphthoyl)indole).
(XXIX)JWH-412(1-Pentyl-3-(4-fluoro-1-naphthoyl)indole).
(XXX)JWH-424(1-Pentyl-3-(8-bromo-1-naphthoyl)indole).
(XXXI)AM-1220(1-[(1-Methyl-2-piperidinyl)methyl]-3-(1-naphthoyl)in-dole).
Ch.
2018-13LAWSOFFLORIDACh.
2018-1327CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
(XXXII)AM-1235(1-(5-Fluoropentyl)-6-nitro-3-(1-naphthoyl)indole).
(XXXIII)AM-2201(1-(5-Fluoropentyl)-3-(1-naphthoyl)indole).
(XXXIV)ChloroJWH-018(1-(Chloropentyl)-3-(1-naphthoyl)indole).
(XXXV)BromoJWH-018(1-(Bromopentyl)-3-(1-naphthoyl)indole).
(XXXVI)AM-2232(1-(4-Cyanobutyl)-3-(1-naphthoyl)indole).
(XXXVII)THJ-2201(1-(5-Fluoropentyl)-3-(1-naphthoyl)indazole).
(XXXVIII)MAM-2201(1-(5-Fluoropentyl)-3-(4-methyl-1-naphthoyl)in-dole).
(XXXIX)EAM-2201(1-(5-Fluoropentyl)-3-(4-ethyl-1-naphthoyl)indole).
(XL)EG-018(9-Pentyl-3-(1-naphthoyl)carbazole).
(XLI)EG-2201(9-(5-Fluoropentyl)-3-(1-naphthoyl)carbazole).
c.
Naphthoylpyrroles.
—Anycompoundcontaininganaphthoylpyrrolestructure,withorwithoutsubstitutiononthepyrroleringtoanyextent,whetherornotsubstitutedonthenaphthylringtoanyextent,including,butnotlimitedto:(I)JWH-030(1-Pentyl-3-(1-naphthoyl)pyrrole).
(II)JWH-031(1-Hexyl-3-(1-naphthoyl)pyrrole).
(III)JWH-145(1-Pentyl-5-phenyl-3-(1-naphthoyl)pyrrole).
(IV)JWH-146(1-Heptyl-5-phenyl-3-(1-naphthoyl)pyrrole).
(V)JWH-147(1-Hexyl-5-phenyl-3-(1-naphthoyl)pyrrole).
(VI)JWH-307(1-Pentyl-5-(2-fluorophenyl)-3-(1-naphthoyl)pyrrole).
(VII)JWH-309(1-Pentyl-5-(1-naphthalenyl)-3-(1-naphthoyl)pyrrole).
(VIII)JWH-368(1-Pentyl-5-(3-fluorophenyl)-3-(1-naphthoyl)pyrrole).
(IX)JWH-369(1-Pentyl-5-(2-chlorophenyl)-3-(1-naphthoyl)pyrrole).
(X)JWH-370(1-Pentyl-5-(2-methylphenyl)-3-(1-naphthoyl)pyrrole).
d.
Naphthylmethylenindenes.
—Anycompoundcontaininganaphthyl-methylenindenestructure,withorwithoutsubstitutionatthe3-positionoftheindeneringtoanyextent,whetherornotsubstitutedonthenaphthylringtoanyextent,including,butnotlimitedto,JWH-176(3-Pentyl-1-(naphthylmethylene)indene).
Ch.
2018-13LAWSOFFLORIDACh.
2018-1328CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
e.
PhenylacetylindolesandPhenylacetylindazoles.
—Anycompoundcon-tainingaphenylacetylindoleorphenylacetylindazolestructure,withorwithoutsubstitutionontheindoleorindazoleringtoanyextent,whetherornotsubstitutedonthephenylringtoanyextent,including,butnotlimitedto:(I)JWH-167(1-Pentyl-3-(phenylacetyl)indole).
(II)JWH-201(1-Pentyl-3-(4-methoxyphenylacetyl)indole).
(III)JWH-203(1-Pentyl-3-(2-chlorophenylacetyl)indole).
(IV)JWH-250(1-Pentyl-3-(2-methoxyphenylacetyl)indole).
(V)JWH-251(1-Pentyl-3-(2-methylphenylacetyl)indole).
(VI)JWH-302(1-Pentyl-3-(3-methoxyphenylacetyl)indole).
(VII)Cannabipiperidiethanone.
(VIII)RCS-8(1-(2-Cyclohexylethyl)-3-(2-methoxyphenylacetyl)indole).
f.
Cyclohexylphenols.
—Anycompoundcontainingacyclohexylphenolstructure,withorwithoutsubstitutionatthe5-positionofthephenolicringtoanyextent,whetherornotsubstitutedonthecyclohexylringtoanyextent,including,butnotlimitedto:(I)CP47,497(2-(3-Hydroxycyclohexyl)-5-(2-methyloctan-2-yl)phenol).
(II)Cannabicyclohexanol(CP47,497dimethyloctyl(C8)homologue).
(III)CP-55,940(2-(3-Hydroxy-6-propanol-cyclohexyl)-5-(2-methyloctan-2-yl)phenol).
g.
BenzoylindolesandBenzoylindazoles.
—Anycompoundcontainingabenzoylindoleorbenzoylindazolestructure,withorwithoutsubstitutionontheindoleorindazoleringtoanyextent,whetherornotsubstitutedonthephenylringtoanyextent,including,butnotlimitedto:(I)AM-679(1-Pentyl-3-(2-iodobenzoyl)indole).
(II)AM-694(1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole).
(III)AM-1241(1-[(N-Methyl-2-piperidinyl)methyl]-3-(2-iodo-5-nitroben-zoyl)indole).
(IV)Pravadoline(1-[2-(4-Morpholinyl)ethyl]-2-methyl-3-(4-methoxyben-zoyl)indole).
(V)AM-2233(1-[(N-Methyl-2-piperidinyl)methyl]-3-(2-iodobenzoyl)in-dole).
(VI)RCS-4(1-Pentyl-3-(4-methoxybenzoyl)indole).
Ch.
2018-13LAWSOFFLORIDACh.
2018-1329CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
(VII)RCS-4C4homologue(1-Butyl-3-(4-methoxybenzoyl)indole).
(VIII)AM-630(1-[2-(4-Morpholinyl)ethyl]-2-methyl-6-iodo-3-(4-methox-ybenzoyl)indole).
h.
TetramethylcyclopropanoylindolesandTetramethylcyclopropanoy-lindazoles.
—Anycompoundcontainingatetramethylcyclopropanoylindoleortetramethylcyclopropanoylindazolestructure,withorwithoutsubstitu-tionontheindoleorindazoleringtoanyextent,whetherornotsubstitutedonthetetramethylcyclopropylgrouptoanyextent,including,butnotlimitedto:(I)UR-144(1-Pentyl-3-(2,2,3,3-tetramethylcyclopropanoyl)indole).
(II)XLR11(1-(5-Fluoropentyl)-3-(2,2,3,3-tetramethylcyclopropanoyl)in-dole).
(III)ChloroUR-144(1-(Chloropentyl)-3-(2,2,3,3-tetramethylcyclopropa-noyl)indole).
(IV)A-796,260(1-[2-(4-Morpholinyl)ethyl]-3-(2,2,3,3-tetramethylcyclo-propanoyl)indole).
(V)A-834,735(1-[4-(Tetrahydropyranyl)methyl]-3-(2,2,3,3-tetramethyl-cyclopropanoyl)indole).
(VI)M-144(1-(5-Fluoropentyl)-2-methyl-3-(2,2,3,3-tetramethylcyclopro-panoyl)indole).
(VII)FUB-144(1-(4-Fluorobenzyl)-3-(2,2,3,3-tetramethylcyclopropa-noyl)indole).
(VIII)FAB-144(1-(5-Fluoropentyl)-3-(2,2,3,3-tetramethylcyclopropa-noyl)indazole).
(IX)XLR12(1-(4,4,4-Trifluorobutyl)-3-(2,2,3,3-tetramethylcyclopropa-noyl)indole).
(X)AB-005(1-[(1-Methyl-2-piperidinyl)methyl]-3-(2,2,3,3-tetramethyl-cyclopropanoyl)indole).
i.
Adamantoylindoles,Adamantoylindazoles,Adamantylindolecarbox-amides,andAdamantylindazolecarboxamides.
—Anycompoundcontaininganadamantoylindole,adamantoylindazole,adamantylindolecarboxamide,oradamantylindazolecarboxamidestructure,withorwithoutsubstitutionontheindoleorindazoleringtoanyextent,whetherornotsubstitutedontheadamantylringtoanyextent,including,butnotlimitedto:(I)AKB48(N-Adamant-1-yl1-pentylindazole-3-carboxamide).
(II)FluoroAKB48(N-Adamant-1-yl1-(fluoropentyl)indazole-3-carbox-amide).
Ch.
2018-13LAWSOFFLORIDACh.
2018-1330CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
(III)STS-135(N-Adamant-1-yl1-(5-fluoropentyl)indole-3-carboxamide).
(IV)AM-1248(1-(1-Methylpiperidine)methyl-3-(1-adamantoyl)indole).
(V)AB-001(1-Pentyl-3-(1-adamantoyl)indole).
(VI)APICA(N-Adamant-1-yl1-pentylindole-3-carboxamide).
(VII)FluoroAB-001(1-(Fluoropentyl)-3-(1-adamantoyl)indole).
j.
Quinolinylindolecarboxylates,Quinolinylindazolecarboxylates,Quino-linylindolecarboxamides,andQuinolinylindazolecarboxamides.
—Anycom-poundcontainingaquinolinylindolecarboxylate,quinolinylindazolecarbox-ylate,isoquinolinylindolecarboxylate,isoquinolinylindazolecarboxylate,quinolinylindolecarboxamide,quinolinylindazolecarboxamide,isoquinoli-nylindolecarboxamide,orisoquinolinylindazolecarboxamidestructure,withorwithoutsubstitutionontheindoleorindazoleringtoanyextent,whetherornotsubstitutedonthequinolineorisoquinolineringtoanyextent,including,butnotlimitedto:(I)PB-22(8-Quinolinyl1-pentylindole-3-carboxylate).
(II)FluoroPB-22(8-Quinolinyl1-(fluoropentyl)indole-3-carboxylate).
(III)BB-22(8-Quinolinyl1-(cyclohexylmethyl)indole-3-carboxylate).
(IV)FUB-PB-22(8-Quinolinyl1-(4-fluorobenzyl)indole-3-carboxylate).
(V)NPB-22(8-Quinolinyl1-pentylindazole-3-carboxylate).
(VI)FluoroNPB-22(8-Quinolinyl1-(fluoropentyl)indazole-3-carboxy-late).
(VII)FUB-NPB-22(8-Quinolinyl1-(4-fluorobenzyl)indazole-3-carboxy-late).
(VIII)THJ(8-Quinolinyl1-pentylindazole-3-carboxamide).
(IX)FluoroTHJ(8-Quinolinyl1-(fluoropentyl)indazole-3-carboxamide).
k.
NaphthylindolecarboxylatesandNaphthylindazolecarboxylates.
—Anycompoundcontaininganaphthylindolecarboxylateornaphthylindazolecarboxylatestructure,withorwithoutsubstitutionontheindoleorindazoleringtoanyextent,whetherornotsubstitutedonthenaphthylringtoanyextent,including,butnotlimitedto:(I)NM-2201(1-Naphthalenyl1-(5-fluoropentyl)indole-3-carboxylate).
(II)SDB-005(1-Naphthalenyl1-pentylindazole-3-carboxylate).
(III)FluoroSDB-005(1-Naphthalenyl1-(fluoropentyl)indazole-3-car-boxylate).
Ch.
2018-13LAWSOFFLORIDACh.
2018-1331CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
(IV)FDU-PB-22(1-Naphthalenyl1-(4-fluorobenzyl)indole-3-carboxy-late).
(V)3-CAF(2-Naphthalenyl1-(2-fluorophenyl)indazole-3-carboxylate).
l.
NaphthylindolecarboxamidesandNaphthylindazolecarboxamides.
Anycompoundcontaininganaphthylindolecarboxamideornaphthylinda-zolecarboxamidestructure,withorwithoutsubstitutionontheindoleorindazoleringtoanyextent,whetherornotsubstitutedonthenaphthylringtoanyextent,including,butnotlimitedto:(I)NNEI(N-Naphthalen-1-yl1-pentylindole-3-carboxamide).
(II)Fluoro-NNEI(N-Naphthalen-1-yl1-(fluoropentyl)indole-3-carboxa-mide).
(III)Chloro-NNEI(N-Naphthalen-1-yl1-(chloropentyl)indole-3-carbox-amide).
(IV)MN-18(N-Naphthalen-1-yl1-pentylindazole-3-carboxamide).
(V)FluoroMN-18(N-Naphthalen-1-yl1-(fluoropentyl)indazole-3-car-boxamide).
m.
Alkylcarbonylindolecarboxamides,Alkylcarbonylindazolecarbox-amides,Alkylcarbonylindolecarboxylates,andAlkylcarbonylindazolecarboxylates.
—Anycompoundcontaininganalkylcarbonylgroup,including1-amino-3-methyl-1-oxobutan-2-yl,1-methoxy-3-methyl-1-oxobutan-2-yl,1-amino-1-oxo-3-phenylpropan-2-yl,1-methoxy-1-oxo-3-phenylpropan-2-yl,withanindolecarboxamide,indazolecarboxamide,indolecarboxylate,orindazolecarboxylate,withorwithoutsubstitutionontheindoleorindazoleringtoanyextent,whetherornotsubstitutedonthealkylcarbonylgrouptoanyextent,including,butnotlimitedto:(I)ADBICA,(N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentylindole-3-carboxamide).
(II)FluoroADBICA(N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(fluoropentyl)indole-3-carboxamide).
(III)FluoroABICA(N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(fluoro-pentyl)indole-3-carboxamide).
(IV)AB-PINACA(N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-pentylinda-zole-3-carboxamide).
(V)FluoroAB-PINACA(N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(fluoropentyl)indazole-3-carboxamide).
(VI)ADB-PINACA(N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-penty-lindazole-3-carboxamide).
Ch.
2018-13LAWSOFFLORIDACh.
2018-1332CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
(VII)FluoroADB-PINACA(N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(fluoropentyl)indazole-3-carboxamide).
(VIII)AB-FUBINACA(N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)indazole-3-carboxamide).
(IX)ADB-FUBINACA(N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)indazole-3-carboxamide).
(X)AB-CHMINACA(N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(cyclo-hexylmethyl)indazole-3-carboxamide).
(XI)MA-CHMINACA(N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1-(cy-clohexylmethyl)indazole-3-carboxamide).
(XII)MAB-CHMINACA(N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)indazole-3-carboxamide).
(XIII)AMB(N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1-pentylindazole-3-carboxamide).
(XIV)Fluoro-AMB(N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1-(fluoro-pentyl)indazole-3-carboxamide).
(XV)FUB-AMB(N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1-(4-fluoro-benzyl)indazole-3-carboxamide).
(XVI)MDMB-CHMINACA(N-(1-Methoxy-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)indazole-3-carboxamide).
(XVII)MDMB-FUBINACA(N-(1-Methoxy-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)indazole-3-carboxamide).
(XVIII)MDMB-CHMICA(N-(1-Methoxy-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)indole-3-carboxamide).
(XIX)PX-1(N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5-fluoropentyl)indole-3-carboxamide).
(XX)PX-2(N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5-fluoropentyl)in-dazole-3-carboxamide).
(XXI)PX-3(N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(cyclohexyl-methyl)indazole-3-carboxamide).
(XXII)PX-4(N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(4-fluorobenzyl)indazole-3-carboxamide).
(XXIII)MO-CHMINACA(N-(1-Methoxy-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)indazole-3-carboxylate).
Ch.
2018-13LAWSOFFLORIDACh.
2018-1333CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
n.
CumylindolecarboxamidesandCumylindazolecarboxamides.
—AnycompoundcontainingaN-(2-phenylpropan-2-yl)indolecarboxamideorN-(2-phenylpropan-2-yl)indazolecarboxamidestructure,withorwithoutsubstitutionontheindoleorindazoleringtoanyextent,whetherornotsubstitutedonthephenylringofthecumylgrouptoanyextent,including,butnotlimitedto:(I)CUMYL-PICA(N-(2-Phenylpropan-2-yl)-1-pentylindole-3-carboxa-mide).
(II)FluoroCUMYL-PICA(N-(2-Phenylpropan-2-yl)-1-(fluoropentyl)in-dole-3-carboxamide).
o.
OtherSyntheticCannabinoids.
—Anymaterial,compound,mixture,orpreparationthatcontainsanyquantityofaSyntheticCannabinoid,asdescribedinsub-subparagraphsa.
-n.
:(I)Withorwithoutmodificationorreplacementofacarbonyl,carbox-amide,alkylene,alkyl,orcarboxylatelinkagebetweeneithertwocorerings,orlinkagebetweenacoreringandgroupstructure,withorwithouttheadditionofacarbonorreplacementofacarbon;(II)Withorwithoutreplacementofacoreringorgroupstructure,whetherornotsubstitutedontheringorgroupstructurestoanyextent;and(III)Isacannabinoidreceptoragonist,unlessspecificallyexceptedorunlesslistedinanotherscheduleorcontainedwithinapharmaceuticalproductapprovedbytheUnitedStatesFoodandDrugAdministration.
191.
SubstitutedCathinones.
—Unlessspecificallyexcepted,listedinanotherschedule,orcontainedwithinapharmaceuticalproductapprovedbytheUnitedStatesFoodandDrugAdministration,anymaterial,compound,mixture,orpreparation,includingitssalts,isomers,esters,orethers,andsaltsofisomers,esters,orethers,whenevertheexistenceofsuchsaltsispossiblewithinanyofthefollowingspecificchemicaldesignations:a.
Anycompoundcontaininga2-amino-1-phenyl-1-propanonestructure;b.
Anycompoundcontaininga2-amino-1-naphthyl-1-propanonestruc-ture;orc.
Anycompoundcontaininga2-amino-1-thiophenyl-1-propanonestruc-ture,whetherornotthecompoundisfurthermodified:(I)Withorwithoutsubstitutionontheringsystemtoanyextentwithalkyl,alkylthio,thio,fusedalkylenedioxy,alkoxy,haloalkyl,hydroxyl,nitro,fusedfuran,fusedbenzofuran,fuseddihydrofuran,fusedtetrahydropyran,fusedalkylring,orhalidesubstituents;Ch.
2018-13LAWSOFFLORIDACh.
2018-1334CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
(II)Withorwithoutsubstitutionatthe3-propanonepositionwithanalkylsubstituentorremovalofthemethylgroupatthe3-propanoneposition;(III)Withorwithoutsubstitutionatthe2-aminonitrogenatomwithalkyl,dialkyl,acetyl,orbenzylgroups,whetherornotfurthersubstitutedintheringsystem;or(IV)Withorwithoutinclusionofthe2-aminonitrogenatominacyclicstructure,including,butnotlimitedto:(A)Methcathinone.
(B)Ethcathinone.
(C)Methylone(3,4-Methylenedioxymethcathinone).
(D)2,3-Methylenedioxymethcathinone.
(E)MDPV(3,4-Methylenedioxypyrovalerone).
(F)Methylmethcathinone.
(G)Methoxymethcathinone.
(H)Fluoromethcathinone.
(I)Methylethcathinone.
(J)Butylone(3,4-Methylenedioxy-alpha-methylaminobutyrophenone).
(K)Ethylone(3,4-Methylenedioxy-N-ethylcathinone).
(L)BMDP(3,4-Methylenedioxy-N-benzylcathinone).
(M)Naphyrone(Naphthylpyrovalerone).
(N)Bromomethcathinone.
(O)Buphedrone(alpha-Methylaminobutyrophenone).
(P)Eutylone(3,4-Methylenedioxy-alpha-ethylaminobutyrophenone).
(Q)Dimethylcathinone.
(R)Dimethylmethcathinone.
(S)Pentylone(3,4-Methylenedioxy-alpha-methylaminovalerophenone).
(T)Pentedrone(alpha-Methylaminovalerophenone).
(U)MDPPP(3,4-Methylenedioxy-alpha-pyrrolidinopropiophenone).
Ch.
2018-13LAWSOFFLORIDACh.
2018-1335CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
(V)MDPBP(3,4-Methylenedioxy-alpha-pyrrolidinobutyrophenone).
(W)MPPP(Methyl-alpha-pyrrolidinopropiophenone).
(X)PPP(Pyrrolidinopropiophenone).
(Y)PVP(Pyrrolidinovalerophenone)or(Pyrrolidinopentiophenone).
(Z)MOPPP(Methoxy-alpha-pyrrolidinopropiophenone).
(AA)MPHP(Methyl-alpha-pyrrolidinohexanophenone).
(BB)F-MABP(Fluoromethylaminobutyrophenone).
(CC)Me-EABP(Methylethylaminobutyrophenone).
(DD)PBP(Pyrrolidinobutyrophenone).
(EE)MeO-PBP(Methoxypyrrolidinobutyrophenone).
(FF)Et-PBP(Ethylpyrrolidinobutyrophenone).
(GG)3-Me-4-MeO-MCAT(3-Methyl-4-Methoxymethcathinone).
(HH)Dimethylone(3,4-Methylenedioxy-N,N-dimethylcathinone).
(II)3,4-Methylenedioxy-N,N-diethylcathinone.
(JJ)3,4-Methylenedioxy-N-acetylcathinone.
(KK)3,4-Methylenedioxy-N-acetylmethcathinone.
(LL)3,4-Methylenedioxy-N-acetylethcathinone.
(MM)Methylbuphedrone(Methyl-alpha-methylaminobutyrophenone).
(NN)Methyl-alpha-methylaminohexanophenone.
(OO)N-Ethyl-N-methylcathinone.
(PP)PHP(Pyrrolidinohexanophenone).
(QQ)PV8(Pyrrolidinoheptanophenone).
(RR)Chloromethcathinone.
(SS)4-Bromo-2,5-dimethoxy-alpha-aminoacetophenone.
192.
SubstitutedPhenethylamines.
—Unlessspecificallyexceptedorunlesslistedinanotherschedule,orcontainedwithinapharmaceuticalproductapprovedbytheUnitedStatesFoodandDrugAdministration,anymaterial,compound,mixture,orpreparation,includingitssalts,isomers,esters,orethers,andsaltsofisomers,esters,orethers,whenevertheCh.
2018-13LAWSOFFLORIDACh.
2018-1336CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
existenceofsuchsaltsispossiblewithinanyofthefollowingspecificchemicaldesignations,anycompoundcontainingaphenethylaminestruc-ture,withoutabeta-ketogroup,andwithoutabenzylgroupattachedtotheaminegroup,whetherornotthecompoundisfurthermodifiedwithorwithoutsubstitutiononthephenylringtoanyextentwithalkyl,alkylthio,nitro,alkoxy,thio,halide,fusedalkylenedioxy,fusedfuran,fusedbenzofur-an,fuseddihydrofuran,orfusedtetrahydropyransubstituents,whetherornotfurthersubstitutedonaringtoanyextent,withorwithoutsubstitutionatthealphaorbetapositionbyanyalkylsubstituent,withorwithoutsubstitutionatthenitrogenatom,andwithorwithoutinclusionofthe2-aminonitrogenatominacyclicstructure,including,butnotlimitedto:a.
2C-B(4-Bromo-2,5-dimethoxyphenethylamine).
b.
2C-E(4-Ethyl-2,5-dimethoxyphenethylamine).
c.
2C-T-4(4-Isopropylthio-2,5-dimethoxyphenethylamine).
d.
2C-C(4-Chloro-2,5-dimethoxyphenethylamine).
e.
2C-T(4-Methylthio-2,5-dimethoxyphenethylamine).
f.
2C-T-2(4-Ethylthio-2,5-dimethoxyphenethylamine).
g.
2C-T-7(4-(n)-Propylthio-2,5-dimethoxyphenethylamine).
h.
2C-I(4-Iodo-2,5-dimethoxyphenethylamine).
i.
2C-D(4-Methyl-2,5-dimethoxyphenethylamine).
j.
2C-H(2,5-Dimethoxyphenethylamine).
k.
2C-N(4-Nitro-2,5-dimethoxyphenethylamine).
l.
2C-P(4-(n)-Propyl-2,5-dimethoxyphenethylamine).
m.
MDMA(3,4-Methylenedioxymethamphetamine).
n.
MBDB(Methylbenzodioxolylbutanamine)or(3,4-Methylenedioxy-N-methylbutanamine).
o.
MDA(3,4-Methylenedioxyamphetamine).
p.
2,5-Dimethoxyamphetamine.
q.
Fluoroamphetamine.
r.
Fluoromethamphetamine.
s.
MDEA(3,4-Methylenedioxy-N-ethylamphetamine).
t.
DOB(4-Bromo-2,5-dimethoxyamphetamine).
Ch.
2018-13LAWSOFFLORIDACh.
2018-1337CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
u.
DOC(4-Chloro-2,5-dimethoxyamphetamine).
v.
DOET(4-Ethyl-2,5-dimethoxyamphetamine).
w.
DOI(4-Iodo-2,5-dimethoxyamphetamine).
x.
DOM(4-Methyl-2,5-dimethoxyamphetamine).
y.
PMA(4-Methoxyamphetamine).
z.
N-Ethylamphetamine.
aa.
3,4-Methylenedioxy-N-hydroxyamphetamine.
bb.
5-Methoxy-3,4-methylenedioxyamphetamine.
cc.
PMMA(4-Methoxymethamphetamine).
dd.
N,N-Dimethylamphetamine.
ee.
3,4,5-Trimethoxyamphetamine.
ff.
4-APB(4-(2-Aminopropyl)benzofuran).
gg.
5-APB(5-(2-Aminopropyl)benzofuran).
hh.
6-APB(6-(2-Aminopropyl)benzofuran).
ii.
7-APB(7-(2-Aminopropyl)benzofuran).
jj.
4-APDB(4-(2-Aminopropyl)-2,3-dihydrobenzofuran).
kk.
5-APDB(5-(2-Aminopropyl)-2,3-dihydrobenzofuran).
ll.
6-APDB(6-(2-Aminopropyl)-2,3-dihydrobenzofuran).
mm.
7-APDB(7-(2-Aminopropyl)-2,3-dihydrobenzofuran).
nn.
4-MAPB(4-(2-Methylaminopropyl)benzofuran).
oo.
5-MAPB(5-(2-Methylaminopropyl)benzofuran).
pp.
6-MAPB(6-(2-Methylaminopropyl)benzofuran).
qq.
7-MAPB(7-(2-Methylaminopropyl)benzofuran).
rr.
5-EAPB(5-(2-Ethylaminopropyl)benzofuran).
ss.
5-MAPDB(5-(2-Methylaminopropyl)-2,3-dihydrobenzofuran),whichdoesnotincludephenethylamine,mescalineasdescribedinsubpar-agraph20.
,substitutedcathinonesasdescribedinsubparagraph191.
,N-Benzylphenethylaminecompoundsasdescribedinsubparagraph193.
,ormethamphetamineasdescribedinsubparagraph(2)(c)5.
(2)(c)4.
Ch.
2018-13LAWSOFFLORIDACh.
2018-1338CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
193.
N-BenzylPhenethylamineCompounds.
—Unlessspecificallyex-ceptedorunlesslistedinanotherschedule,orcontainedwithinapharmaceuticalproductapprovedbytheUnitedStatesFoodandDrugAdministration,anymaterial,compound,mixture,orpreparation,includingitssalts,isomers,esters,orethers,andsaltsofisomers,esters,orethers,whenevertheexistenceofsuchsaltsispossiblewithinanyofthefollowingspecificchemicaldesignations,anycompoundcontainingaphenethylaminestructurewithoutabeta-ketogroup,withsubstitutiononthenitrogenatomoftheaminogroupwithabenzylsubstituent,withorwithoutsubstitutiononthephenylorbenzylringtoanyextentwithalkyl,alkoxy,thio,alkylthio,halide,fusedalkylenedioxy,fusedfuran,fusedbenzofuran,orfusedtetrahydropyransubstituents,whetherornotfurthersubstitutedonaringtoanyextent,withorwithoutsubstitutionatthealphapositionbyanyalkylsubstituent,including,butnotlimitedto:a.
25B-NBOMe(4-Bromo-2,5-dimethoxy-[N-(2-methoxybenzyl)]phe-nethylamine).
b.
25B-NBOH(4-Bromo-2,5-dimethoxy-[N-(2-hydroxybenzyl)]phenethy-lamine).
c.
25B-NBF(4-Bromo-2,5-dimethoxy-[N-(2-fluorobenzyl)]phenethyla-mine).
d.
25B-NBMD(4-Bromo-2,5-dimethoxy-[N-(2,3-methylenedioxybenzyl)]phenethylamine).
e.
25I-NBOMe(4-Iodo-2,5-dimethoxy-[N-(2-methoxybenzyl)]phenethy-lamine).
f.
25I-NBOH(4-Iodo-2,5-dimethoxy-[N-(2-hydroxybenzyl)]phenethyla-mine).
g.
25I-NBF(4-Iodo-2,5-dimethoxy-[N-(2-fluorobenzyl)]phenethylamine).
h.
25I-NBMD(4-Iodo-2,5-dimethoxy-[N-(2,3-methylenedioxybenzyl)]phenethylamine).
i.
25T2-NBOMe(4-Methylthio-2,5-dimethoxy-[N-(2-methoxybenzyl)]phenethylamine).
j.
25T4-NBOMe(4-Isopropylthio-2,5-dimethoxy-[N-(2-methoxybenzyl)]phenethylamine).
k.
25T7-NBOMe(4-(n)-Propylthio-2,5-dimethoxy-[N-(2-methoxybenzyl)]phenethylamine).
l.
25C-NBOMe(4-Chloro-2,5-dimethoxy-[N-(2-methoxybenzyl)]phe-nethylamine).
Ch.
2018-13LAWSOFFLORIDACh.
2018-1339CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
m.
25C-NBOH(4-Chloro-2,5-dimethoxy-[N-(2-hydroxybenzyl)]phe-nethylamine).
n.
25C-NBF(4-Chloro-2,5-dimethoxy-[N-(2-fluorobenzyl)]phenethyla-mine).
o.
25C-NBMD(4-Chloro-2,5-dimethoxy-[N-(2,3-methylenedioxybenzyl)]phenethylamine).
p.
25H-NBOMe(2,5-Dimethoxy-[N-(2-methoxybenzyl)]phenethyla-mine).
q.
25H-NBOH(2,5-Dimethoxy-[N-(2-hydroxybenzyl)]phenethylamine).
r.
25H-NBF(2,5-Dimethoxy-[N-(2-fluorobenzyl)]phenethylamine).
s.
25D-NBOMe(4-Methyl-2,5-dimethoxy-[N-(2-methoxybenzyl)]phe-nethylamine),whichdoesnotincludesubstitutedcathinonesasdescribedinsubparagraph191.
194.
SubstitutedTryptamines.
—Unlessspecificallyexceptedorunlesslistedinanotherschedule,orcontainedwithinapharmaceuticalproductapprovedbytheUnitedStatesFoodandDrugAdministration,anymaterial,compound,mixture,orpreparationcontaininga2-(1H-indol-3-yl)ethana-mine,forexampletryptamine,structurewithorwithoutmono-ordi-substitutionoftheaminenitrogenwithalkyloralkenylgroups,orbyinclusionoftheaminonitrogenatominacyclicstructure,whetherornotsubstitutedatthealphapositionwithanalkylgroup,whetherornotsubstitutedontheindoleringtoanyextentwithanyalkyl,alkoxy,halo,hydroxyl,oracetoxygroups,including,butnotlimitedto:a.
Alpha-Ethyltryptamine.
b.
Bufotenine.
c.
DET(Diethyltryptamine).
d.
DMT(Dimethyltryptamine).
e.
MET(N-Methyl-N-ethyltryptamine).
f.
DALT(N,N-Diallyltryptamine).
g.
EiPT(N-Ethyl-N-isopropyltryptamine).
h.
MiPT(N-Methyl-N-isopropyltryptamine).
i.
5-Hydroxy-AMT(5-Hydroxy-alpha-methyltryptamine).
j.
5-Hydroxy-N-methyltryptamine.
Ch.
2018-13LAWSOFFLORIDACh.
2018-1340CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
k.
5-MeO-MiPT(5-Methoxy-N-methyl-N-isopropyltryptamine).
l.
5-MeO-AMT(5-Methoxy-alpha-methyltryptamine).
m.
Methyltryptamine.
n.
5-MeO-DMT(5-Methoxy-N,N-dimethyltryptamine).
o.
5-Me-DMT(5-Methyl-N,N-dimethyltryptamine).
p.
5-MeO-DiPT(5-Methoxy-N,N-Diisopropyltryptamine).
q.
DiPT(N,N-Diisopropyltryptamine).
r.
DPT(N,N-Dipropyltryptamine).
s.
4-Hydroxy-DiPT(4-Hydroxy-N,N-diisopropyltryptamine).
t.
5-MeO-DALT(5-Methoxy-N,N-Diallyltryptamine).
u.
4-AcO-DMT(4-Acetoxy-N,N-dimethyltryptamine).
v.
4-AcO-DiPT(4-Acetoxy-N,N-diisopropyltryptamine).
w.
4-Hydroxy-DET(4-Hydroxy-N,N-diethyltryptamine).
x.
4-Hydroxy-MET(4-Hydroxy-N-methyl-N-ethyltryptamine).
y.
4-Hydroxy-MiPT(4-Hydroxy-N-methyl-N-isopropyltryptamine).
z.
Methyl-alpha-ethyltryptamine.
aa.
Bromo-DALT(Bromo-N,N-diallyltryptamine),whichdoesnotincludetryptamine,psilocynasdescribedinsubparagraph34.
,orpsilocybinasdescribedinsubparagraph33.
195.
SubstitutedPhenylcyclohexylamines.
—Unlessspecificallyex-ceptedorunlesslistedinanotherschedule,orcontainedwithinapharmaceuticalproductapprovedbytheUnitedStatesFoodandDrugAdministration,anymaterial,compound,mixture,orpreparationcontain-ingaphenylcyclohexylaminestructure,withorwithoutanysubstitutiononthephenylring,anysubstitutiononthecyclohexylring,anyreplacementofthephenylringwithathiophenylorbenzothiophenylring,withorwithoutsubstitutionontheaminewithalkyl,dialkyl,oralkoxysubstituents,inclusionofthenitrogeninacyclicstructure,oranycombinationoftheabove,including,butnotlimitedto:a.
BTCP(Benzothiophenylcyclohexylpiperidine)orBCP(Benocyclidine).
b.
PCE(N-Ethyl-1-phenylcyclohexylamine)(Ethylamineanalogofphen-cyclidine).
Ch.
2018-13LAWSOFFLORIDACh.
2018-1341CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
c.
PCPY(N-(1-Phenylcyclohexyl)-pyrrolidine)(Pyrrolidineanalogofphencyclidine).
d.
PCPr(Phenylcyclohexylpropylamine).
e.
TCP(1-[1-(2-Thienyl)-cyclohexyl]-piperidine)(Thiopheneanalogofphencyclidine).
f.
PCEEA(Phenylcyclohexyl(ethoxyethylamine)).
g.
PCMPA(Phenylcyclohexyl(methoxypropylamine)).
h.
Methoxetamine.
i.
3-Methoxy-PCE((3-Methoxyphenyl)cyclohexylethylamine).
j.
Bromo-PCP((Bromophenyl)cyclohexylpiperidine).
k.
Chloro-PCP((Chlorophenyl)cyclohexylpiperidine).
l.
Fluoro-PCP((Fluorophenyl)cyclohexylpiperidine).
m.
Hydroxy-PCP((Hydroxyphenyl)cyclohexylpiperidine).
n.
Methoxy-PCP((Methoxyphenyl)cyclohexylpiperidine).
o.
Methyl-PCP((Methylphenyl)cyclohexylpiperidine).
p.
Nitro-PCP((Nitrophenyl)cyclohexylpiperidine).
q.
Oxo-PCP((Oxophenyl)cyclohexylpiperidine).
r.
Amino-PCP((Aminophenyl)cyclohexylpiperidine).
196.
W-15,4-chloro-N-[1-(2-phenylethyl)-2-piperidinylidene]-benzene-sulfonamide.
197.
W-18,4-chloro-N-[1-[2-(4-nitrophenyl)ethyl]-2-piperidinylidene]-benzenesulfonamide.
198.
AH-7921,3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]-benzamide.
199.
U47700,trans-3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methyl-benzamide.
200.
MT-45,1-cyclohexyl-4-(1,2-diphenylethyl)-piperazine,dihy-drochloride.
(2)SCHEDULEII.
—AsubstanceinScheduleIIhasahighpotentialforabuseandhasacurrentlyacceptedbutseverelyrestrictedmedicaluseintreatmentintheUnitedStates,andabuseofthesubstancemayleadtoCh.
2018-13LAWSOFFLORIDACh.
2018-1342CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
severepsychologicalorphysicaldependence.
ThefollowingsubstancesarecontrolledinScheduleII:(a)Unlessspecificallyexceptedorunlesslistedinanotherschedule,anyofthefollowingsubstances,whetherproduceddirectlyorindirectlybyextractionfromsubstancesofvegetableoriginorindependentlybymeansofchemicalsynthesis:1.
Opiumandanysalt,compound,derivative,orpreparationofopium,exceptnalmefeneorisoquinolinealkaloidsofopium,including,butnotlimitedtothefollowing:a.
Rawopium.
b.
Opiumextracts.
c.
Opiumfluidextracts.
d.
Powderedopium.
e.
Granulatedopium.
f.
Tinctureofopium.
g.
Codeine.
h.
Dihydroetorphine.
i.
h.
Ethylmorphine.
j.
i.
Etorphinehydrochloride.
k.
j.
Hydrocodoneandhydrocodonecombinationproducts.
l.
k.
Hydromorphone.
m.
l.
Levo-alphacetylmethadol(alsoknownaslevo-alpha-acetylmetha-dol,levomethadylacetate,orLAAM).
n.
m.
Metopon(methyldihydromorphinone).
o.
n.
Morphine.
p.
Oripavine.
q.
o.
Oxycodone.
r.
p.
Oxymorphone.
s.
q.
Thebaine.
2.
Anysalt,compound,derivative,orpreparationofasubstancewhichischemicallyequivalenttooridenticalwithanyofthesubstancesreferredtoCh.
2018-13LAWSOFFLORIDACh.
2018-1343CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
insubparagraph1.
,exceptthatthesesubstancesshallnotincludetheisoquinolinealkaloidsofopium.
3.
AnypartoftheplantofthespeciesPapaversomniferum,L.
4.
Cocaineorecgonine,includinganyoftheirstereoisomers,andanysalt,compound,derivative,orpreparationofcocaineorecgonine,exceptthatthesesubstancesshallnotincludeioflupaneI123.
(b)Unlessspecificallyexceptedorunlesslistedinanotherschedule,anyofthefollowingsubstances,includingtheirisomers,esters,ethers,salts,andsaltsofisomers,esters,andethers,whenevertheexistenceofsuchisomers,esters,ethers,andsaltsispossiblewithinthespecificchemicaldesignation:1.
Alfentanil.
2.
Alphaprodine.
3.
Anileridine.
4.
Bezitramide.
5.
Bulkpropoxyphene(nondosageforms).
6.
Carfentanil.
7.
Dihydrocodeine.
8.
Diphenoxylate.
9.
Fentanyl.
10.
Isomethadone.
11.
Levomethorphan.
12.
Levorphanol.
13.
Metazocine.
14.
Methadone.
15.
Methadone-Intermediate,4-cyano-2-dimethylamino-4,4-diphenylbutane.
16.
Moramide-Intermediate,2-methyl-3-morpholoino-1,1-diphenylpropane-carboxylicacid.
17.
Nabilone.
18.
Pethidine(meperidine).
Ch.
2018-13LAWSOFFLORIDACh.
2018-1344CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
19.
Pethidine-Intermediate-A,4-cyano-1-methyl-4-phenylpiperidine.
20.
Pethidine-Intermediate-B,ethyl-4-phenylpiperidine-4-carboxylate.
21.
Pethidine-Intermediate-C,1-methyl-4-phenylpiperidine-4-car-boxylicacid.
22.
Phenazocine.
23.
Phencyclidine.
24.
1-Phenylcyclohexylamine.
25.
Piminodine.
26.
1-Piperidinocyclohexanecarbonitrile.
27.
Racemethorphan.
28.
Racemorphan.
29.
Remifentanil.
30.
29.
Sufentanil.
31.
Tapentadol.
32.
Thiafentanil.
(c)Unlessspecificallyexceptedorunlesslistedinanotherschedule,anymaterial,compound,mixture,orpreparationwhichcontainsanyquantityofthefollowingsubstances,includingtheirsalts,isomers,opticalisomers,saltsoftheirisomers,andsaltsoftheiropticalisomers:1.
Amobarbital.
2.
Amphetamine.
3.
Glutethimide.
4.
Lisdexamfetamine.
5.
4.
Methamphetamine.
6.
5.
Methylphenidate.
7.
6.
Pentobarbital.
8.
7.
Phenmetrazine.
9.
8.
Phenylacetone.
Ch.
2018-13LAWSOFFLORIDACh.
2018-1345CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
10.
9.
Secobarbital.
(d)Dronabinol(syntheticTHC)inoralsolutioninadrugproductapprovedbytheUnitedStatesFoodandDrugAdministration.
(3)SCHEDULEIII.
—AsubstanceinScheduleIIIhasapotentialforabuselessthanthesubstancescontainedinSchedulesIandIIandhasacurrentlyacceptedmedicaluseintreatmentintheUnitedStates,andabuseofthesubstancemayleadtomoderateorlowphysicaldependenceorhighpsychologicaldependenceor,inthecaseofanabolicsteroids,mayleadtophysicaldamage.
ThefollowingsubstancesarecontrolledinScheduleIII:(a)Unlessspecificallyexceptedorunlesslistedinanotherschedule,anymaterial,compound,mixture,orpreparationwhichcontainsanyquantityofthefollowingsubstanceshavingadepressantorstimulanteffectonthenervoussystem:1.
Anysubstancewhichcontainsanyquantityofaderivativeofbarbituricacid,includingthiobarbituricacid,oranysaltofaderivativeofbarbituricacidorthiobarbituricacid,including,butnotlimitedto,butabarbitalandbutalbital.
2.
Benzphetamine.
3.
Buprenorphine.
4.
3.
Chlorhexadol.
5.
4.
Chlorphentermine.
6.
5.
Clortermine.
7.
Embutramide.
8.
6.
Lysergicacid.
9.
7.
Lysergicacidamide.
10.
8.
Methyprylon.
11.
Perampanel.
12.
9.
Phendimetrazine.
13.
10.
Sulfondiethylmethane.
14.
11.
Sulfonethylmethane.
15.
12.
Sulfonmethane.
16.
13.
Tiletamineandzolazepamoranysaltthereof.
(b)Nalorphine.
Ch.
2018-13LAWSOFFLORIDACh.
2018-1346CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
(c)Unlessspecificallyexceptedorunlesslistedinanotherschedule,anymaterial,compound,mixture,orpreparationcontaininglimitedquantitiesofanyofthefollowingcontrolledsubstancesoranysaltsthereof:1.
Notmorethan1.
8gramsofcodeineper100millilitersornotmorethan90milligramsperdosageunit,withanequalorgreaterquantityofanisoquinolinealkaloidofopium.
2.
Notmorethan1.
8gramsofcodeineper100millilitersornotmorethan90milligramsperdosageunit,withrecognizedtherapeuticamountsofoneormoreactiveingredientswhicharenotcontrolledsubstances.
3.
Notmorethan300milligramsofhydrocodoneper100millilitersornotmorethan15milligramsperdosageunit,withafourfoldorgreaterquantityofanisoquinolinealkaloidofopium.
4.
Notmorethan300milligramsofhydrocodoneper100millilitersornotmorethan15milligramsperdosageunit,withrecognizedtherapeuticamountsofoneormoreactiveingredientsthatarenotcontrolledsubstances.
5.
Notmorethan1.
8gramsofdihydrocodeineper100millilitersornotmorethan90milligramsperdosageunit,withrecognizedtherapeuticamountsofoneormoreactiveingredientswhicharenotcontrolledsubstances.
6.
Notmorethan300milligramsofethylmorphineper100millilitersornotmorethan15milligramsperdosageunit,withoneormoreactive,nonnarcoticingredientsinrecognizedtherapeuticamounts.
7.
Notmorethan50milligramsofmorphineper100millilitersorper100grams,withrecognizedtherapeuticamountsofoneormoreactiveingredientswhicharenotcontrolledsubstances.
Forpurposesofchargingapersonwithaviolationofs.
893.
135involvinganycontrolledsubstancedescribedinsubparagraph3.
orsubparagraph4.
,thecontrolledsubstanceisaScheduleIIIcontrolledsubstancepursuanttothisparagraphbuttheweightofthecontrolledsubstancepermillilitersorperdosageunitisnotrelevanttothechargingofaviolationofs.
893.
135.
Theweightofthecontrolledsubstanceshallbedeterminedpursuanttos.
893.
135(6).
(d)Anabolicsteroids.
1.
Theterm"anabolicsteroid"meansanydrugorhormonalsubstance,chemicallyandpharmacologicallyrelatedtotestosterone,otherthanestrogens,progestins,andcorticosteroids,thatpromotesmusclegrowthandincludes:a.
Androsterone.
Ch.
2018-13LAWSOFFLORIDACh.
2018-1347CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
b.
Androsteroneacetate.
c.
Boldenone.
d.
Boldenoneacetate.
e.
Boldenonebenzoate.
f.
Boldenoneundecylenate.
g.
Chlorotestosterone(Clostebol).
h.
Dehydrochlormethyltestosterone.
i.
Dihydrotestosterone(Stanolone).
j.
Drostanolone.
k.
Ethylestrenol.
l.
Fluoxymesterone.
m.
Formebulone(Formebolone).
n.
Mesterolone.
o.
Methandrostenolone(Methandienone).
p.
Methandranone.
q.
Methandriol.
r.
Methenolone.
s.
Methyltestosterone.
t.
Mibolerone.
u.
Nortestosterone(Nandrolone).
v.
Norethandrolone.
w.
Nortestosteronedecanoate.
x.
Nortestosteronephenylpropionate.
y.
Nortestosteronepropionate.
z.
Oxandrolone.
aa.
Oxymesterone.
bb.
Oxymetholone.
Ch.
2018-13LAWSOFFLORIDACh.
2018-1348CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
cc.
Stanozolol.
dd.
Testolactone.
ee.
Testosterone.
ff.
Testosteroneacetate.
gg.
Testosteronebenzoate.
hh.
Testosteronecypionate.
ii.
Testosteronedecanoate.
jj.
Testosteroneenanthate.
kk.
Testosteroneisocaproate.
ll.
Testosteroneoleate.
mm.
Testosteronephenylpropionate.
nn.
Testosteronepropionate.
oo.
Testosteroneundecanoate.
pp.
Trenbolone.
qq.
Trenboloneacetate.
rr.
Anysalt,ester,orisomerofadrugorsubstancedescribedorlistedinthissubparagraphifthatsalt,ester,orisomerpromotesmusclegrowth.
2.
ThetermdoesnotincludeananabolicsteroidthatisexpresslyintendedforadministrationthroughimplantstocattleorothernonhumanspeciesandthathasbeenapprovedbytheUnitedStatesSecretaryofHealthandHumanServicesforsuchadministration.
However,anypersonwhoprescribes,dispenses,ordistributessuchasteroidforhumanuseisconsideredtohaveprescribed,dispensed,ordistributedananabolicsteroidwithinthemeaningofthisparagraph.
(e)Ketamine,includinganyisomers,esters,ethers,salts,andsaltsofisomers,esters,andethers,whenevertheexistenceofsuchisomers,esters,ethers,andsaltsispossiblewithinthespecificchemicaldesignation.
(f)Dronabinol(syntheticTHC)insesameoilandencapsulatedinasoftgelatincapsuleinadrugproductapprovedbytheUnitedStatesFoodandDrugAdministration.
(g)Anydrugproductcontaininggamma-hydroxybutyricacid,includingitssalts,isomers,andsaltsofisomers,forwhichanapplicationisapprovedunders.
505oftheFederalFood,Drug,andCosmeticAct.
Ch.
2018-13LAWSOFFLORIDACh.
2018-1349CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
(4)(a)SCHEDULEIV.
—AsubstanceinScheduleIVhasalowpotentialforabuserelativetothesubstancesinScheduleIIIandhasacurrentlyacceptedmedicaluseintreatmentintheUnitedStates,andabuseofthesubstancemayleadtolimitedphysicalorpsychologicaldependencerelativetothesubstancesinScheduleIII.
(b)Unlessspecificallyexceptedorunlesslistedinanotherschedule,anymaterial,compound,mixture,orpreparationwhichcontainsanyquantityofthefollowingsubstances,includingitssalts,isomers,andsaltsofisomerswhenevertheexistenceofsuchsalts,isomers,andsaltsofisomersispossiblewithinthespecificchemicaldesignation,arecontrolledinScheduleIV:1.
Alfaxalone.
2.
(a)Alprazolam.
3.
(b)Barbital.
4.
(c)Bromazepam.
5.
(iii)Butorphanoltartrate.
6.
(d)Camazepam.
7.
(jjj)Carisoprodol.
8.
(e)Cathine.
9.
(f)Chloralbetaine.
10.
(g)Chloralhydrate.
11.
(h)Chlordiazepoxide.
12.
(i)Clobazam.
13.
(j)Clonazepam.
14.
(k)Clorazepate.
15.
(l)Clotiazepam.
16.
(m)Cloxazolam.
17.
Dexfenfluramine.
18.
(n)Delorazepam.
19.
Dichloralphenazone.
20.
(p)Diazepam.
21.
(q)Diethylpropion.
Ch.
2018-13LAWSOFFLORIDACh.
2018-1350CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
22.
Eluxadoline.
23.
(r)Estazolam.
24.
Eszopiclone.
25.
(s)Ethchlorvynol.
26.
(t)Ethinamate.
27.
(u)Ethylloflazepate.
28.
(v)Fencamfamin.
29.
(w)Fenfluramine.
30.
(x)Fenproporex.
31.
(y)Fludiazepam.
32.
(z)Flurazepam.
33.
Fospropofol.
34.
(aa)Halazepam.
35.
(bb)Haloxazolam.
36.
(cc)Ketazolam.
37.
(dd)Loprazolam.
38.
(ee)Lorazepam.
39.
Lorcaserin.
40.
(ff)Lormetazepam.
41.
(gg)Mazindol.
42.
(hh)Mebutamate.
43.
(ii)Medazepam.
44.
(jj)Mefenorex.
45.
(kk)Meprobamate.
46.
(ll)Methohexital.
47.
(mm)Methylphenobarbital.
48.
(nn)Midazolam.
Ch.
2018-13LAWSOFFLORIDACh.
2018-1351CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
49.
Modafinil.
50.
(oo)Nimetazepam.
51.
(pp)Nitrazepam.
52.
(qq)Nordiazepam.
53.
(rr)Oxazepam.
54.
(ss)Oxazolam.
55.
(tt)Paraldehyde.
56.
(uu)Pemoline.
57.
(vv)Pentazocine.
58.
Petrichloral.
59.
(ww)Phenobarbital.
60.
(xx)Phentermine.
61.
(yy)Pinazepam.
62.
(zz)Pipradrol.
63.
(aaa)Prazepam.
64.
(o)Propoxyphene(dosageforms).
65.
(bbb)Propylhexedrine,excludinganypatentorproprietaryprepara-tioncontainingpropylhexedrine,unlessotherwiseprovidedbyfederallaw.
66.
(ccc)Quazepam.
67.
Sibutramine.
68.
(eee)SPA[(-)-1dimethylamino-1,2diphenylethane].
69.
Suvorexant.
70.
(fff)Temazepam.
71.
(ddd)Tetrazepam.
72.
Tramadol.
73.
(ggg)Triazolam.
74.
Zaleplon.
Ch.
2018-13LAWSOFFLORIDACh.
2018-1352CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
75.
Zolpidem.
76.
Zopiclone.
77.
(hhh)Notmorethan1milligramofdifenoxinandnotlessthan25microgramsofatropinesulfateperdosageunit.
(5)SCHEDULEV.
—Asubstance,compound,mixture,orpreparationofasubstanceinScheduleVhasalowpotentialforabuserelativetothesubstancesinScheduleIVandhasacurrentlyacceptedmedicaluseintreatmentintheUnitedStates,andabuseofsuchcompound,mixture,orpreparationmayleadtolimitedphysicalorpsychologicaldependencerelativetothesubstancesinScheduleIV.
(a)SubstancescontrolledinScheduleVincludeanycompound,mixture,orpreparationcontaininganyofthefollowinglimitedquantitiesofcontrolledsubstances,whichmustshallincludeoneormoreactivemedicinalingredientsthatwhicharenotcontrolledsubstancesinsufficientproportiontoconferuponthecompound,mixture,orpreparationvaluablemedicinalqualitiesotherthanthosepossessedbythecontrolledsubstancealone:1.
Notmorethan200milligramsofcodeineper100millilitersorper100grams.
2.
Notmorethan100milligramsofdihydrocodeineper100millilitersorper100grams.
3.
Notmorethan100milligramsofethylmorphineper100millilitersorper100grams.
4.
Notmorethan2.
5milligramsofdiphenoxylateandnotlessthan25microgramsofatropinesulfateperdosageunit.
5.
Notmorethan100milligramsofopiumper100millilitersorper100grams.
6.
Notmorethan0.
5milligramsofdifenoxinandnotlessthan25microgramsofatropinesulfateperdosageunit.
(b)Unlessaspecificexceptionexistsorunlesslistedinanotherschedule,anymaterial,compound,mixture,orpreparationthatcontainsanyquantityofthefollowingsubstancesiscontrolledinScheduleV:1.
Brivaracetam.
2.
Ezogabine.
3.
Lacosamide.
4.
PregabalinNarcoticdrugs.
Unlessspecificallyexceptedorunlesslistedinanotherschedule,anymaterial,compound,mixture,orpreparationCh.
2018-13LAWSOFFLORIDACh.
2018-1353CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
containinganyofthefollowingnarcoticdrugsandtheirsalts:Buprenor-phine.
(c)Stimulants.
Unlessspecificallyexceptedorunlesslistedinanotherschedule,anymaterial,compound,mixture,orpreparationwhichcontainsanyquantityofthefollowingsubstanceshavingastimulanteffectonthecentralnervoussystem,includingitssalts,isomers,andsaltsofisomers:Pyrovalerone.
Section9.
Subsection(1)ofsection893.
04,FloridaStatutes,isamendedtoread:893.
04Pharmacistandpractitioner.
—(1)Apharmacist,ingoodfaithandinthecourseofprofessionalpracticeonly,maydispensecontrolledsubstancesuponawritten,ororal,orelectronicprescriptionofapractitioner,underthefollowingconditions:(a)Oralprescriptionsmustbepromptlyreducedtowritingbythepharmacistorrecordedelectronicallyifpermittedbyfederallaw.
(b)Thewrittenprescriptionmustbedatedandsignedbytheprescribingpractitioneronthedaywhenissued.
(c)Thereshallappearonthefaceoftheprescriptionorwrittenrecordthereofforthecontrolledsubstancethefollowinginformation:1.
Thefullnameandaddressofthepersonforwhom,ortheowneroftheanimalforwhich,thecontrolledsubstanceisdispensed.
2.
Thefullnameandaddressoftheprescribingpractitionerandthepractitioner'sfederalcontrolledsubstanceregistrynumbershallbeprintedthereon.
3.
Iftheprescriptionisforananimal,thespeciesofanimalforwhichthecontrolledsubstanceisprescribed.
4.
Thenameofthecontrolledsubstanceprescribedandthestrength,quantity,anddirectionsforusethereof.
5.
Thenumberoftheprescription,asrecordedintheprescriptionfilesofthepharmacyinwhichitisfilled.
6.
Theinitialsofthepharmacistfillingtheprescriptionandthedatefilled.
(d)Theprescriptionshallberetainedonfilebytheproprietorofthepharmacyinwhichitisfilledforaperiodof2years.
(e)Affixedtotheoriginalcontainerinwhichacontrolledsubstanceisdelivereduponaprescriptionorauthorizedrefillthereof,ashereinafterprovided,thereshallbealabelbearingthefollowinginformation:Ch.
2018-13LAWSOFFLORIDACh.
2018-1354CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
1.
Thenameandaddressofthepharmacyfromwhichsuchcontrolledsubstancewasdispensed.
2.
Thedateonwhichtheprescriptionforsuchcontrolledsubstancewasfilled.
3.
Thenumberofsuchprescription,asrecordedintheprescriptionfilesofthepharmacyinwhichitisfilled.
4.
Thenameoftheprescribingpractitioner.
5.
Thenameofthepatientforwhom,oroftheownerandspeciesoftheanimalforwhich,thecontrolledsubstanceisprescribed.
6.
Thedirectionsfortheuseofthecontrolledsubstanceprescribedintheprescription.
7.
Aclear,concisewarningthatitisacrimetotransferthecontrolledsubstancetoanypersonotherthanthepatientforwhomprescribed.
(f)AprescriptionforacontrolledsubstancelistedinScheduleIImaybedispensedonlyuponawrittenorelectronicprescriptionofapractitioner,exceptthatinanemergencysituation,asdefinedbyregulationoftheDepartmentofHealth,suchcontrolledsubstancemaybedispenseduponoralprescriptionbutislimitedtoa72-hoursupply.
AprescriptionforacontrolledsubstancelistedinScheduleIImaynotberefilled.
(g)AprescriptionforacontrolledsubstancelistedinScheduleIII,ScheduleIV,orScheduleVmaynotbefilledorrefilledmorethanfivetimeswithinaperiodof6monthsafterthedateonwhichtheprescriptionwaswrittenunlesstheprescriptionisrenewedbyapractitioner.
Section10.
Section893.
055,FloridaStatutes,isamendedtoread:(Substantialrewordingofsection.
Sees.
893.
055,F.
S.
,forpresenttext.
)893.
055Prescriptiondrugmonitoringprogram.
—(1)Asusedinthissection,theterm:(a)"Activeinvestigation"meansaninvestigationthatisbeingconductedwithareasonable,goodfaithbeliefthatitcouldleadtothefilingofadministrative,civil,orcriminalproceedings,orthatisongoingandcontinuingandforwhichthereisareasonable,goodfaithanticipationofsecuringanarrestorprosecutionintheforeseeablefuture.
(b)"Administration"meanstheobtainingandgivingofasingledoseofacontrolledsubstancebyalegallyauthorizedpersontoapatientforherorhisconsumption.
Ch.
2018-13LAWSOFFLORIDACh.
2018-1355CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
(c)"Controlledsubstance"meansacontrolledsubstancelistedinScheduleII,ScheduleIII,ScheduleIV,orScheduleVofs.
893.
03or21U.
S.
C.
s.
812.
(d)"Dispense"meansthetransferofpossessionofoneormoredosesofacontrolledsubstancebyadispensertotheultimateconsumerortohisorheragent.
(e)"Dispenser"meansadispensinghealthcarepractitioner,pharmacy,orpharmacistlicensedtodispensecontrolledsubstancesinorintothisstate.
(f)"Healthcarepractitioner"or"practitioner"meansanypractitionerlicensedunderchapter458,chapter459,chapter461,chapter463,chapter464,chapter465,orchapter466.
(g)"Healthcareregulatoryboard"hasthesamemeaningasins.
456.
001(1).
(h)"Lawenforcementagency"meanstheDepartmentofLawEnforce-ment,asheriff'sofficeinthisstate,apolicedepartmentinthisstate,oralawenforcementagencyoftheFederalGovernmentwhichenforcesthelawsofthisstateortheUnitedStatesrelatingtocontrolledsubstancesandwhoseagentsandofficersareempoweredbylawtoconductcriminalinvestigationsandmakearrests.
(i)"Pharmacy"includesacommunitypharmacy,aninstitutionalphar-macy,anuclearpharmacy,aspecialpharmacy,oranInternetpharmacythatislicensedbythedepartmentunderchapter465andthatdispensesordeliverscontrolledsubstancestoanindividualoraddressinthisstate.
(j)"Prescriber"meansaprescribingphysician,prescribingpractitioner,orotherprescribinghealthcarepractitionerauthorizedbythelawsofthisstatetoordercontrolledsubstances.
(k)"Programmanager"meansanemployeeoforapersoncontractedbythedepartmentwhoisdesignatedtoensuretheintegrityoftheprescriptiondrugmonitoringprograminaccordancewiththerequirementsestablishedinthissection.
(2)(a)Thedepartmentshallmaintainanelectronicsystemtocollectandstorecontrolledsubstancedispensinginformationandshallreleasetheinformationasauthorizedinthissectionands.
893.
0551.
Theelectronicsystemmust:1.
Notinfringeuponthelegitimateprescribingordispensingofacontrolledsubstancebyaprescriberordispenseractingingoodfaithandinthecourseofprofessionalpractice.
2.
BeconsistentwithstandardsoftheAmericanSocietyforAutomationinPharmacy.
Ch.
2018-13LAWSOFFLORIDACh.
2018-1356CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
3.
ComplywiththeHealthInsurancePortabilityandAccountabilityActasitpertainstoprotectedhealthinformation,electronicprotectedhealthinformation,andallotherrelevantstateandfederalprivacyandsecuritylawsandregulations.
4.
Purgeorcausetobepurgedinformationinthedatabasethatismorethan4yearsold.
(b)Thedepartmentmaycollaboratewithprofessionalhealthcareregulatoryboards,appropriateorganizations,andotherstateagenciestoidentifyindicatorsofcontrolledsubstanceabuse.
(3)(a)Foreachcontrolledsubstancedispensedtoapatientinthisstate,thefollowinginformationmustbereportedbythedispensertothesystemassoonthereafteraspossiblebutnolaterthanthecloseofthenextbusinessdayafterthedaythecontrolledsubstanceisdispensedunlessanextensionorexemptionisapprovedbythedepartment:1.
Thenameoftheprescribingpractitioner,thepractitioner'sfederalDrugEnforcementAdministrationregistrationnumber,thepractitioner'sNationalProviderIdentificationorotherappropriateidentifier,andthedateoftheprescription.
2.
Thedatetheprescriptionwasfilledandthemethodofpayment,suchascashbyanindividual,insurancecoveragethroughathirdparty,orMedicaidpayment.
Thisparagraphdoesnotauthorizethedepartmenttoincludeindividualcreditcardnumbersorotheraccountnumbersinthesystem.
3.
Thefullname,address,telephonenumber,anddateofbirthofthepersonforwhomtheprescriptionwaswritten.
4.
Thename,nationaldrugcode,quantity,andstrengthofthecontrolledsubstancedispensed.
5.
Thefullname,federalDrugEnforcementAdministrationregistrationnumber,StateofFloridaDepartmentofHealthissuedpharmacypermitnumber,andaddressofthepharmacyorotherlocationfromwhichthecontrolledsubstancewasdispensed.
Ifthecontrolledsubstancewasdispensedbyapractitionerotherthanapharmacist,thepractitioner'sfullname,address,federalDrugEnforcementAdministrationregistrationnumber,StateofFloridaDepartmentofHealthissuedlicensenumber,andNationalProviderIdentification.
6.
Whetherthedrugwasdispensedasaninitialprescriptionorarefill,andthenumberofrefillsordered.
7.
Thenameoftheindividualpickingupthecontrolledsubstanceprescriptionandtypeandissueroftheidentificationprovided.
Ch.
2018-13LAWSOFFLORIDACh.
2018-1357CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
8.
Otherappropriateidentifyinginformationasdeterminedbydepart-mentrule.
(b)Thefollowingactsofadministrationordispensingareexemptfromthereportingrequirementsofthissubsection:1.
Allactsofadministrationofacontrolledsubstance.
2.
ThedispensingofacontrolledsubstanceinthehealthcaresystemoftheDepartmentofCorrections.
3.
Thedispensingofacontrolledsubstancetoapersonundertheageof16.
(4)Thefollowingpersonsmustbeprovideddirectaccesstoinformationinthesystem:(a)Aprescriberordispenserorhisorherdesignee.
(b)AnemployeeoftheUnitedStatesDepartmentofVeteransAffairs,theUnitedStatesDepartmentofDefense,ortheIndianHealthServicewhoprovideshealthcareservicespursuanttosuchemploymentandwhohastheauthoritytoprescribeordispensecontrolledsubstancesshallhaveaccesstotheinformationintheprogram'ssystemuponverificationofemployment.
(c)Theprogrammanagerordesignatedprogramandsupportstafftoadministerthesystem.
1.
Inordertocalculateperformancemeasurespursuanttosubsection(14),theprogrammanagerorprogramandsupportstaffmemberswhohavebeendirectedbytheprogrammanagertocalculateperformancemeasuresmayhavedirectaccesstoinformationthatcontainsnoidentifyinginformationofanypatient,physician,healthcarepractitioner,prescriber,ordispenser.
2.
Theprogrammanagerordesignatedprogramandsupportstaffmustprovidethedepartment,uponrequest,datathatdoesnotcontainpatient,physician,healthcarepractitioner,prescriber,ordispenseridentifyinginformationforpublichealthcareandsafetyinitiativespurposes.
3.
Theprogrammanager,upondeterminingapatternconsistentwiththedepartment'srulesestablishedundersubsection(16),mayproviderelevantinformationtotheprescriberanddispenser.
4.
Theprogrammanager,upondeterminingapatternconsistentwiththerulesestablishedundersubsection(16)andhavingcausetobelieveaviolationofs.
893.
13(7)(a)8.
,(8)(a),or(8)(b)hasoccurred,mayproviderelevantinformationtotheapplicablelawenforcementagency.
TheprogrammanageranddesignatedprogramandsupportstaffmustcompletealevelIIbackgroundscreening.
Ch.
2018-13LAWSOFFLORIDACh.
2018-1358CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
(5)Thefollowingentitiesmaynotdirectlyaccessinformationinthesystem,butmayrequestinformationfromtheprogrammanagerordesignatedprogramandsupportstaff:(a)Thedepartmentanditshealthcareregulatoryboards,asappro-priate,forinvestigationsinvolvinglicenseesauthorizedtoprescribeordispensecontrolledsubstances.
(b)TheAttorneyGeneralforMedicaidfraudcasesinvolvingprescribedcontrolledsubstances.
(c)Alawenforcementagencyduringactiveinvestigationsofpotentialcriminalactivity,fraud,ortheftregardingprescribedcontrolledsubstances.
(d)Amedicalexaminerwhenconductinganauthorizedinvestigationunders.
406.
11,todeterminethecauseofdeathofanindividual.
(e)Animpairedpractitionerconsultantwhoisretainedbythedepart-mentunders.
456.
076toreviewthesysteminformationofanimpairedpractitionerprogramparticipantorareferralwhohasagreedtobeevaluatedormonitoredthroughtheprogramandwhohasseparatelyagreedinwritingtotheconsultant'saccesstoandreviewofsuchinformation.
(f)Apatientorthelegalguardianordesignatedhealthcaresurrogateofanincapacitatedpatientwhosubmitsawrittenandnotarizedrequestthatincludesthepatient'sfullname,address,phonenumber,dateofbirth,andacopyofagovernment-issuedphotoidentification.
(6)Thedepartmentmayenterintooneormorereciprocalagreementsorcontractstoshareprescriptiondrugmonitoringinformationwithotherstates,districts,orterritoriesiftheprescriptiondrugmonitoringprogramsofsuchotherstates,districts,orterritoriesarecompatiblewiththeFloridaprogram.
(a)Indeterminingcompatibility,thedepartmentshallconsider:1.
Thesafeguardsforprivacyofpatientrecordsandthesuccessoftheprograminprotectingpatientprivacy.
2.
Thepersonsauthorizedtoviewthedatacollectedbytheprogram.
Comparableentitiesandlicensedhealthcarepractitionersinotherstates,districts,orterritoriesoftheUnitedStates,lawenforcementagencies,theAttorneyGeneral'sMedicaidFraudControlUnit,medicalregulatoryboards,and,asneeded,managementstaffthathavesimilardutiesasmanagementstaffwhoworkwiththeprescriptiondrugmonitoringprogramasauthorizedins.
893.
0551areauthorizedaccessuponapprovalbythedepartment.
3.
Theschedulesofthecontrolledsubstancesthataremonitoredbytheprogram.
Ch.
2018-13LAWSOFFLORIDACh.
2018-1359CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
4.
Thedatareportedtoorincludedintheprogram'ssystem.
5.
Anyimplementingcriteriadeemedessentialforathoroughcompar-ison.
6.
Thecostsandbenefitstothestateofsharingprescriptioninformation.
(b)Thedepartmentshallassesstheprescriptiondrugmonitoringprogram'scontinuedcompatibilitywithotherstates',districts',orterritories'programsevery4years.
(c)Anyagreementsorcontractsforsharingofprescriptiondrugmonitoringinformationbetweenthedepartmentandotherstates,districts,orterritoriesshallcontainthesamerestrictionsandrequirementsasthissectionors.
893.
0551,andtheinformationmustbeprovidedaccordingtothedepartment'sdeterminationofcompatibility.
(7)Thedepartmentmayenterintoagreementsorcontractstoestablishsecureconnectionsbetweenthesystemandaprescribingordispensinghealthcarepractitioner'selectronichealthrecordkeepingsystem.
Theelectronichealthrecordkeepingsystemownerorlicenseholderwillberesponsibleforensuringthatonlyauthorizedindividualshaveaccesstoprescriptiondrugmonitoringprograminformation.
(8)Aprescriberordispenseroradesigneeofaprescriberordispensermustconsultthesystemtoreviewapatient'scontrolledsubstancedispensinghistorybeforeprescribingordispensingacontrolledsubstanceforapatientage16orolder.
ThisrequirementdoesnotapplywhenprescribingordispensinganonopioidcontrolledsubstancelistedinScheduleVofs.
893.
03or21U.
S.
C.
812.
Forpurposesofthissubsection,a"nonopioidcontrolledsubstance"isacontrolledsubstancethatdoesnotcontainanyamountofasubstancelistedasanopioidins.
893.
03or21U.
S.
C.
812.
(a)Thedutytoconsultthesystemdoesnotapplywhenthesystem:1.
Isdeterminedbythedepartmenttobenonoperational;or2.
Cannotbeaccessedbytheprescriberordispenseroradesigneeoftheprescriberordispenserbecauseofatemporarytechnologicalorelectricalfailure.
(b)Aprescriberordispenserordesigneeofaprescriberordispenserwhodoesnotconsultthesystemunderthissubsectionshalldocumentthereasonheorshedidnotconsultthesysteminthepatient'smedicalrecordorprescriptionrecordandshallnotprescribeordispensegreaterthana3-daysupplyofacontrolledsubstancetothepatient.
(c)ThedepartmentshallissueanondisciplinarycitationtoanyprescriberordispenserwhofailstoconsultthesystemasrequiredbythisCh.
2018-13LAWSOFFLORIDACh.
2018-1360CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
subsectionforaninitialoffense.
Eachsubsequentoffenseissubjecttodisciplinaryactionpursuanttos.
456.
073.
(9)Apersonwhowillfullyandknowinglyfailstoreportthedispensingofacontrolledsubstanceasrequiredbythissectioncommitsamisdemeanorofthefirstdegree,punishableasprovidedins.
775.
082ors.
775.
083.
(10)Informationintheprescriptiondrugmonitoringprogram'ssystemmaybereleasedonlyasprovidedinthissectionands.
893.
0551.
Thecontentofthesystemisintendedtobeinformationalonly.
Informationinthesystemisnotsubjecttodiscoveryorintroductionintoevidenceinanyciviloradministrativeactionagainstaprescriber,dispenser,pharmacy,orpatientarisingoutofmattersthatarethesubjectofinformationinthesystem.
Theprogrammanagerandauthorizedpersonswhoparticipateinpreparing,reviewing,issuing,oranyotheractivityrelatedtomanagementofthesystemmaynotbepermittedorrequiredtotestifyinanysuchciviloradministrativeactionastoanyfindings,recommendations,evaluations,opinions,orotheractionstakeninconnectionwithmanagementofthesystem.
(11)Aprescriberordispenser,orhisorherdesignee,mayhaveaccesstotheinformationunderthissectionwhichrelatestoapatientofthatprescriberordispenserasneededforthepurposeofreviewingthepatient'scontrolleddrugprescriptionhistory.
Aprescriberordispenseractingingoodfaithisimmunefromanycivil,criminal,oradministrativeliabilitythatmightotherwisebeincurredorimposedforreceivingorusinginformationfromtheprescriptiondrugmonitoringprogram.
Thissubsectiondoesnotcreateaprivatecauseofaction,andapersonmaynotrecoverdamagesagainstaprescriberordispenserauthorizedtoaccessinformationunderthissubsectionforaccessingorfailingtoaccesssuchinformation.
(12)(a)Allcostsincurredbythedepartmentinadministeringtheprescriptiondrugmonitoringprogramshallbefundedthroughfederalgrants,privatefundingappliedfororreceivedbythestate,orstatefundsappropriatedintheGeneralAppropriationsAct.
Thedepartmentmaynot:1.
Commitfundsforthemonitoringprogramwithoutensuringfundingisavailable;or2.
Usefundsprovided,directlyorindirectly,byprescriptiondrugmanufacturerstoimplementtheprogram.
(b)Thedepartmentshallcooperatewiththedirect-supportorganizationestablishedundersubsection(15)inseekingfederalgrantfunds,othernonstategrantfunds,gifts,donations,orotherprivatemoneysforthedepartmentifthecostsofdoingsoareimmaterial.
Immaterialcostsinclude,butarenotlimitedto,thecostsofmailingandpersonnelassignedtoresearchorapplyforagrant.
Thedepartmentmaycompetitivelyprocureandcontractpursuanttos.
287.
057foranygoodsandservicesrequiredbythissection.
Ch.
2018-13LAWSOFFLORIDACh.
2018-1361CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
(13)Thedepartmentshallconductorparticipateinstudiestoexaminethefeasibilityofenhancingtheprescriptiondrugmonitoringprogramforthepurposesofpublichealthinitiativesandstatisticalreporting.
Suchstudiesshallrespecttheprivacyofthepatient,theprescriber,andthedispenser.
Suchstudiesmaybeconductedbythedepartmentoracontractedvendorinorderto:(a)Improvethequalityofhealthcareservicesandsafetybyimprovingprescribinganddispensingpracticesforcontrolledsubstances;(b)Takeadvantageofadvancesintechnology;(c)Reduceduplicativeprescriptionsandtheoverprescribingofcon-trolledsubstances;and(d)Reducedrugabuse.
(14)ThedepartmentshallannuallyreportonperformancemeasurestotheGovernor,thePresidentoftheSenate,andtheSpeakeroftheHouseofRepresentativesbyDecember1.
Performancemeasuresmayinclude,butarenotlimitedto,thefollowingoutcomes:(a)Reductionoftherateofinappropriateuseofcontrolledsubstancesthroughdepartmenteducationandsafetyefforts.
(b)Reductionofthequantityofcontrolledsubstancesobtainedbyindividualsattemptingtoengageinfraudanddeceit.
(c)Increasedcoordinationamongpartnersparticipatingintheprescrip-tiondrugmonitoringprogram.
(d)Involvementofstakeholdersinachievingimprovedpatienthealthcareandsafetyandreductionofcontrolledsubstanceabuseandcontrolledsubstancediversion.
(15)Thedepartmentmayestablishadirect-supportorganizationtoprovideassistance,funding,andpromotionalsupportfortheactivitiesauthorizedfortheprescriptiondrugmonitoringprogram.
(a)Asusedinthissubsection,theterm"direct-supportorganization"meansanorganizationthatis:1.
AFloridacorporationnotforprofitincorporatedunderchapter617,exemptedfromfilingfees,andapprovedbytheDepartmentofState.
2.
Organizedandoperatedtoconductprogramsandactivities;raisefunds;requestandreceivegrants,gifts,andbequestsofmoney;acquire,receive,hold,andinvest,initsownname,securities,funds,objectsofvalue,orotherproperty,eitherrealorpersonal;andmakeexpendituresorprovidefundingtoorforthedirectorindirectbenefitofthedepartmentinthefurtheranceoftheprescriptiondrugmonitoringprogram.
Ch.
2018-13LAWSOFFLORIDACh.
2018-1362CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
(b)TheStateSurgeonGeneralshallappointaboardofdirectorsforthedirect-supportorganization.
1.
TheboardofdirectorsshallconsistofnofewerthanfivememberswhoshallserveatthepleasureoftheStateSurgeonGeneral.
2.
TheStateSurgeonGeneralshallprovideguidancetomembersoftheboardtoensurethatmoneysreceivedbythedirect-supportorganizationarenotreceivedfrominappropriatesources.
Inappropriatesourcesinclude,butarenotlimitedto,donors,grantors,persons,prescriptiondrugmanufac-turers,ororganizationsthatmaymonetarilyorsubstantivelybenefitfromthepurchaseofgoodsorservicesbythedepartmentinfurtheranceoftheprescriptiondrugmonitoringprogram.
(c)Thedirect-supportorganizationshalloperateunderwrittencontractwiththedepartment.
Thecontractmust,ataminimum,providefor:1.
Approvalofthearticlesofincorporationandbylawsofthedirect-supportorganizationbythedepartment.
2.
Submissionofanannualbudgetfortheapprovalofthedepartment.
3.
Thereversion,withoutpenalty,tothedepartment'sgrantsanddonationstrustfundfortheadministrationoftheprescriptiondrugmonitoringprogramofallmoneysandpropertyheldintrustbythedirect-supportorganizationforthebenefitoftheprescriptiondrugmonitor-ingprogramifthedirect-supportorganizationceasestoexistorifthecontractisterminated.
4.
Thefiscalyearofthedirect-supportorganization,whichmustbeginJuly1ofeachyearandendJune30ofthefollowingyear.
5.
Thedisclosureofthematerialprovisionsofthecontracttodonorsofgifts,contributions,orbequests,includingsuchdisclosureonallpromotionalandfundraisingpublications,andanexplanationtosuchdonorsofthedistinctionbetweenthedepartmentandthedirect-supportorganization.
6.
Thedirect-supportorganization'scollecting,expending,andprovidingoffundstothedepartmentforthedevelopment,implementation,andoperationoftheprescriptiondrugmonitoringprogramasdescribedinthissection.
Thedirect-supportorganizationmaycollectandexpendfundstobeusedforthefunctionsofthedirect-supportorganization'sboardofdirectors,asnecessaryandapprovedbythedepartment.
Inaddition,thedirect-supportorganizationmaycollectandprovidefundingtothedepartmentinfurtheranceoftheprescriptiondrugmonitoringprogramby:a.
Establishingandadministeringtheprescriptiondrugmonitoringprogram'selectronicsystem,includinghardwareandsoftware.
b.
Conductingstudiesontheefficiencyandeffectivenessoftheprogramtoincludefeasibilitystudiesasdescribedinsubsection(13).
Ch.
2018-13LAWSOFFLORIDACh.
2018-1363CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
c.
Providingfundsforfutureenhancementsoftheprogramwithintheintentofthissection.
d.
Providingusertrainingoftheprescriptiondrugmonitoringprogram,includingdistributionofmaterialstopromotepublicawarenessandeducationandconductingworkshopsorothermeetingsforhealthcarepractitioners,pharmacists,andothersasappropriate.
e.
Providingfundsfortravelexpenses.
f.
Providingfundsforadministrativecosts,includingpersonnel,audits,facilities,andequipment.
g.
Fulfillingallotherrequirementsnecessarytoimplementandoperatetheprogramasoutlinedinthissection.
7.
Certificationbythedepartmentthatthedirect-supportorganizationiscomplyingwiththetermsofthecontractinamannerconsistentwithandinfurtheranceofthegoalsandpurposesoftheprescriptiondrugmonitoringprogramandinthebestinterestsofthestate.
Suchcertificationmustbemadeannuallyandreportedintheofficialminutesofameetingofthedirect-supportorganization.
(d)Theactivitiesofthedirect-supportorganizationmustbeconsistentwiththegoalsandmissionofthedepartment,asdeterminedbythedepartment,andinthebestinterestsofthestate.
Thedirect-supportorganizationmustobtainwrittenapprovalfromthedepartmentforanyactivitiesinsupportoftheprescriptiondrugmonitoringprogrambeforeundertakingthoseactivities.
(e)Thedirect-supportorganizationshallprovideforanindependentannualfinancialauditinaccordancewiths.
215.
981.
CopiesoftheauditshallbeprovidedtothedepartmentandtheOfficeofPolicyandBudgetintheExecutiveOfficeoftheGovernor.
(f)Thedirect-supportorganizationmaynotexerciseanypowerunders.
617.
0302(12)or(16).
(g)Thedirect-supportorganizationisnotconsideredalobbyingfirmwithinthemeaningofs.
11.
045.
(h)Thedepartmentmaypermit,withoutcharge,appropriateuseofadministrativeservices,property,andfacilitiesofthedepartmentbythedirect-supportorganization,subjecttothissection.
Theusemustbedirectlyinkeepingwiththeapprovedpurposesofthedirect-supportorganizationandmaynotbemadeattimesorplacesthatwouldunreasonablyinterferewithopportunitiesforthepublictousesuchfacilitiesforestablishedpurposes.
Anymoneysreceivedfromrentalsoffacilitiesandpropertiesmanagedbythedepartmentmaybeheldinaseparatedepositoryaccountinthenameofthedirect-supportorganizationandsubjecttotheprovisionsoftheletterofagreementwiththedepartment.
TheletterofagreementmustCh.
2018-13LAWSOFFLORIDACh.
2018-1364CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
providethatanyfundsheldintheseparatedepositoryaccountinthenameofthedirect-supportorganizationmustreverttothedepartmentifthedirect-supportorganizationisnolongerapprovedbythedepartmenttooperateinthebestinterestsofthestate.
(i)Thedepartmentmayadoptrulesunders.
120.
54togoverntheuseofadministrativeservices,property,orfacilitiesofthedepartmentorofficebythedirect-supportorganization.
(j)Thedepartmentmaynotpermittheuseofanyadministrativeservices,property,orfacilitiesofthestatebyadirect-supportorganizationifthatorganizationdoesnotprovideequalmembershipandemploymentopportunitiestoallpersonsregardlessofrace,color,religion,gender,age,ornationalorigin.
(k)ThissubsectionisrepealedOctober1,2027,unlessreviewedandsavedfromrepealbytheLegislature.
(16)Thedepartmentshalladoptrulesnecessarytoimplementthissection.
Section11.
Section893.
0551,FloridaStatutes,isamendedtoread:893.
0551Publicrecordsexemptionfortheprescriptiondrugmonitoringprogram.
—(1)Forpurposesofthissection,thetermsusedinthissectionhavethesamemeaningsasprovidedins.
893.
055.
(2)Thefollowinginformationofapatientorpatient'sagent,ahealthcarepractitioner,adispenser,anemployeeofthepractitionerwhoisactingonbehalfofandatthedirectionofthepractitioner,apharmacist,orapharmacythatiscontainedinrecordsheldbythedepartmentunders.
893.
055isconfidentialandexemptfroms.
119.
07(1)ands.
24(a),Art.
IoftheStateConstitution:(a)Name.
(b)Address.
(c)Telephonenumber.
(d)Insuranceplannumber.
(e)Government-issuedidentificationnumber.
(f)Providernumber.
(g)DrugEnforcementAdministrationnumber.
(h)Anyotheruniqueidentifyinginformationornumber.
Ch.
2018-13LAWSOFFLORIDACh.
2018-1365CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
(3)Thedepartmentshalldisclosesuchconfidentialandexemptinforma-tiontothefollowingpersonsorentitiesuponrequestandafterusingaverificationprocesstoensurethelegitimacyoftherequestasprovidedins.
893.
055:(a)Ahealthcarepractitioner,orhisorherdesignee,whocertifiesthattheinformationisnecessarytoprovidemedicaltreatmenttoacurrentpatientinaccordancewithss.
893.
04,893.
05,and893.
055.
(b)AnemployeeoftheUnitedStatesDepartmentofVeteransAffairs,theUnitedStatesDepartmentofDefense,ortheIndianHealthServicewhoprovideshealthcareservicespursuanttosuchemploymentandwhohastheauthoritytoprescribeordispensecontrolledsubstancesshallhaveaccesstotheinformationintheprogram'ssystemuponverificationofsuchemploy-ment.
(c)Theprogrammanageranddesignatedsupportstaffforadministra-tionoftheprogram,andtoproviderelevantinformationtotheprescriber,dispenser,andappropriatelawenforcementagencies,inaccordancewiths.
893.
055.
(d)Thedepartmentanditsrelevanthealthcareregulatoryboardsforinvestigationsinvolvinglicenseesauthorizedtoprescribeordispensecontrolledsubstances.
Thedepartmentorhealthcareregulatoryboardmayrequestinformationfromtheprogrambutmaynothavedirectaccesstoitssystem.
Thedepartmentmayprovidetoalawenforcementagencypursuanttoss.
456.
066and456.
073onlyinformationthatisrelevanttothespecificcontrolledsubstancesinvestigationthatpromptedtherequestfortheinformation.
(e)(a)TheAttorneyGeneralorhisorherdesigneewhenworkingonMedicaidfraudcasesinvolvingprescribedcontrolledsubstancesprescrip-tiondrugsorwhentheAttorneyGeneralhasinitiatedareviewofspecificidentifiersofMedicaidfraudorspecificidentifiersthatwarrantaMedicaidinvestigationregardingprescribedcontrolledsubstancesprescriptiondrugs.
TheAttorneyGeneral'sMedicaidfraudinvestigatorsmaynothavedirectaccesstothedepartment'ssystemdatabase.
TheAttorneyGeneralorhisorherdesigneemaydisclosetoacriminaljusticeagency,asdefinedins.
119.
011,onlytheconfidentialandexemptinformationreceivedfromthedepartmentthatisrelevanttoanidentifiedactiveinvestigationthatpromptedtherequestfortheinformation.
(b)Thedepartment'srelevanthealthcareregulatoryboardsresponsibleforthelicensure,regulation,ordisciplineofapractitioner,pharmacist,orotherpersonwhoisauthorizedtoprescribe,administer,ordispensecontrolledsubstancesandwhoisinvolvedinaspecificcontrolledsubstancesinvestigationforprescriptiondrugsinvolvingadesignatedperson.
Thehealthcareregulatoryboardsmayrequestinformationfromthedepartmentbutmaynothavedirectaccesstoitsdatabase.
Thehealthcareregulatoryboardsmayprovidetoalawenforcementagencypursuanttoss.
456.
066andCh.
2018-13LAWSOFFLORIDACh.
2018-1366CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
456.
073onlyinformationthatisrelevanttothespecificcontrolledsubstancesinvestigationthatpromptedtherequestfortheinformation.
(f)(c)Alawenforcementagencythathasinitiatedanactiveinvestigationinvolvingaspecificviolationoflawregardingprescriptiondrugabuseordiversionofprescribedcontrolledsubstancesandthathasenteredintoauseragreementwiththedepartment.
Alawenforcementagencymayrequestinformationfromthedepartmentbutmaynothavedirectaccesstoitssystemdatabase.
Thelawenforcementagencymaydisclosetoacriminaljusticeagency,asdefinedins.
119.
011,onlyconfidentialandexemptinformationreceivedfromthedepartmentthatisrelevanttoanidentifiedactiveinvestigationthatpromptedtherequestforsuchinformation.
(g)Adistrictmedicalexaminerorassociatemedicalexaminer,asdescribedins.
406.
06,pursuanttohisorherofficialduties,asrequiredbys.
406.
11,todeterminethecauseofdeathofanindividual.
Suchmedicalexaminersmayrequestinformationfromthedepartmentbutmaynothavedirectaccesstothesystem(d)Ahealthcarepractitioner,orhisorherdesignee,whocertifiesthattheinformationisnecessarytoprovidemedicaltreatmenttoacurrentpatientinaccordancewithss.
893.
05and893.
055.
(e)Apharmacist,orhisorherdesignee,whocertifiesthattherequestedinformationwillbeusedtodispensecontrolledsubstancestoacurrentpatientinaccordancewithss.
893.
04and893.
055.
(f)Apatientorthelegalguardianordesignatedhealthcaresurrogateforanincapacitatedpatient,ifapplicable,makingarequestasprovidedins.
893.
055(7)(c)4.
(g)Thepatient'spharmacy,prescriber,ordispenser,orthedesigneeofthepharmacy,prescriber,ordispenser,whocertifiesthattheinformationisnecessarytoprovidemedicaltreatmenttohisorhercurrentpatientinaccordancewiths.
893.
055.
(h)Animpairedpractitionerconsultantwhohasbeenauthorizedinwritingbyaparticipantin,orbyareferralto,theimpairedpractitionerprogramtoaccessandreviewinformationasprovidedins.
893.
055(5)(e)893.
055(7)(c)5.
(i)Apatientorthelegalguardianordesignatedhealthcaresurrogateforanincapacitatedpatient,ifapplicable,makingarequestasprovidedins.
893.
055(5)(f).
(4)Ifthedepartmentdeterminesconsistentwithitsrulesthatapatternofcontrolledsubstanceabuseexists,thedepartmentmaydisclosesuchconfidentialandexemptinformationtotheapplicablelawenforcementagencyinaccordancewiths.
893.
055.
Thelawenforcementagencymaydisclosetoacriminaljusticeagency,asdefinedins.
119.
011,onlyconfidentialandexemptinformationreceivedfromthedepartmentthatisCh.
2018-13LAWSOFFLORIDACh.
2018-1367CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
relevanttoanidentifiedactiveinvestigationthatisspecifictoaviolationofs.
893.
13(7)(a)8.
,s.
893.
13(8)(a),ors.
893.
13(8)(b).
(5)Beforedisclosingconfidentialandexemptinformationtoacriminaljusticeagencyoralawenforcementagencypursuanttothissection,thedisclosingpersonorentitymusttakestepstoensurethecontinuedconfidentialityofallconfidentialandexemptinformation.
Ataminimum,thesestepsmustincluderedactinganynonrelevantinformation.
(6)Anagencyorpersonwhoobtainsanyconfidentialandexemptinformationpursuanttothissectionmustmaintaintheconfidentialandexemptstatusofthatinformationandmaynotdisclosesuchinformationunlessauthorizedbylaw.
Informationsharedwithastateattorneypursuanttoparagraph(3)(f)(3)(a)orparagraph(3)(h)(3)(c)maybereleasedonlyinresponsetoadiscoverydemandifsuchinformationisdirectlyrelatedtothecriminalcaseforwhichtheinformationwasrequested.
Unrelatedinforma-tionmaybereleasedonlyuponanorderofacourtofcompetentjurisdiction.
(7)Apersonwhowillfullyandknowinglyviolatesthissectioncommitsafelonyofthethirddegree,punishableasprovidedins.
775.
082,s.
775.
083,ors.
775.
084.
Section12.
Paragraphs(a),(c),(d),(e),(f),and(h)ofsubsection(1),subsection(2),paragraphs(a)and(b)ofsubsection(4),andsubsections(5)and(7)ofsection893.
13,FloridaStatutes,areamendedtoread:893.
13Prohibitedacts;penalties.
—(1)(a)Exceptasauthorizedbythischapterandchapter499,apersonmaynotsell,manufacture,ordeliver,orpossesswithintenttosell,manufacture,ordeliver,acontrolledsubstance.
Apersonwhoviolatesthisprovisionwithrespectto:1.
Acontrolledsubstancenamedordescribedins.
893.
03(1)(a),(1)(b),(1)(d),(2)(a),(2)(b),or(2)(c)5.
(2)(c)4.
commitsafelonyoftheseconddegree,punishableasprovidedins.
775.
082,s.
775.
083,ors.
775.
084.
2.
Acontrolledsubstancenamedordescribedins.
893.
03(1)(c),(2)(c)1.
,(2)(c)2.
,(2)(c)3.
,(2)(c)5.
,(2)(c)6.
,(2)(c)7.
,(2)(c)8.
,(2)(c)9.
,(2)(c)10.
,(3),or(4)commitsafelonyofthethirddegree,punishableasprovidedins.
775.
082,s.
775.
083,ors.
775.
084.
3.
Acontrolledsubstancenamedordescribedins.
893.
03(5)commitsamisdemeanorofthefirstdegree,punishableasprovidedins.
775.
082ors.
775.
083.
(c)Exceptasauthorizedbythischapter,apersonmaynotsell,manufacture,ordeliver,orpossesswithintenttosell,manufacture,ordeliver,acontrolledsubstancein,on,orwithin1,000feetoftherealpropertycomprisingachildcarefacilityasdefinedins.
402.
302orapublicorprivateelementary,middle,orsecondaryschoolbetweenthehoursof6a.
m.
and12Ch.
2018-13LAWSOFFLORIDACh.
2018-1368CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
midnight,oratanytimein,on,orwithin1,000feetofrealpropertycomprisingastate,county,ormunicipalpark,acommunitycenter,orapubliclyownedrecreationalfacility.
Asusedinthisparagraph,theterm"communitycenter"meansafacilityoperatedbyanonprofitcommunity-basedorganizationfortheprovisionofrecreational,social,oreducationalservicestothepublic.
Apersonwhoviolatesthisparagraphwithrespectto:1.
Acontrolledsubstancenamedordescribedins.
893.
03(1)(a),(1)(b),(1)(d),(2)(a),(2)(b),or(2)(c)5.
(2)(c)4.
commitsafelonyofthefirstdegree,punishableasprovidedins.
775.
082,s.
775.
083,ors.
775.
084.
Thedefendantmustbesentencedtoaminimumtermofimprisonmentof3calendaryearsunlesstheoffensewascommittedwithin1,000feetoftherealpropertycomprisingachildcarefacilityasdefinedins.
402.
302.
2.
Acontrolledsubstancenamedordescribedins.
893.
03(1)(c),(2)(c)1.
,(2)(c)2.
,(2)(c)3.
,(2)(c)5.
,(2)(c)6.
,(2)(c)7.
,(2)(c)8.
,(2)(c)9.
,(2)(c)10.
,(3),or(4)commitsafelonyoftheseconddegree,punishableasprovidedins.
775.
082,s.
775.
083,ors.
775.
084.
3.
Anyothercontrolledsubstance,exceptaslawfullysold,manufac-tured,ordelivered,mustbesentencedtopaya$500fineandtoserve100hoursofpublicserviceinadditiontoanyotherpenaltyprescribedbylaw.
Thisparagraphdoesnotapplytoachildcarefacilityunlesstheowneroroperatorofthefacilitypostsasignthatisnotlessthan2squarefeetinsizewithawordlegendidentifyingthefacilityasalicensedchildcarefacilityandthatispostedonthepropertyofthechildcarefacilityinaconspicuousplacewherethesignisreasonablyvisibletothepublic.
(d)Exceptasauthorizedbythischapter,apersonmaynotsell,manufacture,ordeliver,orpossesswithintenttosell,manufacture,ordeliver,acontrolledsubstancein,on,orwithin1,000feetoftherealpropertycomprisingapublicorprivatecollege,university,orotherpostsecondaryeducationalinstitution.
Apersonwhoviolatesthisparagraphwithrespectto:1.
Acontrolledsubstancenamedordescribedins.
893.
03(1)(a),(1)(b),(1)(d),(2)(a),(2)(b),or(2)(c)5.
(2)(c)4.
commitsafelonyofthefirstdegree,punishableasprovidedins.
775.
082,s.
775.
083,ors.
775.
084.
2.
Acontrolledsubstancenamedordescribedins.
893.
03(1)(c),(2)(c)1.
,(2)(c)2.
,(2)(c)3.
,(2)(c)5.
,(2)(c)6.
,(2)(c)7.
,(2)(c)8.
,(2)(c)9.
,(2)(c)10.
,(3),or(4)commitsafelonyoftheseconddegree,punishableasprovidedins.
775.
082,s.
775.
083,ors.
775.
084.
3.
Anyothercontrolledsubstance,exceptaslawfullysold,manufac-tured,ordelivered,mustbesentencedtopaya$500fineandtoserve100hoursofpublicserviceinadditiontoanyotherpenaltyprescribedbylaw.
(e)Exceptasauthorizedbythischapter,apersonmaynotsell,manufacture,ordeliver,orpossesswithintenttosell,manufacture,orCh.
2018-13LAWSOFFLORIDACh.
2018-1369CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
deliver,acontrolledsubstancenotauthorizedbylawin,on,orwithin1,000feetofaphysicalplaceforworshipatwhichachurchorreligiousorganizationregularlyconductsreligiousservicesorwithin1,000feetofaconveniencebusinessasdefinedins.
812.
171.
Apersonwhoviolatesthisparagraphwithrespectto:1.
Acontrolledsubstancenamedordescribedins.
893.
03(1)(a),(1)(b),(1)(d),(2)(a),(2)(b),or(2)(c)5.
(2)(c)4.
commitsafelonyofthefirstdegree,punishableasprovidedins.
775.
082,s.
775.
083,ors.
775.
084.
2.
Acontrolledsubstancenamedordescribedins.
893.
03(1)(c),(2)(c)1.
,(2)(c)2.
,(2)(c)3.
,(2)(c)5.
,(2)(c)6.
,(2)(c)7.
,(2)(c)8.
,(2)(c)9.
,(2)(c)10.
,(3),or(4)commitsafelonyoftheseconddegree,punishableasprovidedins.
775.
082,s.
775.
083,ors.
775.
084.
3.
Anyothercontrolledsubstance,exceptaslawfullysold,manufac-tured,ordelivered,mustbesentencedtopaya$500fineandtoserve100hoursofpublicserviceinadditiontoanyotherpenaltyprescribedbylaw.
(f)Exceptasauthorizedbythischapter,apersonmaynotsell,manufacture,ordeliver,orpossesswithintenttosell,manufacture,ordeliver,acontrolledsubstancein,on,orwithin1,000feetoftherealpropertycomprisingapublichousingfacilityatanytime.
Asusedinthissection,theterm"realpropertycomprisingapublichousingfacility"meansrealproperty,asdefinedins.
421.
03(12),ofapubliccorporationcreatedasahousingauthoritypursuanttopartIofchapter421.
Apersonwhoviolatesthisparagraphwithrespectto:1.
Acontrolledsubstancenamedordescribedins.
893.
03(1)(a),(1)(b),(1)(d),(2)(a),(2)(b),or(2)(c)5.
(2)(c)4.
commitsafelonyofthefirstdegree,punishableasprovidedins.
775.
082,s.
775.
083,ors.
775.
084.
2.
Acontrolledsubstancenamedordescribedins.
893.
03(1)(c),(2)(c)1.
,(2)(c)2.
,(2)(c)3.
,(2)(c)5.
,(2)(c)6.
,(2)(c)7.
,(2)(c)8.
,(2)(c)9.
,(2)(c)10.
,(3),or(4)commitsafelonyoftheseconddegree,punishableasprovidedins.
775.
082,s.
775.
083,ors.
775.
084.
3.
Anyothercontrolledsubstance,exceptaslawfullysold,manufac-tured,ordelivered,mustbesentencedtopaya$500fineandtoserve100hoursofpublicserviceinadditiontoanyotherpenaltyprescribedbylaw.
(h)Exceptasauthorizedbythischapter,apersonmaynotsell,manufacture,ordeliver,orpossesswithintenttosell,manufacture,ordeliver,acontrolledsubstancein,on,orwithin1,000feetoftherealpropertycomprisinganassistedlivingfacility,asthattermisusedinchapter429.
Apersonwhoviolatesthisparagraphwithrespectto:1.
Acontrolledsubstancenamedordescribedins.
893.
03(1)(a),(1)(b),(1)(d),(2)(a),(2)(b),or(2)(c)5.
(2)(c)4.
commitsafelonyofthefirstdegree,punishableasprovidedins.
775.
082,s.
775.
083,ors.
775.
084.
Ch.
2018-13LAWSOFFLORIDACh.
2018-1370CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
2.
Acontrolledsubstancenamedordescribedins.
893.
03(1)(c),(2)(c)1.
,(2)(c)2.
,(2)(c)3.
,(2)(c)5.
,(2)(c)6.
,(2)(c)7.
,(2)(c)8.
,(2)(c)9.
,(2)(c)10.
,(3),or(4)commitsafelonyoftheseconddegree,punishableasprovidedins.
775.
082,s.
775.
083,ors.
775.
084.
3.
Anyothercontrolledsubstance,exceptaslawfullysold,manufac-tured,ordelivered,mustbesentencedtopaya$500fineandtoserve100hoursofpublicserviceinadditiontoanyotherpenaltyprescribedbylaw.
(2)(a)Exceptasauthorizedbythischapterandchapter499,apersonmaynotpurchase,orpossesswithintenttopurchase,acontrolledsubstance.
Apersonwhoviolatesthisprovisionwithrespectto:1.
Acontrolledsubstancenamedordescribedins.
893.
03(1)(a),(1)(b),(1)(d),(2)(a),(2)(b),or(2)(c)5.
(2)(c)4.
commitsafelonyoftheseconddegree,punishableasprovidedins.
775.
082,s.
775.
083,ors.
775.
084.
2.
Acontrolledsubstancenamedordescribedins.
893.
03(1)(c),(2)(c)1.
,(2)(c)2.
,(2)(c)3.
,(2)(c)5.
,(2)(c)6.
,(2)(c)7.
,(2)(c)8.
,(2)(c)9.
,(2)(c)10.
,(3),or(4)commitsafelonyofthethirddegree,punishableasprovidedins.
775.
082,s.
775.
083,ors.
775.
084.
3.
Acontrolledsubstancenamedordescribedins.
893.
03(5)commitsamisdemeanorofthefirstdegree,punishableasprovidedins.
775.
082ors.
775.
083.
(b)Exceptasprovidedinthischapter,apersonmaynotpurchasemorethan10gramsofanysubstancenamedordescribedins.
893.
03(1)(a)or(1)(b),oranycombinationthereof,oranymixturecontaininganysuchsubstance.
Apersonwhoviolatesthisparagraphcommitsafelonyofthefirstdegree,punishableasprovidedins.
775.
082,s.
775.
083,ors.
775.
084.
(4)Exceptasauthorizedbythischapter,aperson18yearsofageoroldermaynotdeliveranycontrolledsubstancetoapersonyoungerthan18yearsofage,useorhireapersonyoungerthan18yearsofageasanagentoremployeeinthesaleordeliveryofsuchasubstance,orusesuchpersontoassistinavoidingdetectionorapprehensionforaviolationofthischapter.
Apersonwhoviolatesthissubsectionwithrespectto:(a)Acontrolledsubstancenamedordescribedins.
893.
03(1)(a),(1)(b),(1)(d),(2)(a),(2)(b),or(2)(c)5.
(2)(c)4.
commitsafelonyofthefirstdegree,punishableasprovidedins.
775.
082,s.
775.
083,ors.
775.
084.
(b)Acontrolledsubstancenamedordescribedins.
893.
03(1)(c),(2)(c)1.
,(2)(c)2.
,(2)(c)3.
,(2)(c)5.
,(2)(c)6.
,(2)(c)7.
,(2)(c)8.
,(2)(c)9.
,(2)(c)10.
,(3),or(4)commitsafelonyoftheseconddegree,punishableasprovidedins.
775.
082,s.
775.
083,ors.
775.
084.
Impositionofsentencemaynotbesuspendedordeferred,andthepersonsoconvictedmaynotbeplacedonprobation.
Ch.
2018-13LAWSOFFLORIDACh.
2018-1371CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
(5)Apersonmaynotbringintothisstateanycontrolledsubstanceunlessthepossessionofsuchcontrolledsubstanceisauthorizedbythischapterorunlesssuchpersonislicensedtodosobytheappropriatefederalagency.
Apersonwhoviolatesthisprovisionwithrespectto:(a)Acontrolledsubstancenamedordescribedins.
893.
03(1)(a),(1)(b),(1)(d),(2)(a),(2)(b),or(2)(c)5.
(2)(c)4.
commitsafelonyoftheseconddegree,punishableasprovidedins.
775.
082,s.
775.
083,ors.
775.
084.
(b)Acontrolledsubstancenamedordescribedins.
893.
03(1)(c),(2)(c)1.
,(2)(c)2.
,(2)(c)3.
,(2)(c)5.
,(2)(c)6.
,(2)(c)7.
,(2)(c)8.
,(2)(c)9.
,(2)(c)10.
,(3),or(4)commitsafelonyofthethirddegree,punishableasprovidedins.
775.
082,s.
775.
083,ors.
775.
084.
(c)Acontrolledsubstancenamedordescribedins.
893.
03(5)commitsamisdemeanorofthefirstdegree,punishableasprovidedins.
775.
082ors.
775.
083.
(7)(e)Apersonorhealthcarepractitionerwhoviolatestheprovisionsofsubparagraph(a)13.
orparagraph(b)commitsafelonyofthesecondthirddegree,punishableasprovidedins.
775.
082,s.
775.
083,ors.
775.
084,ifanycontrolledsubstancethatisthesubjectoftheoffenseislistedinScheduleII,ScheduleIII,orScheduleIV.
Section13.
Section893.
147,FloridaStatutes,isamended,toread:893.
147Use,possession,manufacture,delivery,transportation,adver-tisement,orretailsaleofdrugparaphernalia,specifiedmachines,andmaterials.
—(1)USEORPOSSESSIONOFDRUGPARAPHERNALIA.
—Itisunlawfulforanypersontouse,ortopossesswithintenttouse,drugparaphernalia:(a)Toplant,propagate,cultivate,grow,harvest,manufacture,com-pound,convert,produce,process,prepare,test,analyze,pack,repack,store,contain,orconcealacontrolledsubstanceinviolationofthischapter;or(b)Toinject,ingest,inhale,orotherwiseintroduceintothehumanbodyacontrolledsubstanceinviolationofthischapter.
Anypersonwhoviolatesthissubsectionisguiltyofamisdemeanorofthefirstdegree,punishableasprovidedins.
775.
082ors.
775.
083.
(2)MANUFACTUREORDELIVERYOFDRUGPARAPHERNALIA.
Itisunlawfulforanypersontodeliver,possesswithintenttodeliver,ormanufacturewithintenttodeliverdrugparaphernalia,knowing,orundercircumstanceswhereonereasonablyshouldknow,thatitwillbeused:Ch.
2018-13LAWSOFFLORIDACh.
2018-1372CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
(a)Toplant,propagate,cultivate,grow,harvest,manufacture,com-pound,convert,produce,process,prepare,test,analyze,pack,repack,store,contain,orconcealacontrolledsubstanceinviolationofthisact;or(b)Toinject,ingest,inhale,orotherwiseintroduceintothehumanbodyacontrolledsubstanceinviolationofthisact.
Anypersonwhoviolatesthissubsectionisguiltyofafelonyofthethirddegree,punishableasprovidedins.
775.
082,s.
775.
083,ors.
775.
084.
(3)DELIVERYOFDRUGPARAPHERNALIATOAMINOR.
—(a)Anyperson18yearsofageoroverwhoviolatessubsection(2)bydeliveringdrugparaphernaliatoapersonunder18yearsofageisguiltyofafelonyoftheseconddegree,punishableasprovidedins.
775.
082,s.
775.
083,ors.
775.
084.
(b)Itisunlawfulforanypersontosellorotherwisedeliverhypodermicsyringes,needles,orotherobjectswhichmaybeused,areintendedforuse,oraredesignedforuseinparenterallyinjectingsubstancesintothehumanbodytoanypersonunder18yearsofage,exceptthathypodermicsyringes,needles,orothersuchobjectsmaybelawfullydispensedtoapersonunder18yearsofagebyalicensedpractitioner,parent,orlegalguardianorbyapharmacistpursuanttoavalidprescriptionforsame.
Anypersonwhoviolatestheprovisionsofthisparagraphisguiltyofamisdemeanorofthefirstdegree,punishableasprovidedins.
775.
082ors.
775.
083.
(4)TRANSPORTATIONOFDRUGPARAPHERNALIA.
—Itisunlawfultouse,possesswiththeintenttouse,ormanufacturewiththeintenttousedrugparaphernalia,knowingorundercircumstancesinwhichonereason-ablyshouldknowthatitwillbeusedtotransport:(a)Acontrolledsubstanceinviolationofthischapter;or(b)Contrabandasdefinedins.
932.
701(2)(a)1.
Anypersonwhoviolatesthissubsectioncommitsafelonyofthethirddegree,punishableasprovidedins.
775.
082,s.
775.
083,ors.
775.
084.
(5)ADVERTISEMENTOFDRUGPARAPHERNALIA.
—Itisunlawfulforanypersontoplaceinanynewspaper,magazine,handbill,orotherpublicationanyadvertisement,knowing,orundercircumstanceswhereonereasonablyshouldknow,thatthepurposeoftheadvertisement,inwholeorinpart,istopromotethesaleofobjectsdesignedorintendedforuseasdrugparaphernalia.
Anypersonwhoviolatesthissubsectionisguiltyofamisdemeanorofthefirstdegree,punishableasprovidedins.
775.
082ors.
775.
083.
(6)RETAILSALEOFDRUGPARAPHERNALIA.
—Ch.
2018-13LAWSOFFLORIDACh.
2018-1373CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
(a)Itisunlawfulforapersontoknowinglyandwillfullysellorofferforsaleatretailanydrugparaphernaliadescribedins.
893.
145(12)(a)-(c)or(g)-(m),otherthanapipethatisprimarilymadeofbriar,meerschaum,clay,orcorncob.
(b)Apersonwhoviolatesparagraph(a)commitsamisdemeanorofthefirstdegree,punishableasprovidedins.
775.
082ors.
775.
083,and,uponasecondorsubsequentviolation,commitsafelonyofthethirddegree,punishableasprovidedins.
775.
082,s.
775.
083,ors.
775.
084.
(7)TABLETINGMACHINES,ENCAPSULATINGMACHINES,ANDCONTROLLEDSUBSTANCECOUNTERFEITINGMATERIALS.
—(a)Exceptasprovidedinparagraph(b),itisunlawfulforanypersontopossess,purchase,deliver,sell,orpossesswithintenttosellordeliveratabletingmachine,anencapsulatingmachine,orcontrolledsubstancecounterfeitingmaterialsknowing,intending,orhavingreasonablecausetobelievethatitwillbeusedtomanufactureacontrolledsubstanceorcounterfeitcontrolledsubstance.
(b)1.
Aregulatedpersonmaypossess,purchase,deliver,sell,orpossesswithintenttodeliverorsellatabletingmachineorencapsulatingmachineaspartofaregulatedtransactionwitharegularcustomerorregularimporterifheorsheisincompliancewith21U.
S.
C.
s.
830.
Forpurposesofthisparagraph,theterms"regulatedperson,""regulatedtransaction,""regularcustomer,"and"regularimporter"havethesamemeaningsasprovidedin21U.
S.
C.
s.
802.
2.
Apersonregisteredunder21U.
S.
C.
s.
822maypossess,purchase,deliver,sell,orpossesswithintenttodeliverorsellatabletingmachineorencapsulatingmachinetomanufactureacontrolledsubstancepursuanttosuchregistration.
3.
Apersonwhoholdsanactive,unencumberedlicenseorapermitunders.
381.
986orchapter465maypossess,purchase,deliver,sell,orpossesswithintenttosellordeliveratabletingmachineorencapsulatingmachinetomanufactureacontrolledsubstance,ifsuchpersonisperformingfunctionsincompliancewithorundertheauthorityofthatlicenseorpermit.
(c)Forpurposesofthissubsection,theterm:1.
"Controlledsubstance"hasthesamemeaningasprovidedins.
893.
02(4).
2.
"Controlledsubstancecounterfeitingmaterial"meansapunch,die,plate,stone,orotheritemdesignedtoprint,imprint,orreproducethetrademark,tradename,orotheridentifyingmark,imprint,ordeviceofanotheroranylikenessofanyoftheforegoinguponadrugorcontainerorlabelingthereofsoastorendersuchdrugacounterfeitcontrolledsubstance.
Ch.
2018-13LAWSOFFLORIDACh.
2018-1374CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
3.
"Counterfeitcontrolledsubstance"hasthesamemeaningasprovidedins.
831.
31(2).
4.
"Encapsulatingmachine"meansmanual,semiautomatic,orfullyautomaticequipmentthatcanbeusedtofillshellsorcapsuleswithpowderedorgranularsolidsorsemisolidmaterialtoproducecoherentsolidtablets.
5.
"Tabletingmachine"meansmanual,semiautomatic,orfullyauto-maticequipmentthatcanbeusedtocompactormoldpowderedorgranularsolidsorsemisolidmaterialtoproducecoherentsolidtablets.
(d)1.
Exceptasprovidedinsubparagraph2.
,apersonwhoviolatesthissubsectioncommitsafelonyofthethirddegree,punishableasprovidedins.
775.
082,s.
775.
083,ors.
775.
084.
2.
Anypersonwhoviolatesthissubsectionknowing,intending,orhavingreasonablecausetobelievethatsuchactionwillresultintheunlawfulmanufactureofacontrolledsubstanceorcounterfeitcontrolledsubstancethatcontains:a.
Asubstancecontrolledunders.
893.
03(1);b.
Cocaine,asdescribedins.
893.
03(2)(a)4.
;c.
Opiumoranysyntheticornaturalsalt,compound,derivative,orpreparationofopium;d.
Methadone;e.
Alfentanil,asdescribedins.
893.
03(2)(b)1.
;f.
Carfentanil,asdescribedins.
893.
03(2)(b)6.
;g.
Fentanyl,asdescribedins.
893.
03(2)(b)9.
;h.
Sufentanil,asdescribedins.
893.
03(2)(b)30.
;ori.
Acontrolledsubstanceanalog,asdescribedins.
893.
0356,ofanysubstancespecifiedinsub-subparagraphsa.
-h.
,commitsafelonyoftheseconddegree,punishableasprovidedins.
775.
082,s.
775.
083,ors.
775.
084.
Section14.
EffectiveJanuary1,2019,paragraphs(pp)and(qq)ofsubsection(1)ofsection458.
331,FloridaStatutes,areamendedtoread:458.
331Groundsfordisciplinaryaction;actionbytheboardanddepartment.
—(1)Thefollowingactsconstitutegroundsfordenialofalicenseordisciplinaryaction,asspecifiedins.
456.
072(2):Ch.
2018-13LAWSOFFLORIDACh.
2018-1375CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
(pp)Applicabletoalicenseewhoservesasthedesignatedphysicianofapain-managementclinicasdefinedins.
458.
3265ors.
459.
0137:1.
Registeringapain-managementclinicthroughmisrepresentationorfraud;2.
Procuring,orattemptingtoprocure,theregistrationofapain-managementclinicforanyotherpersonbymakingorcausingtobemade,anyfalserepresentation;3.
Failingtocomplywithanyrequirementofchapter499,theFloridaDrugandCosmeticAct;21U.
S.
C.
ss.
301-392,theFederalFood,Drug,andCosmeticAct;21U.
S.
C.
ss.
821etseq.
,theDrugAbusePreventionandControlAct;orchapter893,theFloridaComprehensiveDrugAbusePreventionandControlAct;4.
Beingconvictedorfoundguiltyof,regardlessofadjudicationto,afelonyoranyothercrimeinvolvingmoralturpitude,fraud,dishonesty,ordeceitinanyjurisdictionofthecourtsofthisstate,ofanyotherstate,oroftheUnitedStates;5.
Beingconvictedof,ordisciplinedbyaregulatoryagencyoftheFederalGovernmentoraregulatoryagencyofanotherstatefor,anyoffensethatwouldconstituteaviolationofthischapter;6.
Beingconvictedof,orenteringapleaofguiltyornolocontendereto,regardlessofadjudication,acrimeinanyjurisdictionofthecourtsofthisstate,ofanyotherstate,oroftheUnitedStateswhichrelatestothepracticeof,ortheabilitytopractice,alicensedhealthcareprofession;7.
Beingconvictedof,orenteringapleaofguiltyornolocontendereto,regardlessofadjudication,acrimeinanyjurisdictionofthecourtsofthisstate,ofanyotherstate,oroftheUnitedStateswhichrelatestohealthcarefraud;8.
Dispensinganymedicinaldrugbaseduponacommunicationthatpurportstobeaprescriptionasdefinedins.
465.
003(14)ors.
893.
02ifthedispensingpractitionerknowsorhasreasontobelievethatthepurportedprescriptionisnotbaseduponavalidpractitioner-patientrelationship;or9.
Failingtotimelynotifytheboardofthedateofhisorherterminationfromapain-managementclinicasrequiredbys.
458.
3265(3)458.
3265(2).
(qq)Failingtotimelynotifythedepartmentofthetheftofprescriptionblanksfromapain-managementclinicorabreachofothermethodsforprescribingwithin24hoursasrequiredbys.
458.
3265(3)458.
3265(2).
Section15.
EffectiveJanuary1,2019,paragraphs(rr)and(ss)ofsubsection(1)ofsection459.
015,FloridaStatutes,areamendedtoread:Ch.
2018-13LAWSOFFLORIDACh.
2018-1376CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
459.
015Groundsfordisciplinaryaction;actionbytheboardanddepartment.
—(1)Thefollowingactsconstitutegroundsfordenialofalicenseordisciplinaryaction,asspecifiedins.
456.
072(2):(rr)Applicabletoalicenseewhoservesasthedesignatedphysicianofapain-managementclinicasdefinedins.
458.
3265ors.
459.
0137:1.
Registeringapain-managementclinicthroughmisrepresentationorfraud;2.
Procuring,orattemptingtoprocure,theregistrationofapain-managementclinicforanyotherpersonbymakingorcausingtobemade,anyfalserepresentation;3.
Failingtocomplywithanyrequirementofchapter499,theFloridaDrugandCosmeticAct;21U.
S.
C.
ss.
301-392,theFederalFood,Drug,andCosmeticAct;21U.
S.
C.
ss.
821etseq.
,theDrugAbusePreventionandControlAct;orchapter893,theFloridaComprehensiveDrugAbusePreventionandControlAct;4.
Beingconvictedorfoundguiltyof,regardlessofadjudicationto,afelonyoranyothercrimeinvolvingmoralturpitude,fraud,dishonesty,ordeceitinanyjurisdictionofthecourtsofthisstate,ofanyotherstate,oroftheUnitedStates;5.
Beingconvictedof,ordisciplinedbyaregulatoryagencyoftheFederalGovernmentoraregulatoryagencyofanotherstatefor,anyoffensethatwouldconstituteaviolationofthischapter;6.
Beingconvictedof,orenteringapleaofguiltyornolocontendereto,regardlessofadjudication,acrimeinanyjurisdictionofthecourtsofthisstate,ofanyotherstate,oroftheUnitedStateswhichrelatestothepracticeof,ortheabilitytopractice,alicensedhealthcareprofession;7.
Beingconvictedof,orenteringapleaofguiltyornolocontendereto,regardlessofadjudication,acrimeinanyjurisdictionofthecourtsofthisstate,ofanyotherstate,oroftheUnitedStateswhichrelatestohealthcarefraud;8.
Dispensinganymedicinaldrugbaseduponacommunicationthatpurportstobeaprescriptionasdefinedins.
465.
003(14)ors.
893.
02ifthedispensingpractitionerknowsorhasreasontobelievethatthepurportedprescriptionisnotbaseduponavalidpractitioner-patientrelationship;or9.
Failingtotimelynotifytheboardofthedateofhisorherterminationfromapain-managementclinicasrequiredbys.
459.
0137(3)459.
0137(2).
Ch.
2018-13LAWSOFFLORIDACh.
2018-1377CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
(ss)Failingtotimelynotifythedepartmentofthetheftofprescriptionblanksfromapain-managementclinicorabreachofothermethodsforprescribingwithin24hoursasrequiredbys.
459.
0137(3)459.
0137(2).
Section16.
Paragraph(b)ofsubsection(4)ofsection463.
0055,FloridaStatutes,isamendedtoread:463.
0055Administrationandprescriptionofocularpharmaceuticalagents.
—(4)Acertifiedoptometristshallbeissuedaprescribernumberbytheboard.
Anyprescriptionwrittenbyacertifiedoptometristforanocularpharmaceuticalagentpursuanttothissectionshallhavetheprescribernumberprintedthereon.
Acertifiedoptometristmaynotadministerorprescribe:(b)Acontrolledsubstanceforthetreatmentofchronicnonmalignantpainasdefinedins.
456.
44(1)(f)456.
44(1)(e).
Section17.
Paragraph(a)ofsubsection(1)ofsection782.
04,FloridaStatutes,isamendedtoread:782.
04Murder.
—(1)(a)Theunlawfulkillingofahumanbeing:1.
Whenperpetratedfromapremeditateddesigntoeffectthedeathofthepersonkilledoranyhumanbeing;2.
Whencommittedbyapersonengagedintheperpetrationof,orintheattempttoperpetrate,any:a.
Traffickingoffenseprohibitedbys.
893.
135(1),b.
Arson,c.
Sexualbattery,d.
Robbery,e.
Burglary,f.
Kidnapping,g.
Escape,h.
Aggravatedchildabuse,i.
Aggravatedabuseofanelderlypersonordisabledadult,j.
Aircraftpiracy,Ch.
2018-13LAWSOFFLORIDACh.
2018-1378CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
k.
Unlawfulthrowing,placing,ordischargingofadestructivedeviceorbomb,l.
Carjacking,m.
Home-invasionrobbery,n.
Aggravatedstalking,o.
Murderofanotherhumanbeing,p.
Resistinganofficerwithviolencetohisorherperson,q.
Aggravatedfleeingoreludingwithseriousbodilyinjuryordeath,r.
Felonythatisanactofterrorismorisinfurtheranceofanactofterrorism,includingafelonyunders.
775.
30,s.
775.
32,s.
775.
33,s.
775.
34,ors.
775.
35,ors.
Humantrafficking;or3.
Whichresultedfromtheunlawfuldistributionbyaperson18yearsofageorolderofanyofthefollowingsubstances,ormixturecontaininganyofthefollowingsubstances,whensuchsubstanceormixtureisproventobetheproximatecauseofthedeathoftheuser:a.
Asubstancecontrolledunders.
893.
03(1);b.
Cocaine,asdescribedins.
893.
03(2)(a)4.
;c.
Opiumoranysyntheticornaturalsalt,compound,derivative,orpreparationofopium;d.
Methadone;e.
Alfentanil,asdescribedins.
893.
03(2)(b)1.
;f.
Carfentanil,asdescribedins.
893.
03(2)(b)6.
;g.
Fentanyl,asdescribedins.
893.
03(2)(b)9.
;h.
Sufentanil,asdescribedins.
893.
03(2)(b)30.
893.
03(2)(b)29.
;ori.
Acontrolledsubstanceanalog,asdescribedins.
893.
0356,ofanysubstancespecifiedinsub-subparagraphsa.
-h.
,ismurderinthefirstdegreeandconstitutesacapitalfelony,punishableasprovidedins.
775.
082.
Section18.
Paragraphs(c)and(f)ofsubsection(1)ofsection893.
135,FloridaStatutes,areamendedtoread:Ch.
2018-13LAWSOFFLORIDACh.
2018-1379CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
893.
135Trafficking;mandatorysentences;suspensionorreductionofsentences;conspiracytoengageintrafficking.
—(1)Exceptasauthorizedinthischapterorinchapter499andnotwithstandingtheprovisionsofs.
893.
13:(c)1.
Apersonwhoknowinglysells,purchases,manufactures,delivers,orbringsintothisstate,orwhoisknowinglyinactualorconstructivepossessionof,4gramsormoreofanymorphine,opium,hydromorphone,oranysalt,derivative,isomer,orsaltofanisomerthereof,includingheroin,asdescribedins.
893.
03(1)(b),(2)(a),(3)(c)3.
,or(3)(c)4.
,or4gramsormoreofanymixturecontaininganysuchsubstance,butlessthan30kilogramsofsuchsubstanceormixture,commitsafelonyofthefirstdegree,whichfelonyshallbeknownas"traffickinginillegaldrugs,"punishableasprovidedins.
775.
082,s.
775.
083,ors.
775.
084.
Ifthequantityinvolved:a.
Is4gramsormore,butlessthan14grams,suchpersonshallbesentencedtoamandatoryminimumtermofimprisonmentof3yearsandshallbeorderedtopayafineof$50,000.
b.
Is14gramsormore,butlessthan28grams,suchpersonshallbesentencedtoamandatoryminimumtermofimprisonmentof15yearsandshallbeorderedtopayafineof$100,000.
c.
Is28gramsormore,butlessthan30kilograms,suchpersonshallbesentencedtoamandatoryminimumtermofimprisonmentof25yearsandshallbeorderedtopayafineof$500,000.
2.
Apersonwhoknowinglysells,purchases,manufactures,delivers,orbringsintothisstate,orwhoisknowinglyinactualorconstructivepossessionof,14gramsormoreofhydrocodone,asdescribedins.
893.
03(2)(a)1.
k.
893.
03(2)(a)1.
j.
,codeine,asdescribedins.
893.
03(2)(a)1.
g.
,oranysaltthereof,or14gramsormoreofanymixturecontaininganysuchsubstance,commitsafelonyofthefirstdegree,whichfelonyshallbeknownas"traffickinginhydrocodone,"punishableasprovidedins.
775.
082,s.
775.
083,ors.
775.
084.
Ifthequantityinvolved:a.
Is14gramsormore,butlessthan28grams,suchpersonshallbesentencedtoamandatoryminimumtermofimprisonmentof3yearsandshallbeorderedtopayafineof$50,000.
b.
Is28gramsormore,butlessthan50grams,suchpersonshallbesentencedtoamandatoryminimumtermofimprisonmentof7yearsandshallbeorderedtopayafineof$100,000.
c.
Is50gramsormore,butlessthan200grams,suchpersonshallbesentencedtoamandatoryminimumtermofimprisonmentof15yearsandshallbeorderedtopayafineof$500,000.
Ch.
2018-13LAWSOFFLORIDACh.
2018-1380CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
d.
Is200gramsormore,butlessthan30kilograms,suchpersonshallbesentencedtoamandatoryminimumtermofimprisonmentof25yearsandshallbeorderedtopayafineof$750,000.
3.
Apersonwhoknowinglysells,purchases,manufactures,delivers,orbringsintothisstate,orwhoisknowinglyinactualorconstructivepossessionof,7gramsormoreofoxycodone,asdescribedins.
893.
03(2)(a)1.
q.
893.
03(2)(a)1.
o.
,oranysaltthereof,or7gramsormoreofanymixturecontaininganysuchsubstance,commitsafelonyofthefirstdegree,whichfelonyshallbeknownas"traffickinginoxycodone,"punish-ableasprovidedins.
775.
082,s.
775.
083,ors.
775.
084.
Ifthequantityinvolved:a.
Is7gramsormore,butlessthan14grams,suchpersonshallbesentencedtoamandatoryminimumtermofimprisonmentof3yearsandshallbeorderedtopayafineof$50,000.
b.
Is14gramsormore,butlessthan25grams,suchpersonshallbesentencedtoamandatoryminimumtermofimprisonmentof7yearsandshallbeorderedtopayafineof$100,000.
c.
Is25gramsormore,butlessthan100grams,suchpersonshallbesentencedtoamandatoryminimumtermofimprisonmentof15yearsandshallbeorderedtopayafineof$500,000.
d.
Is100gramsormore,butlessthan30kilograms,suchpersonshallbesentencedtoamandatoryminimumtermofimprisonmentof25yearsandshallbeorderedtopayafineof$750,000.
4.
a.
Apersonwhoknowinglysells,purchases,manufactures,delivers,orbringsintothisstate,orwhoisknowinglyinactualorconstructivepossessionof,4gramsormoreof:(I)Alfentanil,asdescribedins.
893.
03(2)(b)1.
;(II)Carfentanil,asdescribedins.
893.
03(2)(b)6.
;(III)Fentanyl,asdescribedins.
893.
03(2)(b)9.
;(IV)Sufentanil,asdescribedins.
893.
03(2)(b)30.
893.
03(2)(b)29.
;(V)Afentanylderivative,asdescribedins.
893.
03(1)(a)62.
;(VI)Acontrolledsubstanceanalog,asdescribedins.
893.
0356,ofanysubstancedescribedinsub-sub-subparagraphs(I)-(V);or(VII)Amixturecontaininganysubstancedescribedinsub-sub-subpar-agraphs(I)-(VI),commitsafelonyofthefirstdegree,whichfelonyshallbeknownas"traffickinginfentanyl,"punishableasprovidedins.
775.
082,s.
775.
083,ors.
775.
084.
Ch.
2018-13LAWSOFFLORIDACh.
2018-1381CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
b.
Ifthequantityinvolvedundersub-subparagrapha.
:(I)Is4gramsormore,butlessthan14grams,suchpersonshallbesentencedtoamandatoryminimumtermofimprisonmentof3years,andshallbeorderedtopayafineof$50,000.
(II)Is14gramsormore,butlessthan28grams,suchpersonshallbesentencedtoamandatoryminimumtermofimprisonmentof15years,andshallbeorderedtopayafineof$100,000.
(III)Is28gramsormore,suchpersonshallbesentencedtoamandatoryminimumtermofimprisonmentof25years,andshallbeorderedtopayafineof$500,000.
5.
Apersonwhoknowinglysells,purchases,manufactures,delivers,orbringsintothisstate,orwhoisknowinglyinactualorconstructivepossessionof,30kilogramsormoreofanymorphine,opium,oxycodone,hydrocodone,codeine,hydromorphone,oranysalt,derivative,isomer,orsaltofanisomerthereof,includingheroin,asdescribedins.
893.
03(1)(b),(2)(a),(3)(c)3.
,or(3)(c)4.
,or30kilogramsormoreofanymixturecontaininganysuchsubstance,commitsthefirstdegreefelonyoftraffickinginillegaldrugs.
Apersonwhohasbeenconvictedofthefirstdegreefelonyoftraffickinginillegaldrugsunderthissubparagraphshallbepunishedbylifeimprisonmentandisineligibleforanyformofdiscretionaryearlyreleaseexceptpardonorexecutiveclemencyorconditionalmedicalreleaseunders.
947.
149.
However,ifthecourtdeterminesthat,inadditiontocommittinganyactspecifiedinthisparagraph:a.
Thepersonintentionallykilledanindividualorcounseled,com-manded,induced,procured,orcausedtheintentionalkillingofanindividualandsuchkillingwastheresult;orb.
Theperson'sconductincommittingthatactledtoanatural,thoughnotinevitable,lethalresult,suchpersoncommitsthecapitalfelonyoftraffickinginillegaldrugs,punishableasprovidedinss.
775.
082and921.
142.
Apersonsentencedforacapitalfelonyunderthisparagraphshallalsobesentencedtopaythemaximumfineprovidedundersubparagraph1.
6.
Apersonwhoknowinglybringsintothisstate60kilogramsormoreofanymorphine,opium,oxycodone,hydrocodone,codeine,hydromorphone,oranysalt,derivative,isomer,orsaltofanisomerthereof,includingheroin,asdescribedins.
893.
03(1)(b),(2)(a),(3)(c)3.
,or(3)(c)4.
,or60kilogramsormoreofanymixturecontaininganysuchsubstance,andwhoknowsthattheprobableresultofsuchimportationwouldbethedeathofaperson,commitscapitalimportationofillegaldrugs,acapitalfelonypunishableasprovidedinss.
775.
082and921.
142.
Apersonsentencedforacapitalfelonyunderthisparagraphshallalsobesentencedtopaythemaximumfineprovidedundersubparagraph1.
Ch.
2018-13LAWSOFFLORIDACh.
2018-1382CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
(f)1.
Anypersonwhoknowinglysells,purchases,manufactures,delivers,orbringsintothisstate,orwhoisknowinglyinactualorconstructivepossessionof,14gramsormoreofamphetamine,asdescribedins.
893.
03(2)(c)2.
,ormethamphetamine,asdescribedins.
893.
03(2)(c)5.
893.
03(2)(c)4.
,orofanymixturecontainingamphetamineormethamphe-tamine,orphenylacetone,phenylaceticacid,pseudoephedrine,orephedrineinconjunctionwithotherchemicalsandequipmentutilizedinthemanufactureofamphetamineormethamphetamine,commitsafelonyofthefirstdegree,whichfelonyshallbeknownas"traffickinginampheta-mine,"punishableasprovidedins.
775.
082,s.
775.
083,ors.
775.
084.
Ifthequantityinvolved:a.
Is14gramsormore,butlessthan28grams,suchpersonshallbesentencedtoamandatoryminimumtermofimprisonmentof3years,andthedefendantshallbeorderedtopayafineof$50,000.
b.
Is28gramsormore,butlessthan200grams,suchpersonshallbesentencedtoamandatoryminimumtermofimprisonmentof7years,andthedefendantshallbeorderedtopayafineof$100,000.
c.
Is200gramsormore,suchpersonshallbesentencedtoamandatoryminimumtermofimprisonmentof15calendaryearsandpayafineof$250,000.
2.
Anypersonwhoknowinglymanufacturesorbringsintothisstate400gramsormoreofamphetamine,asdescribedins.
893.
03(2)(c)2.
,ormethamphetamine,asdescribedins.
893.
03(2)(c)5.
893.
03(2)(c)4.
,orofanymixturecontainingamphetamineormethamphetamine,orphenylace-tone,phenylaceticacid,pseudoephedrine,orephedrineinconjunctionwithotherchemicalsandequipmentusedinthemanufactureofamphetamineormethamphetamine,andwhoknowsthattheprobableresultofsuchmanufactureorimportationwouldbethedeathofanypersoncommitscapitalmanufactureorimportationofamphetamine,acapitalfelonypunishableasprovidedinss.
775.
082and921.
142.
Anypersonsentencedforacapitalfelonyunderthisparagraphshallalsobesentencedtopaythemaximumfineprovidedundersubparagraph1.
Section19.
Paragraphs(b)through(e)and(g)ofsubsection(3)ofsection921.
0022,FloridaStatutes,areamendedtoread:921.
0022CriminalPunishmentCode;offenseseverityrankingchart.
—(3)OFFENSESEVERITYRANKINGCHART(b)LEVEL2Ch.
2018-13LAWSOFFLORIDACh.
2018-1383CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
FloridaStatuteFelonyDegreeDescription379.
2431(1)(e)3.
3rdPossessionof11orfewermarineturtleeggsinviolationoftheMarineTurtleProtectionAct.
379.
2431(1)(e)4.
3rdPossessionofmorethan11marineturtleeggsinviolationoftheMarineTurtleProtectionAct.
403.
413(6)(c)3rdDumpswastelitterexceeding500lbs.
inweightor100cubicfeetinvolumeoranyquantityforcommercialpurposes,orhazar-douswaste.
517.
07(2)3rdFailuretofurnishaprospectusmeetingrequirements.
590.
28(1)3rdIntentionalburningoflands.
784.
05(3)3rdStoringorleavingaloadedfirearmwithinreachofminorwhousesittoinflictinjuryordeath.
787.
04(1)3rdInviolationofcourtorder,take,entice,etc.
,minorbeyondstatelimits.
806.
13(1)(b)3.
3rdCriminalmischief;damage$1,000ormoretopubliccommunicationoranyotherpublicservice.
810.
061(2)3rdImpairingorimpedingtelephoneorpowertoadwelling;facilitatingorfurtheringburglary.
810.
09(2)(e)3rdTrespassingonpostedcommercialhorticul-tureproperty.
812.
014(2)(c)1.
3rdGrandtheft,3rddegree;$300ormorebutlessthan$5,000.
812.
014(2)(d)3rdGrandtheft,3rddegree;$100ormorebutlessthan$300,takenfromunenclosedcurtilageofdwelling.
812.
015(7)3rdPossession,use,orattempteduseofanantishopliftingorinventorycontroldevicecountermeasure.
817.
234(1)(a)2.
3rdFalsestatementinsupportofinsuranceclaim.
817.
481(3)(a)3rdObtaincreditorpurchasewithfalse,expired,counterfeit,etc.
,creditcard,valueover$300.
Ch.
2018-13LAWSOFFLORIDACh.
2018-1384CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
FloridaStatuteFelonyDegreeDescription817.
52(3)3rdFailuretoredeliverhiredvehicle.
817.
543rdWithintenttodefraud,obtainmortgagenote,etc.
,byfalserepresentation.
817.
60(5)3rdDealingincreditcardsofanother.
817.
60(6)(a)3rdForgery;purchasegoods,serviceswithfalsecard.
817.
613rdFraudulentuseofcreditcardsover$100ormorewithin6months.
826.
043rdKnowinglymarriesorhassexualintercoursewithpersontowhomrelated.
831.
013rdForgery.
831.
023rdUtteringforgedinstrument;uttersorpub-lishesalterationwithintenttodefraud.
831.
073rdForgingbankbills,checks,drafts,orpro-missorynotes.
831.
083rdPossessing10ormoreforgednotes,bills,checks,ordrafts.
831.
093rdUtteringforgednotes,bills,checks,drafts,orpromissorynotes.
831.
113rdBringingintothestateforgedbankbills,checks,drafts,ornotes.
832.
05(3)(a)3rdCashingordepositingitemwithintenttodefraud.
843.
083rdFalsepersonation.
893.
13(2)(a)2.
3rdPurchaseofanys.
893.
03(1)(c),(2)(c)1.
,(2)(c)2.
,(2)(c)3.
,(2)(c)5.
,(2)(c)6.
,(2)(c)7.
,(2)(c)8.
,(2)(c)9.
,(2)(c)10.
,(3),or(4)drugsotherthancannabis.
893.
147(2)3rdManufactureordeliveryofdrugparapher-nalia.
(c)LEVEL3Ch.
2018-13LAWSOFFLORIDACh.
2018-1385CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
FloridaStatuteFelonyDegreeDescription119.
10(2)(b)3rdUnlawfuluseofconfidentialinformationfrompolicereports.
316.
066(3)(b)-(d)3rdUnlawfullyobtainingorusingconfidentialcrashreports.
316.
193(2)(b)3rdFelonyDUI,3rdconviction.
316.
1935(2)3rdFleeingorattemptingtoeludelawenforce-mentofficerinpatrolvehiclewithsirenandlightsactivated.
319.
30(4)3rdPossessionbyjunkyardofmotorvehiclewithidentificationnumberplateremoved.
319.
33(1)(a)3rdAlterorforgeanycertificateoftitletoamotorvehicleormobilehome.
319.
33(1)(c)3rdProcureorpasstitleonstolenvehicle.
319.
33(4)3rdWithintenttodefraud,possess,sell,etc.
,ablank,forged,orunlawfullyobtainedtitleorregistration.
327.
35(2)(b)3rdFelonyBUI.
328.
05(2)3rdPossess,sell,orcounterfeitfictitious,stolen,orfraudulenttitlesorbillsofsaleofvessels.
328.
07(4)3rdManufacture,exchange,orpossessvesselwithcounterfeitorwrongIDnumber.
376.
302(5)3rdFraudrelatedtoreimbursementforcleanupexpensesundertheInlandProtectionTrustFund.
379.
2431(1)(e)5.
3rdTaking,disturbing,mutilating,destroying,causingtobedestroyed,transferring,selling,offeringtosell,molesting,orharassingmar-ineturtles,marineturtleeggs,ormarineturtlenestsinviolationoftheMarineTurtleProtectionAct.
379.
2431(1)(e)6.
3rdPossessinganymarineturtlespeciesorhatchling,orpartsthereof,orthenestofanymarineturtlespeciesdescribedintheMarineTurtleProtectionAct.
379.
2431(1)(e)7.
3rdSolicitingtocommitorconspiringtocommitaviolationoftheMarineTurtleProtectionAct.
Ch.
2018-13LAWSOFFLORIDACh.
2018-1386CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
FloridaStatuteFelonyDegreeDescription400.
9935(4)(a)or(b)3rdOperatingaclinic,orofferingservicesre-quiringlicensure,withoutalicense.
400.
9935(4)(e)3rdFilingafalselicenseapplicationorotherrequiredinformationorfailingtoreportinformation.
440.
1051(3)3rdFalsereportofworkers'compensationfraudorretaliationformakingsuchareport.
501.
001(2)(b)2ndTamperswithaconsumerproductorthecontainerusingmateriallyfalse/misleadinginformation.
624.
401(4)(a)3rdTransactinginsurancewithoutacertificateofauthority.
624.
401(4)(b)1.
3rdTransactinginsurancewithoutacertificateofauthority;premiumcollectedlessthan$20,000.
626.
902(1)(a)&(b)3rdRepresentinganunauthorizedinsurer.
697.
083rdEquityskimming.
790.
15(3)3rdPersondirectsanothertodischargefirearmfromavehicle.
806.
10(1)3rdMaliciouslyinjure,destroy,orinterferewithvehiclesorequipmentusedinfirefighting.
806.
10(2)3rdInterfereswithorassaultsfirefighterinperformanceofduty.
810.
09(2)(c)3rdTrespassonpropertyotherthanstructureorconveyancearmedwithfirearmordangerousweapon.
812.
014(2)(c)2.
3rdGrandtheft;$5,000ormorebutlessthan$10,000.
812.
0145(2)(c)3rdTheftfromperson65yearsofageorolder;$300ormorebutlessthan$10,000.
815.
04(5)(b)2ndComputeroffensedevisedtodefraudorob-tainproperty.
817.
034(4)(a)3.
3rdEngagesinschemetodefraud(FloridaCom-municationsFraudAct),propertyvaluedatlessthan$20,000.
Ch.
2018-13LAWSOFFLORIDACh.
2018-1387CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
FloridaStatuteFelonyDegreeDescription817.
2333rdBurningtodefraudinsurer.
817.
234(8)(b)&(c)3rdUnlawfulsolicitationofpersonsinvolvedinmotorvehicleaccidents.
817.
234(11)(a)3rdInsurancefraud;propertyvaluelessthan$20,000.
817.
2363rdFilingafalsemotorvehicleinsuranceappli-cation.
817.
23613rdCreating,marketing,orpresentingafalseorfraudulentmotorvehicleinsurancecard.
817.
413(2)3rdSaleofusedgoodsasnew.
828.
12(2)3rdTorturesanyanimalwithintenttoinflictintensepain,seriousphysicalinjury,ordeath.
831.
28(2)(a)3rdCounterfeitingapaymentinstrumentwithintenttodefraudorpossessingacounterfeitpaymentinstrument.
831.
292ndPossessionofinstrumentsforcounterfeitingdriverlicensesoridentificationcards.
838.
021(3)(b)3rdThreatensunlawfulharmtopublicservant.
843.
193rdInjure,disable,orkillpolicedogorhorse.
860.
15(3)3rdOverchargingforrepairsandparts.
870.
01(2)3rdRiot;incitingorencouraging.
893.
13(1)(a)2.
3rdSell,manufacture,ordelivercannabis(orothers.
893.
03(1)(c),(2)(c)1.
,(2)(c)2.
,(2)(c)3.
,(2)(c)5.
,(2)(c)6.
,(2)(c)7.
,(2)(c)8.
,(2)(c)9.
,(2)(c)10.
,(3),or(4)drugs).
893.
13(1)(d)2.
2ndSell,manufacture,ordelivers.
893.
03(1)(c),(2)(c)1.
,(2)(c)2.
,(2)(c)3.
,(2)(c)5.
,(2)(c)6.
,(2)(c)7.
,(2)(c)8.
,(2)(c)9.
,(2)(c)10.
,(3),or(4)drugswithin1,000feetofuniversity.
893.
13(1)(f)2.
2ndSell,manufacture,ordelivers.
893.
03(1)(c),(2)(c)1.
,(2)(c)2.
,(2)(c)3.
,(2)(c)5.
,(2)(c)6.
,(2)(c)7.
,(2)(c)8.
,(2)(c)9.
,(2)(c)10.
,(3),or(4)drugswithin1,000feetofpublichousingfacility.
893.
13(4)(c)3rdUseorhireofminor;delivertominorothercontrolledsubstances.
Ch.
2018-13LAWSOFFLORIDACh.
2018-1388CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
FloridaStatuteFelonyDegreeDescription893.
13(6)(a)3rdPossessionofanycontrolledsubstanceotherthanfelonypossessionofcannabis.
893.
13(7)(a)8.
3rdWithholdinformationfrompractitionerre-gardingpreviousreceiptoforprescriptionforacontrolledsubstance.
893.
13(7)(a)9.
3rdObtainorattempttoobtaincontrolledsub-stancebyfraud,forgery,misrepresentation,etc.
893.
13(7)(a)10.
3rdAffixfalseorforgedlabeltopackageofcontrolledsubstance.
893.
13(7)(a)11.
3rdFurnishfalseorfraudulentmaterialinfor-mationonanydocumentorrecordrequiredbychapter893.
893.
13(8)(a)1.
3rdKnowinglyassistapatient,otherperson,orownerofananimalinobtainingacontrolledsubstancethroughdeceptive,untrue,orfraudulentrepresentationsinorrelatedtothepractitioner'spractice.
893.
13(8)(a)2.
3rdEmployatrickorschemeinthepractitioner'spracticetoassistapatient,otherperson,orownerofananimalinobtainingacontrolledsubstance.
893.
13(8)(a)3.
3rdKnowinglywriteaprescriptionforacon-trolledsubstanceforafictitiousperson.
893.
13(8)(a)4.
3rdWriteaprescriptionforacontrolledsub-stanceforapatient,otherperson,orananimalifthesolepurposeofwritingtheprescriptionisamonetarybenefitforthepractitioner.
918.
13(1)(a)3rdAlter,destroy,orconcealinvestigationevi-dence.
944.
47(1)(a)1.
&2.
3rdIntroducecontrabandtocorrectionalfacility.
944.
47(1)(c)2ndPossesscontrabandwhileuponthegroundsofacorrectionalinstitution.
985.
7213rdEscapesfromajuvenilefacility(securede-tentionorresidentialcommitmentfacility).
Ch.
2018-13LAWSOFFLORIDACh.
2018-1389CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
(d)LEVEL4FloridaStatuteFelonyDegreeDescription316.
1935(3)(a)2ndDrivingathighspeedorwithwantondis-regardforsafetywhilefleeingorattemptingtoeludelawenforcementofficerwhoisinapatrolvehiclewithsirenandlightsactivated.
499.
0051(1)3rdFailuretomaintainordelivertransactionhistory,transactioninformation,ortransac-tionstatements.
499.
0051(5)2ndKnowingsaleordelivery,orpossessionwithintenttosell,contrabandprescriptiondrugs.
517.
07(1)3rdFailuretoregistersecurities.
517.
12(1)3rdFailureofdealer,associatedperson,orissuerofsecuritiestoregister.
784.
07(2)(b)3rdBatteryoflawenforcementofficer,firefigh-ter,etc.
784.
074(1)(c)3rdBatteryofsexuallyviolentpredatorsfacilitystaff.
784.
0753rdBatteryondetentionorcommitmentfacilitystaff.
784.
0783rdBatteryoffacilityemployeebythrowing,tossing,orexpellingcertainfluidsormateri-als.
784.
08(2)(c)3rdBatteryonaperson65yearsofageorolder.
784.
081(3)3rdBatteryonspecifiedofficialoremployee.
784.
082(3)3rdBatterybydetainedpersononvisitororotherdetainee.
784.
083(3)3rdBatteryoncodeinspector.
784.
0853rdBatteryofchildbythrowing,tossing,pro-jecting,orexpellingcertainfluidsormateri-als.
787.
03(1)3rdInterferencewithcustody;wronglytakesminorfromappointedguardian.
787.
04(2)3rdTake,entice,orremovechildbeyondstatelimitswithcriminalintentpendingcustodyproceedings.
Ch.
2018-13LAWSOFFLORIDACh.
2018-1390CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
FloridaStatuteFelonyDegreeDescription787.
04(3)3rdCarryingchildbeyondstatelineswithcrim-inalintenttoavoidproducingchildatcustodyhearingordeliveringtodesignatedperson.
787.
073rdHumansmuggling.
790.
115(1)3rdExhibitingfirearmorweaponwithin1,000feetofaschool.
790.
115(2)(b)3rdPossessingelectricweaponordevice,de-structivedevice,orotherweapononschoolproperty.
790.
115(2)(c)3rdPossessingfirearmonschoolproperty.
800.
04(7)(c)3rdLewdorlasciviousexhibition;offenderlessthan18years.
810.
02(4)(a)3rdBurglary,orattemptedburglary,ofanun-occupiedstructure;unarmed;noassaultorbattery.
810.
02(4)(b)3rdBurglary,orattemptedburglary,ofanun-occupiedconveyance;unarmed;noassaultorbattery.
810.
063rdBurglary;possessionoftools.
810.
08(2)(c)3rdTrespassonproperty,armedwithfirearmordangerousweapon.
812.
014(2)(c)3.
3rdGrandtheft,3rddegree$10,000ormorebutlessthan$20,000.
812.
014(2)(c)4.
-10.
3rdGrandtheft,3rddegree,awill,firearm,motorvehicle,livestock,etc.
812.
0195(2)3rdDealinginstolenpropertybyuseoftheInternet;propertystolen$300ormore.
817.
505(4)(a)3rdPatientbrokering.
817.
563(1)3rdSellordeliversubstanceotherthancon-trolledsubstanceagreedupon,excludings.
893.
03(5)drugs.
817.
568(2)(a)3rdFraudulentuseofpersonalidentificationinformation.
817.
625(2)(a)3rdFraudulentuseofscanningdevice,skimmingdevice,orreencoder.
Ch.
2018-13LAWSOFFLORIDACh.
2018-1391CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
FloridaStatuteFelonyDegreeDescription817.
625(2)(c)3rdPossess,sell,ordeliverskimmingdevice.
828.
125(1)2ndKill,maim,orcausegreatbodilyharmorpermanentbreedingdisabilitytoanyregis-teredhorseorcattle.
837.
02(1)3rdPerjuryinofficialproceedings.
837.
021(1)3rdMakecontradictorystatementsinofficialproceedings.
838.
0223rdOfficialmisconduct.
839.
13(2)(a)3rdFalsifyingrecordsofanindividualinthecareandcustodyofastateagency.
839.
13(2)(c)3rdFalsifyingrecordsoftheDepartmentofChildrenandFamilies.
843.
0213rdPossessionofaconcealedhandcuffkeybyapersonincustody.
843.
0253rdDeprivelawenforcement,correctional,orcorrectionalprobationofficerofmeansofprotectionorcommunication.
843.
15(1)(a)3rdFailuretoappearwhileonbailforfelony(bondestreatureorbondjumping).
847.
0135(5)(c)3rdLewdorlasciviousexhibitionusingcomputer;offenderlessthan18years.
874.
05(1)(a)3rdEncouragingorrecruitinganothertojoinacriminalgang.
893.
13(2)(a)1.
2ndPurchaseofcocaine(orothers.
893.
03(1)(a),(b),or(d),(2)(a),(2)(b),or(2)(c)5.
(2)(c)4.
drugs).
914.
14(2)3rdWitnessesacceptingbribes.
914.
22(1)3rdForce,threaten,etc.
,witness,victim,orinformant.
914.
23(2)3rdRetaliationagainstawitness,victim,orinformant,nobodilyinjury.
918.
123rdTamperingwithjurors.
934.
2153rdUseoftwo-waycommunicationsdevicetofacilitatecommissionofacrime.
Ch.
2018-13LAWSOFFLORIDACh.
2018-1392CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
(e)LEVEL5FloridaStatuteFelonyDegreeDescription316.
027(2)(a)3rdAccidentsinvolvingpersonalinjuriesotherthanseriousbodilyinjury,failuretostop;leavingscene.
316.
1935(4)(a)2ndAggravatedfleeingoreluding.
316.
80(2)2ndUnlawfulconveyanceoffuel;obtainingfuelfraudulently.
322.
34(6)3rdCarelessoperationofmotorvehiclewithsuspendedlicense,resultingindeathorseriousbodilyinjury.
327.
30(5)3rdVesselaccidentsinvolvingpersonalinjury;leavingscene.
379.
365(2)(c)1.
3rdViolationofrulesrelatingto:willfulmoles-tationofstonecrabtraps,lines,orbuoys;illegalbartering,trading,orsale,conspiringoraidinginsuchbarter,trade,orsale,orsupplying,agreeingtosupply,aidinginsupplying,orgivingawaystonecrabtraptagsorcertificates;making,altering,forging,counterfeiting,orreproducingstonecrabtraptags;possessionofforged,counterfeit,orimitationstonecrabtraptags;andengaginginthecommercialharvestofstonecrabswhilelicenseissuspendedorrevoked.
379.
367(4)3rdWillfulmolestationofacommercialharvest-er'sspinylobstertrap,line,orbuoy.
379.
407(5)(b)3.
3rdPossessionof100ormoreundersizedspinylobsters.
381.
0041(11)(b)3rdDonateblood,plasma,ororgansknowingHIVpositive.
440.
10(1)(g)2ndFailuretoobtainworkers'compensationcoverage.
440.
105(5)2ndUnlawfulsolicitationforthepurposeofmakingworkers'compensationclaims.
440.
381(2)2ndSubmissionoffalse,misleading,orincom-pleteinformationwiththepurposeofavoid-ingorreducingworkers'compensationpre-miums.
Ch.
2018-13LAWSOFFLORIDACh.
2018-1393CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
FloridaStatuteFelonyDegreeDescription624.
401(4)(b)2.
2ndTransactinginsurancewithoutacertificateorauthority;premiumcollected$20,000ormorebutlessthan$100,000.
626.
902(1)(c)2ndRepresentinganunauthorizedinsurer;re-peatoffender.
790.
01(2)3rdCarryingaconcealedfirearm.
790.
1622ndThreattothrowordischargedestructivedevice.
790.
163(1)2ndFalsereportofbomb,explosive,weaponofmassdestruction,oruseoffirearmsinviolentmanner.
790.
221(1)2ndPossessionofshort-barreledshotgunorma-chinegun.
790.
232ndFelonsinpossessionoffirearms,ammunition,orelectronicweaponsordevices.
796.
05(1)2ndLiveonearningsofaprostitute;1stoffense.
800.
04(6)(c)3rdLewdorlasciviousconduct;offenderlessthan18yearsofage.
800.
04(7)(b)2ndLewdorlasciviousexhibition;offender18yearsofageorolder.
806.
111(1)3rdPossess,manufacture,ordispensefirebombwithintenttodamageanystructureorproperty.
812.
0145(2)(b)2ndTheftfromperson65yearsofageorolder;$10,000ormorebutlessthan$50,000.
812.
015(8)3rdRetailtheft;propertystolenisvaluedat$300ormoreandoneormorespecifiedacts.
812.
019(1)2ndStolenproperty;dealinginortraffickingin.
812.
131(2)(b)3rdRobberybysuddensnatching.
812.
16(2)3rdOwning,operating,orconductingachopshop.
817.
034(4)(a)2.
2ndCommunicationsfraud,value$20,000to$50,000.
817.
234(11)(b)2ndInsurancefraud;propertyvalue$20,000ormorebutlessthan$100,000.
Ch.
2018-13LAWSOFFLORIDACh.
2018-1394CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
FloridaStatuteFelonyDegreeDescription817.
2341(1),(2)(a)&(3)(a)3rdFilingfalsefinancialstatements,makingfalseentriesofmaterialfactorfalsestate-mentsregardingpropertyvaluesrelatingtothesolvencyofaninsuringentity.
817.
568(2)(b)2ndFraudulentuseofpersonalidentificationinformation;valueofbenefit,servicesre-ceived,paymentavoided,oramountofinjuryorfraud,$5,000ormoreoruseofpersonalidentificationinformationof10ormoreper-sons.
817.
611(2)(a)2ndTrafficinorpossess5to14counterfeitcreditcardsorrelateddocuments.
817.
625(2)(b)2ndSecondorsubsequentfraudulentuseofscanningdevice,skimmingdevice,orreen-coder.
825.
1025(4)3rdLewdorlasciviousexhibitioninthepresenceofanelderlypersonordisabledadult.
827.
071(4)2ndPossesswithintenttopromoteanyphoto-graphicmaterial,motionpicture,etc.
,whichincludessexualconductbyachild.
827.
071(5)3rdPossess,control,orintentionallyviewanyphotographicmaterial,motionpicture,etc.
,whichincludessexualconductbyachild.
839.
13(2)(b)2ndFalsifyingrecordsofanindividualinthecareandcustodyofastateagencyinvolvinggreatbodilyharmordeath.
843.
013rdResistofficerwithviolencetoperson;resistarrestwithviolence.
847.
0135(5)(b)2ndLewdorlasciviousexhibitionusingcomputer;offender18yearsorolder.
847.
0137(2)&(3)3rdTransmissionofpornographybyelectronicdeviceorequipment.
847.
0138(2)&(3)3rdTransmissionofmaterialharmfultominorstoaminorbyelectronicdeviceorequipment.
874.
05(1)(b)2ndEncouragingorrecruitinganothertojoinacriminalgang;secondorsubsequentoffense.
874.
05(2)(a)2ndEncouragingorrecruitingpersonunder13yearsofagetojoinacriminalgang.
Ch.
2018-13LAWSOFFLORIDACh.
2018-1395CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
FloridaStatuteFelonyDegreeDescription893.
13(1)(a)1.
2ndSell,manufacture,ordelivercocaine(orothers.
893.
03(1)(a),(1)(b),(1)(d),(2)(a),(2)(b),or(2)(c)5.
(2)(c)4.
drugs).
893.
13(1)(c)2.
2ndSell,manufacture,ordelivercannabis(orothers.
893.
03(1)(c),(2)(c)1.
,(2)(c)2.
,(2)(c)3.
,(2)(c)5.
,(2)(c)6.
,(2)(c)7.
,(2)(c)8.
,(2)(c)9.
,(2)(c)10.
,(3),or(4)drugs)within1,000feetofachildcarefacility,school,orstate,county,ormunicipalparkorpubliclyownedrecrea-tionalfacilityorcommunitycenter.
893.
13(1)(d)1.
1stSell,manufacture,ordelivercocaine(orothers.
893.
03(1)(a),(1)(b),(1)(d),(2)(a),(2)(b),or(2)(c)5.
(2)(c)4.
drugs)within1,000feetofuniversity.
893.
13(1)(e)2.
2ndSell,manufacture,ordelivercannabisorotherdrugprohibitedunders.
893.
03(1)(c),(2)(c)1.
,(2)(c)2.
,(2)(c)3.
,(2)(c)5.
,(2)(c)6.
,(2)(c)7.
,(2)(c)8.
,(2)(c)9.
,(2)(c)10.
,(3),or(4)within1,000feetofpropertyusedforreligiousservicesoraspecifiedbusinesssite.
893.
13(1)(f)1.
1stSell,manufacture,ordelivercocaine(orothers.
893.
03(1)(a),(1)(b),(1)(d),or(2)(a),(2)(b),or(2)(c)5.
(2)(c)4.
drugs)within1,000feetofpublichousingfacility.
893.
13(4)(b)2ndUseorhireofminor;delivertominorothercontrolledsubstance.
893.
1351(1)3rdOwnership,lease,orrentalfortraffickinginormanufacturingofcontrolledsubstance.
(g)LEVEL7FloridaStatuteFelonyDegreeDescription316.
027(2)(c)1stAccidentinvolvingdeath,failuretostop;leavingscene.
316.
193(3)(c)2.
3rdDUIresultinginseriousbodilyinjury.
Ch.
2018-13LAWSOFFLORIDACh.
2018-1396CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
FloridaStatuteFelonyDegreeDescription316.
1935(3)(b)1stCausingseriousbodilyinjuryordeathtoanotherperson;drivingathighspeedorwithwantondisregardforsafetywhilefleeingorattemptingtoeludelawenforcementofficerwhoisinapatrolvehiclewithsirenandlightsactivated.
327.
35(3)(c)2.
3rdVesselBUIresultinginseriousbodilyinjury.
402.
319(2)2ndMisrepresentationandnegligenceorinten-tionalactresultingingreatbodilyharm,permanentdisfiguration,permanentdisabil-ity,ordeath.
409.
920(2)(b)1.
a.
3rdMedicaidproviderfraud;$10,000orless.
409.
920(2)(b)1.
b.
2ndMedicaidproviderfraud;morethan$10,000,butlessthan$50,000.
456.
065(2)3rdPracticingahealthcareprofessionwithoutalicense.
456.
065(2)2ndPracticingahealthcareprofessionwithoutalicensewhichresultsinseriousbodilyinjury.
458.
327(1)3rdPracticingmedicinewithoutalicense.
459.
013(1)3rdPracticingosteopathicmedicinewithoutalicense.
460.
411(1)3rdPracticingchiropracticmedicinewithoutalicense.
461.
012(1)3rdPracticingpodiatricmedicinewithoutali-cense.
462.
173rdPracticingnaturopathywithoutalicense.
463.
015(1)3rdPracticingoptometrywithoutalicense.
464.
016(1)3rdPracticingnursingwithoutalicense.
465.
015(2)3rdPracticingpharmacywithoutalicense.
466.
026(1)3rdPracticingdentistryordentalhygienewith-outalicense.
467.
2013rdPracticingmidwiferywithoutalicense.
468.
3663rdDeliveringrespiratorycareserviceswithoutalicense.
Ch.
2018-13LAWSOFFLORIDACh.
2018-1397CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
FloridaStatuteFelonyDegreeDescription483.
828(1)3rdPracticingasclinicallaboratorypersonnelwithoutalicense.
483.
901(7)3rdPracticingmedicalphysicswithoutalicense.
484.
013(1)(c)3rdPreparingordispensingopticaldeviceswithoutaprescription.
484.
0533rdDispensinghearingaidswithoutalicense.
494.
0018(2)1stConvictionofanyviolationofchapter494inwhichthetotalmoneyandpropertyunlaw-fullyobtainedexceeded$50,000andtherewerefiveormorevictims.
560.
123(8)(b)1.
3rdFailuretoreportcurrencyorpaymentin-strumentsexceeding$300butlessthan$20,000byamoneyservicesbusiness.
560.
125(5)(a)3rdMoneyservicesbusinessbyunauthorizedperson,currencyorpaymentinstrumentsexceeding$300butlessthan$20,000.
655.
50(10)(b)1.
3rdFailuretoreportfinancialtransactionsex-ceeding$300butlessthan$20,000byfi-nancialinstitution.
775.
21(10)(a)3rdSexualpredator;failuretoregister;failuretorenewdriverlicenseoridentificationcard;otherregistrationviolations.
775.
21(10)(b)3rdSexualpredatorworkingwherechildrenregularlycongregate.
775.
21(10)(g)3rdFailuretoreportorprovidingfalseinforma-tionaboutasexualpredator;harbororcon-cealasexualpredator.
782.
051(3)2ndAttemptedfelonymurderofapersonbyapersonotherthantheperpetratorortheperpetratorofanattemptedfelony.
782.
07(1)2ndKillingofahumanbeingbytheact,pro-curement,orculpablenegligenceofanother(manslaughter).
782.
0712ndKillingofahumanbeingorunbornchildbytheoperationofamotorvehicleinarecklessmanner(vehicularhomicide).
Ch.
2018-13LAWSOFFLORIDACh.
2018-1398CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
FloridaStatuteFelonyDegreeDescription782.
0722ndKillingofahumanbeingbytheoperationofavesselinarecklessmanner(vesselhomicide).
784.
045(1)(a)1.
2ndAggravatedbattery;intentionallycausinggreatbodilyharmordisfigurement.
784.
045(1)(a)2.
2ndAggravatedbattery;usingdeadlyweapon.
784.
045(1)(b)2ndAggravatedbattery;perpetratorawarevictimpregnant.
784.
048(4)3rdAggravatedstalking;violationofinjunctionorcourtorder.
784.
048(7)3rdAggravatedstalking;violationofcourtorder.
784.
07(2)(d)1stAggravatedbatteryonlawenforcementoffi-cer.
784.
074(1)(a)1stAggravatedbatteryonsexuallyviolentpre-datorsfacilitystaff.
784.
08(2)(a)1stAggravatedbatteryonaperson65yearsofageorolder.
784.
081(1)1stAggravatedbatteryonspecifiedofficialoremployee.
784.
082(1)1stAggravatedbatterybydetainedpersononvisitororotherdetainee.
784.
083(1)1stAggravatedbatteryoncodeinspector.
787.
06(3)(a)2.
1stHumantraffickingusingcoercionforlaborandservicesofanadult.
787.
06(3)(e)2.
1stHumantraffickingusingcoercionforlaborandservicesbythetransferortransportofanadultfromoutsideFloridatowithinthestate.
790.
07(4)1stSpecifiedweaponsviolationsubsequenttopreviousconvictionofs.
790.
07(1)or(2).
790.
16(1)1stDischargeofamachinegununderspecifiedcircumstances.
790.
165(2)2ndManufacture,sell,possess,ordeliverhoaxbomb.
790.
165(3)2ndPossessing,displaying,orthreateningtouseanyhoaxbombwhilecommittingorat-temptingtocommitafelony.
Ch.
2018-13LAWSOFFLORIDACh.
2018-1399CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
FloridaStatuteFelonyDegreeDescription790.
166(3)2ndPossessing,selling,using,orattemptingtouseahoaxweaponofmassdestruction.
790.
166(4)2ndPossessing,displaying,orthreateningtouseahoaxweaponofmassdestructionwhilecommittingorattemptingtocommitafelony.
790.
231st,PBLPossessionofafirearmbyapersonwhoqualifiesforthepenaltyenhancementspro-videdforins.
874.
04.
794.
08(4)3rdFemalegenitalmutilation;consentbyaparent,guardian,orapersonincustodialauthoritytoavictimyoungerthan18yearsofage.
796.
05(1)1stLiveonearningsofaprostitute;2ndoffense.
796.
05(1)1stLiveonearningsofaprostitute;3rdandsubsequentoffense.
800.
04(5)(c)1.
2ndLewdorlasciviousmolestation;victimyoungerthan12yearsofage;offenderyoungerthan18yearsofage.
800.
04(5)(c)2.
2ndLewdorlasciviousmolestation;victim12yearsofageorolderbutyoungerthan16yearsofage;offender18yearsofageorolder.
800.
04(5)(e)1stLewdorlasciviousmolestation;victim12yearsofageorolderbutyoungerthan16years;offender18yearsorolder;priorcon-victionforspecifiedsexoffense.
806.
01(2)2ndMaliciouslydamagestructurebyfireorex-plosive.
810.
02(3)(a)2ndBurglaryofoccupieddwelling;unarmed;noassaultorbattery.
810.
02(3)(b)2ndBurglaryofunoccupieddwelling;unarmed;noassaultorbattery.
810.
02(3)(d)2ndBurglaryofoccupiedconveyance;unarmed;noassaultorbattery.
810.
02(3)(e)2ndBurglaryofauthorizedemergencyvehicle.
Ch.
2018-13LAWSOFFLORIDACh.
2018-13100CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
FloridaStatuteFelonyDegreeDescription812.
014(2)(a)1.
1stPropertystolen,valuedat$100,000ormoreorasemitrailerdeployedbyalawenforce-mentofficer;propertystolenwhilecausingotherpropertydamage;1stdegreegrandtheft.
812.
014(2)(b)2.
2ndPropertystolen,cargovaluedatlessthan$50,000,grandtheftin2nddegree.
812.
014(2)(b)3.
2ndPropertystolen,emergencymedicalequip-ment;2nddegreegrandtheft.
812.
014(2)(b)4.
2ndPropertystolen,lawenforcementequipmentfromauthorizedemergencyvehicle.
812.
0145(2)(a)1stTheftfromperson65yearsofageorolder;$50,000ormore.
812.
019(2)1stStolenproperty;initiates,organizes,plans,etc.
,thetheftofpropertyandtrafficsinstolenproperty.
812.
131(2)(a)2ndRobberybysuddensnatching.
812.
133(2)(b)1stCarjacking;nofirearm,deadlyweapon,orotherweapon.
817.
034(4)(a)1.
1stCommunicationsfraud,valuegreaterthan$50,000.
817.
234(8)(a)2ndSolicitationofmotorvehicleaccidentvictimswithintenttodefraud.
817.
234(9)2ndOrganizing,planning,orparticipatinginanintentionalmotorvehiclecollision.
817.
234(11)(c)1stInsurancefraud;propertyvalue$100,000ormore.
817.
2341(2)(b)&(3)(b)1stMakingfalseentriesofmaterialfactorfalsestatementsregardingpropertyvaluesrelat-ingtothesolvencyofaninsuringentitywhichareasignificantcauseoftheinsolvencyofthatentity.
817.
535(2)(a)3rdFilingfalselienorotherunauthorizeddocu-ment.
817.
611(2)(b)2ndTrafficinorpossess15to49counterfeitcreditcardsorrelateddocuments.
Ch.
2018-13LAWSOFFLORIDACh.
2018-13101CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
FloridaStatuteFelonyDegreeDescription825.
102(3)(b)2ndNeglectinganelderlypersonordisabledadultcausinggreatbodilyharm,disability,ordisfigurement.
825.
103(3)(b)2ndExploitinganelderlypersonordisabledadultandpropertyisvaluedat$10,000ormore,butlessthan$50,000.
827.
03(2)(b)2ndNeglectofachildcausinggreatbodilyharm,disability,ordisfigurement.
827.
04(3)3rdImpregnationofachildunder16yearsofagebyperson21yearsofageorolder.
837.
05(2)3rdGivingfalseinformationaboutallegedcapitalfelonytoalawenforcementofficer.
838.
0152ndBribery.
838.
0162ndUnlawfulcompensationorrewardforofficialbehavior.
838.
021(3)(a)2ndUnlawfulharmtoapublicservant.
838.
222ndBidtampering.
843.
0855(2)3rdImpersonationofapublicofficeroremployee.
843.
0855(3)3rdUnlawfulsimulationoflegalprocess.
843.
0855(4)3rdIntimidationofapublicofficeroremployee.
847.
0135(3)3rdSolicitationofachild,viaacomputerservice,tocommitanunlawfulsexact.
847.
0135(4)2ndTravelingtomeetaminortocommitanunlawfulsexact.
872.
062ndAbuseofadeadhumanbody.
874.
05(2)(b)1stEncouragingorrecruitingpersonunder13tojoinacriminalgang;secondorsubsequentoffense.
874.
101st,PBLKnowinglyinitiates,organizes,plans,fi-nances,directs,manages,orsupervisescriminalgang-relatedactivity.
Ch.
2018-13LAWSOFFLORIDACh.
2018-13102CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
FloridaStatuteFelonyDegreeDescription893.
13(1)(c)1.
1stSell,manufacture,ordelivercocaine(orotherdrugprohibitedunders.
893.
03(1)(a),(1)(b),(1)(d),(2)(a),(2)(b),or(2)(c)5.
(2)(c)4.
)within1,000feetofachildcarefacility,school,orstate,county,ormunicipalparkorpubliclyownedrecreationalfacilityorcommunitycenter.
893.
13(1)(e)1.
1stSell,manufacture,ordelivercocaineorotherdrugprohibitedunders.
893.
03(1)(a),(1)(b),(1)(d),(2)(a),(2)(b),or(2)(c)5.
(2)(c)4.
,within1,000feetofpropertyusedforreligiousservicesoraspecifiedbusinesssite.
893.
13(4)(a)1stUseorhireofminor;delivertominorothercontrolledsubstance.
893.
135(1)(a)1.
1stTraffickingincannabis,morethan25lbs.
,lessthan2,000lbs.
893.
135(1)(b)1.
a.
1stTraffickingincocaine,morethan28grams,lessthan200grams.
893.
135(1)(c)1.
a.
1stTraffickinginillegaldrugs,morethan4grams,lessthan14grams.
893.
135(1)(c)2.
a.
1stTraffickinginhydrocodone,14gramsormore,lessthan28grams.
893.
135(1)(c)2.
b.
1stTraffickinginhydrocodone,28gramsormore,lessthan50grams.
893.
135(1)(c)3.
a.
1stTraffickinginoxycodone,7gramsormore,lessthan14grams.
893.
135(1)(c)3.
b.
1stTraffickinginoxycodone,14gramsormore,lessthan25grams.
893.
135(1)(c)4.
b.
(I)1stTraffickinginfentanyl,4gramsormore,lessthan14grams.
893.
135(1)(d)1.
a.
1stTraffickinginphencyclidine,28gramsormore,lessthan200grams.
893.
135(1)(e)1.
1stTraffickinginmethaqualone,200gramsormore,lessthan5kilograms.
893.
135(1)(f)1.
1stTraffickinginamphetamine,14gramsormore,lessthan28grams.
Ch.
2018-13LAWSOFFLORIDACh.
2018-13103CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
FloridaStatuteFelonyDegreeDescription893.
135(1)(g)1.
a.
1stTraffickinginflunitrazepam,4gramsormore,lessthan14grams.
893.
135(1)(h)1.
a.
1stTraffickingingamma-hydroxybutyricacid(GHB),1kilogramormore,lessthan5kilograms.
893.
135(1)(j)1.
a.
1stTraffickingin1,4-Butanediol,1kilogramormore,lessthan5kilograms.
893.
135(1)(k)2.
a.
1stTraffickinginPhenethylamines,10gramsormore,lessthan200grams.
893.
135(1)(m)2.
a.
1stTraffickinginsyntheticcannabinoids,280gramsormore,lessthan500grams.
893.
135(1)(m)2.
b.
1stTraffickinginsyntheticcannabinoids,500gramsormore,lessthan1,000grams.
893.
135(1)(n)2.
a.
1stTraffickinginn-benzylphenethylamines,14gramsormore,lessthan100grams.
893.
1351(2)2ndPossessionofplacefortraffickinginormanufacturingofcontrolledsubstance.
896.
101(5)(a)3rdMoneylaundering,financialtransactionsexceeding$300butlessthan$20,000.
896.
104(4)(a)1.
3rdStructuringtransactionstoevadereportingorregistrationrequirements,financialtransactionsexceeding$300butlessthan$20,000.
943.
0435(4)(c)2ndSexualoffendervacatingpermanentresi-dence;failuretocomplywithreportingre-quirements.
943.
0435(8)2ndSexualoffender;remainsinstateafterin-dicatingintenttoleave;failuretocomplywithreportingrequirements.
943.
0435(9)(a)3rdSexualoffender;failuretocomplywithre-portingrequirements.
943.
0435(13)3rdFailuretoreportorprovidingfalseinforma-tionaboutasexualoffender;harbororconcealasexualoffender.
943.
0435(14)3rdSexualoffender;failuretoreportandrereg-ister;failuretorespondtoaddressverifica-tion;providingfalseregistrationinformation.
Ch.
2018-13LAWSOFFLORIDACh.
2018-13104CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
FloridaStatuteFelonyDegreeDescription944.
607(9)3rdSexualoffender;failuretocomplywithre-portingrequirements.
944.
607(10)(a)3rdSexualoffender;failuretosubmittothetakingofadigitizedphotograph.
944.
607(12)3rdFailuretoreportorprovidingfalseinforma-tionaboutasexualoffender;harbororconcealasexualoffender.
944.
607(13)3rdSexualoffender;failuretoreportandrereg-ister;failuretorespondtoaddressverifica-tion;providingfalseregistrationinformation.
985.
4815(10)3rdSexualoffender;failuretosubmittothetakingofadigitizedphotograph.
985.
4815(12)3rdFailuretoreportorprovidingfalseinforma-tionaboutasexualoffender;harbororconcealasexualoffender.
985.
4815(13)3rdSexualoffender;failuretoreportandrereg-ister;failuretorespondtoaddressverifica-tion;providingfalseregistrationinformation.
Section20.
Forthe2018-2019fiscalyear:(1)Thenonrecurringsumof$27,035,532isappropriatedfromtheFederalGrantsTrustFundtotheDepartmentofChildrenandFamiliesforexpenditureoffundsrelatedtothesecondyearoftheStateTargetedResponsetotheOpioidCrisisgrant,toincreaseaccesstotreatment,reduceunmettreatmentneeds,andreduceopioidoverdose-relateddeathsthroughprevention,treatment,andrecoveryactivities.
(2)Toenhancetheentiresubstanceabusecontinuumofcare,thesumof$14,626,911inrecurringfundsisappropriatedfromtheGeneralRevenueFundtotheDepartmentofChildrenandFamiliesforcommunity-basedservicestoaddresstheopioidcrisis,including,butnotlimitedto,outreach,addictiontreatment,andrecoverysupportservices.
Fundingunderthissubsectionshallbeusedtoexpandcapacitytoincreaseaccesstoandreducewaitlistsfortreatment;increaseeffortstoeffectivelyengageandretainintreatmentyouth,pregnantwomen,high-riskpopulations,andhighutilizersofacutecareservices;andfurtherdeveloparecovery-basedmodelofcare.
Fundingforspecificservicesmayinclude,butarenotlimitedto,casemanagement,residentialservices,outpatientservices,aftercareservices,andmedication-assistedtreatment.
Medication-assistedtreatmentmayinclude,butisnotlimitedto,methadone,buprenorphine,andnaltrexoneextendedreleaseinjectable.
Ch.
2018-13LAWSOFFLORIDACh.
2018-13105CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.
(3)Therecurringsumof$5,000,000fromtheGeneralRevenueFundisappropriatedtotheDepartmentofHealthforthepurchaseofemergencyopioidantagoniststobemadeavailabletoemergencyresponders.
(4)Therecurringsumof$6millionfromtheGeneralRevenueFundisappropriatedtotheOfficeofStateCourtAdministratorformedication-assistedtreatmentofsubstanceabusedisordersinindividualsinvolvedinthecriminaljusticesystem,individualswhohaveahighlikelihoodofbecominginvolvedinthecriminaljusticesystem,orindividualswhoareincourt-ordered,community-baseddrugtreatment.
Suchmedication-assistedtreatmentmayinclude,butisnotlimitedto,methadone,buprenorphine,andnaltrexoneextendedreleaseinjectable.
(5)Thesumsof$873,089inrecurringfundsand$117,700innonrecur-ringfundsareappropriatedfromtheGeneralRevenueFundtotheDepartmentofHealthforimprovementstothePrescriptionDrugMonitor-ingProgramsystempursuanttos.
893.
055,FloridaStatutes.
Section21.
Exceptasotherwiseexpresslyprovidedinthisact,thisactshalltakeeffectJuly1,2018.
ApprovedbytheGovernorMarch19,2018.
FiledinOfficeSecretaryofStateMarch19,2018.
Ch.
2018-13LAWSOFFLORIDACh.
2018-13106CODING:Wordsstrickenaredeletions;wordsunderlinedareadditions.